data_1l1p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l1p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.657 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.744 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 HG21 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 59' ' ' ILE . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.757 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.465 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.402 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.711 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.543 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.558 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.52 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.435 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.425 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 83' ' ' LEU . 1.7 p-10 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.646 HD21 ' CZ ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.676 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.676 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.757 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.744 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.129 0.49 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG11 ' CG2' ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.65 HD11 HG12 ' A' ' 59' ' ' ILE . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.632 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.522 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 59' ' ' ILE . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.494 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' O ' ' O ' ' A' ' 92' ' ' ILE . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.621 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.706 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.706 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.712 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' CG2' ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.454 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.635 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.623 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.623 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.662 HD13 HG12 ' A' ' 59' ' ' ILE . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.415 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.598 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.623 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 15' ' ' VAL . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.769 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.431 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.516 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG12 ' CE2' ' A' ' 55' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.457 HG23 ' HB1' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.405 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.702 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' A' ' 73' ' ' THR . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.723 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.656 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 112.68 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.658 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.673 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 94' ' ' LEU . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.577 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.705 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.699 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.546 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.752 ' HA ' HD11 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.752 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 58' ' ' GLY . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.616 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.414 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.705 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.787 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.673 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.179 0.514 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 46' ' ' MET . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.965 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.589 ' HB ' ' CG2' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.604 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.756 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.698 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.409 ' HG2' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 59' ' ' ILE . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.762 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.605 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 59' ' ' ILE . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CE1' HD22 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.404 ' ND2' HD13 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.686 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.703 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.965 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.2 0.524 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.614 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.601 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.761 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.72 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.689 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.72 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.604 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.773 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.4 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.475 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.785 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.785 HD13 ' HA ' ' A' ' 55' ' ' PHE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.56 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.508 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.761 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.614 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.56 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 17' ' ' ALA . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.628 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.72 HD11 HG12 ' A' ' 59' ' ' ILE . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.641 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.641 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.573 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 58' ' ' GLY . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.56 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.535 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.496 HG21 ' CE2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CE1' HD22 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.712 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.729 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.44 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.564 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' N ' HG21 ' A' ' 15' ' ' VAL . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.63 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG12 ' CG2' ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.619 HD13 HG12 ' A' ' 59' ' ' ILE . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HG12 ' A' ' 29' ' ' VAL . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.58 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.757 ' HA ' HD11 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.477 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE1' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.72 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.028 0.442 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.573 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.699 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.778 HG13 ' HB3' ' A' ' 42' ' ' PHE . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.725 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.778 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.765 ' HA ' HD12 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 51' ' ' MET . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 55' ' ' PHE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.572 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.508 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.492 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.704 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.704 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.725 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.572 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.699 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.751 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.755 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' HA3' ' CE ' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.684 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.473 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.647 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.751 ' HA ' HD12 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.616 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.549 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.401 ' ND2' HD11 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.721 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.721 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.684 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.914 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.113 0.482 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.597 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.527 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.5 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.754 HG21 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.755 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.748 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.589 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.468 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' CG ' ' HE2' ' A' ' 46' ' ' MET . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.597 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.43 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.601 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' ND2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.721 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.721 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.755 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.754 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.473 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.681 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 10' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.769 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.588 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.74 HG13 ' HB3' ' A' ' 42' ' ' PHE . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.602 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.503 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.543 ' HG3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.711 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 55' ' ' PHE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.607 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.555 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.526 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.548 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.518 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.538 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.622 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.588 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 46' ' ' MET . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.554 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.671 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.755 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.496 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.69 ' HG3' HG22 ' A' ' 15' ' ' VAL . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 59' ' ' ILE . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.786 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 3.8 m-70 -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.616 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.496 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.407 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.629 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.712 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.755 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.616 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.459 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.7 ppt_? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.581 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.841 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.74 HG22 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.793 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.661 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 43' ' ' VAL . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.645 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.66 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.834 ' HA ' HD12 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 55' ' ' PHE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 58' ' ' GLY . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.784 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.784 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.527 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.735 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.637 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.768 HG13 ' HB3' ' A' ' 25' ' ' PHE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.727 ' N ' HG23 ' A' ' 92' ' ' ILE . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.793 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.487 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.046 0.45 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.818 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.919 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.724 HG22 ' CG2' ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 89' ' ' LYS . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.659 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 52' ' ' ILE . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.815 ' HA ' HD12 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 57' ' ' ASP . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.455 ' CD2' ' CG ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.668 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' CE2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.436 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.637 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.608 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.71 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.71 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.73 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.85 ' HA ' HG21 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.547 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.574 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.648 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.592 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.714 HD12 HG12 ' A' ' 59' ' ' ILE . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.596 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.479 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HB3' HD13 ' A' ' 44' ' ' LEU . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.714 HG12 HD12 ' A' ' 23' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.494 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.585 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 92' ' ' ILE . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.727 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.727 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.751 HG12 ' CB ' ' A' ' 25' ' ' PHE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.592 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.656 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.496 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.682 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' CB ' ' A' ' 97' ' ' VAL . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.735 HG13 ' HB3' ' A' ' 42' ' ' PHE . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.631 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.752 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.656 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.484 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.511 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.522 HG21 ' CE2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.528 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.631 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.768 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.55 HD22 ' HA2' ' A' ' 61' ' ' GLY . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.619 ' CB ' HG13 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.682 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.555 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.699 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' CG2' ' A' ' 97' ' ' VAL . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.704 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.673 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.5 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' ILE . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.46 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.544 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.54 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE1' HD23 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.715 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG23 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.699 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.4 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.146 0.498 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.834 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 HG22 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.461 HD12 ' CG2' ' A' ' 92' ' ' ILE . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.694 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.563 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 43' ' ' VAL . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.794 ' HA ' HD12 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.556 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.476 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 90' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.549 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.421 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.489 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 80' ' ' ALA . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.715 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.715 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.694 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.536 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.834 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.614 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.511 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.603 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.603 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.596 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.544 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.548 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.614 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.436 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.512 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' HD23 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.692 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.692 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.714 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.868 ' HA ' HG23 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.79 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 121.345 0.593 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.646 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.864 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.768 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 97' ' ' VAL . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.616 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.654 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' GLY . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.405 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 58' ' ' GLY . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.515 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.645 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.864 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.768 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.58 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' A' ' 42' ' ' PHE . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.677 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.442 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.77 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.494 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.736 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.521 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.508 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD2' HD23 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.535 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.477 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.694 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.697 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.697 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.675 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.689 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.73 HG12 ' HB3' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 37' ' ' GLY . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.737 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.789 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HG11 ' A' ' 29' ' ' VAL . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.73 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.749 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 55' ' ' PHE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.545 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.598 ' CE1' HD23 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.598 HD23 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.789 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.646 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 72' ' ' VAL . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.693 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.609 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.403 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.08 0.466 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.963 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.737 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.541 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 43' ' ' VAL . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.704 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' CD1' ' CG1' ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.711 ' HA ' HD12 ' A' ' 59' ' ' ILE . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.448 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.421 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.737 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.786 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.963 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.496 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.284 0.564 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 46' ' ' MET . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.684 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.685 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD11 HG12 ' A' ' 59' ' ' ILE . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.744 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.839 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' N ' HG21 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.639 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 58' ' ' GLY . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.453 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 92' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.403 ' CD1' HD11 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' A' ' 90' ' ' PHE . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.596 ' CE1' HD22 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.618 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.839 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.744 HG13 ' HB3' ' A' ' 25' ' ' PHE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 21' ' ' VAL . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.684 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.678 HD13 HG12 ' A' ' 59' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.767 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.608 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.58 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.799 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 46' ' ' MET . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.455 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.605 ' CE1' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.605 HD21 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.767 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.551 ' HA ' HG23 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.198 0.523 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.633 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.888 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.75 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 59' ' ' ILE . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 42' ' ' PHE . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.575 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.71 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.745 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.7 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD11 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HG3' ' CD2' ' A' ' 62' ' ' HIS . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.494 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.749 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CD2' HD22 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.485 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.495 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.723 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.699 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.73 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.51 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.888 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.119 0.485 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.584 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.672 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG11 ' CG2' ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 42' ' ' PHE . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' VAL . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.823 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.572 ' HG3' HG23 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 44' ' ' LEU . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.546 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.412 ' ND2' HD13 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.735 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.735 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.721 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.511 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.672 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.935 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 59' ' ' ILE . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.651 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.572 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.704 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.704 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.763 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.695 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HA ' HD12 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 58' ' ' GLY . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.596 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.559 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.603 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 73' ' ' THR . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' SER . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.651 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.795 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.473 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.5 ' CG2' HG13 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.614 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.935 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.799 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.562 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.674 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.488 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.488 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.55 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.506 ' CG ' HD23 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.718 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.734 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.733 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 112.98 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -153.57 -59.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.9 mtm 59.72 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.59 -58.85 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.68 151.38 39.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -104.87 133.48 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.058 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -140.3 151.76 45.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.082 0.468 . . . . 0.0 111.258 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -147.48 35.15 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.196 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 -73.41 134.02 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.319 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.657 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.744 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 HG21 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.78 HD12 HG12 ' A' ' 59' ' ' ILE . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.757 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.66 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.465 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.402 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.483 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.711 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.543 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.798 ' HA ' HD11 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.558 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.52 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.646 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.425 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 83' ' ' LEU . 1.7 p-10 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.646 HD21 ' CZ ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HG3' ' CZ ' ' A' ' 34' ' ' PHE . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.66 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.676 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.676 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.757 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.657 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.744 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.14 143.37 50.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 5.2 tt0 -150.12 82.08 1.37 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.421 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.513 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.6 mp -74.47 -55.43 2.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 97.8 Cg_endo -78.14 139.5 17.03 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.444 2.096 . . . . 0.0 112.108 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.23 121.02 15.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.685 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.13 103.06 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.853 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -164.32 140.68 6.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.0 110.818 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.79 160.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ttt -158.38 95.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.89 101.32 14.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.983 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.8 163.55 18.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -115.58 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.406 ' HH2' ' CD ' ' A' ' 20' ' ' ARG . 59.9 m95 -142.58 160.44 40.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.336 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -147.29 38.5 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.916 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 -72.24 131.96 43.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.217 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG11 ' CG2' ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.65 HD11 HG12 ' A' ' 59' ' ' ILE . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.712 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.552 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.632 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.522 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 59' ' ' ILE . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.494 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' O ' ' O ' ' A' ' 92' ' ' ILE . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' CD1' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.706 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.706 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.712 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.592 HD13 ' CG2' ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.454 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.635 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.623 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.15 164.04 11.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 100.24 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.379 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mt -74.27 116.29 51.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.906 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.95 120.52 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.473 2.116 . . . . 0.0 112.549 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -74.85 -34.5 62.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.873 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -178.42 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.919 -0.073 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 p -103.4 101.89 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -94.46 -35.82 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.254 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 111.11 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -70.53 125.09 25.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.47 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -132.0 156.5 46.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -138.73 176.61 8.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -140.13 16.03 2.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.22 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 -68.53 134.18 49.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.13 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.623 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.593 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.666 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.662 HD13 HG12 ' A' ' 59' ' ' ILE . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.415 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.598 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.623 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.602 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 15' ' ' VAL . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.769 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.769 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.431 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.656 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.516 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG12 ' CE2' ' A' ' 55' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.457 HG23 ' HB1' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD22 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.405 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.702 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' A' ' 73' ' ' THR . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.723 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.656 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -63.57 140.26 58.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.87 68.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 5.5 mp -75.02 -58.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.295 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 36.7 Cg_endo -65.52 136.68 47.49 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.332 2.021 . . . . 0.0 112.285 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -94.39 116.21 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.6 141.7 37.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.895 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.65 138.63 38.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.375 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -115.96 139.61 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.58 120.45 26.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -92.9 -26.95 17.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.024 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.83 147.93 41.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.196 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -127.05 137.09 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.489 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 23.3 m95 -136.44 160.08 39.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -146.64 37.2 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.33 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -72.54 132.71 44.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.68 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.658 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.673 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.711 HG23 ' HA ' ' A' ' 94' ' ' LEU . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.577 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.705 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.546 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.752 ' HA ' HD11 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.752 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 58' ' ' GLY . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.616 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.414 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' CE2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.54 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.705 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.787 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.673 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.22 176.28 5.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 177.96 72.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.979 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 92.64 4.71 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.05 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.07 112.18 2.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.377 2.052 . . . . 0.0 112.538 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 136.68 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.84 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.69 179.42 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.74 149.54 48.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.41 95.57 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.0 138.04 47.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.13 151.18 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.041 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.34 138.38 41.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.275 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 44.5 m95 -139.29 156.56 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.523 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -147.17 31.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 -70.78 137.19 49.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.201 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' A' ' 46' ' ' MET . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.965 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.589 ' HB ' ' CG2' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.703 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.604 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.756 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.698 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.409 ' HG2' ' HE3' ' A' ' 46' ' ' MET . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HA ' HD11 ' A' ' 59' ' ' ILE . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.762 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.605 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 59' ' ' ILE . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.523 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.565 ' CE1' HD22 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.404 ' ND2' HD13 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.686 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.703 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.965 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.77 168.48 13.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -165.69 104.4 0.7 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.668 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 mt -74.41 151.72 87.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.331 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.47 132.3 50.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.195 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -97.39 -69.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.756 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.34 109.55 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.902 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -83.31 147.75 27.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -142.14 143.09 32.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -133.92 158.68 42.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -95.96 -71.78 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.55 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.9 150.94 50.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.607 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 54.8 m95 -144.0 166.86 23.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.227 0.537 . . . . 0.0 111.583 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 8' ' ' TRP . 1.4 mmmt -143.65 16.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.235 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 -65.69 140.74 58.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.298 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.614 ' CG2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.601 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.761 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.72 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.689 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.72 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.604 ' O ' HD12 ' A' ' 23' ' ' ILE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.773 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.4 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.475 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.785 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.785 HD13 ' HA ' ' A' ' 55' ' ' PHE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.56 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.508 ' HD2' ' CD1' ' A' ' 78' ' ' TYR . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 29' ' ' VAL . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.761 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.614 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.48 139.29 58.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -164.74 84.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.723 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.5 mp -74.73 -58.89 1.6 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.164 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 32.1 Cg_exo -57.99 145.65 90.63 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.009 1.806 . . . . 0.0 111.99 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.83 123.07 25.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.97 126.56 47.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.945 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.91 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -98.14 169.21 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -142.77 -177.73 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 mmm -102.75 161.37 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -55.49 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.12 159.82 28.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.97 150.64 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -145.6 166.16 26.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HE2' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.23 26.77 1.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 -61.01 139.1 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.977 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.56 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 17' ' ' ALA . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.628 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.72 HD11 HG12 ' A' ' 59' ' ' ILE . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.641 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.641 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.573 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.668 HD12 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.787 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 58' ' ' GLY . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.56 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.828 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.535 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.496 HG21 ' CE2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CE1' HD22 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.712 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.729 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.44 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 166.32 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -171.71 61.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.245 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD11 ' N ' ' A' ' 102' ' ' LEU . 9.6 mp -74.55 148.35 85.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.49 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.38 121.24 8.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.681 2.254 . . . . 0.0 112.231 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.69 96.49 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.21 101.07 13.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.902 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -139.35 -48.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -135.87 160.51 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -120.27 -54.2 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.77 -177.22 4.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.762 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.92 23.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -104.92 139.64 39.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.589 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 47.2 m95 -139.88 157.1 46.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.633 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -147.12 28.47 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.134 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 -71.99 135.26 46.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' N ' HG21 ' A' ' 15' ' ' VAL . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.63 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG12 ' CG2' ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.619 HD13 HG12 ' A' ' 59' ' ' ILE . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD1' HG12 ' A' ' 29' ' ' VAL . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HE3' ' N ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.58 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.757 ' HA ' HD11 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 55' ' ' PHE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.477 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE1' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.72 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? -65.07 173.79 2.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 173.4 92.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.666 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mt -74.42 143.43 79.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.4 135.66 37.31 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.518 2.145 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.94 -45.12 9.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.56 93.66 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.815 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 m -141.31 165.14 28.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -169.83 128.89 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 tpp -97.95 129.88 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -68.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.97 154.21 36.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.77 149.48 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -144.42 167.32 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.274 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.87 20.5 1.28 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.17 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 -68.84 139.52 55.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.066 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.573 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.699 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.778 HG13 ' HB3' ' A' ' 42' ' ' PHE . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.725 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.778 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.765 ' HA ' HD12 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HA ' ' HE3' ' A' ' 51' ' ' MET . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 55' ' ' PHE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.736 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.572 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.508 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.492 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.531 HG23 ' CE2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.704 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.704 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.725 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.572 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.699 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.751 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.61 146.28 44.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -156.01 61.68 0.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.342 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.652 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.5 mp -75.71 -51.09 3.16 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.032 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.652 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 20.2 Cg_exo -65.69 130.89 26.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.312 2.008 . . . . 0.0 111.888 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.2 38.82 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.11 -175.49 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.681 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.87 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.92 -38.73 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -107.33 143.29 35.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.64 102.06 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.6 121.69 24.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.025 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.74 155.93 26.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.86 138.57 48.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.766 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -138.45 152.45 48.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.133 0.492 . . . . 0.0 111.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 104' ' ' GLU . 3.5 ptmt -147.42 30.66 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.755 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -67.36 142.1 56.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 -178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' HA3' ' CE ' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.684 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.473 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.647 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.751 ' HA ' HD12 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.616 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.549 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.401 ' ND2' HD11 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.655 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.721 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.721 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.684 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.914 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.98 169.45 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -179.38 112.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.409 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.488 ' HG ' HH12 ' A' ' 100' ' ' ARG . 3.6 mt -74.68 -52.81 3.48 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.033 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 41.6 Cg_endo -67.28 132.8 28.61 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.728 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.589 ' HA ' ' NZ ' ' A' ' 9' ' ' LYS . 3.7 mm-40 -84.73 -53.49 5.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.78 88.94 2.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.785 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 60.5 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -141.34 179.31 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.987 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -141.7 75.06 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -52.14 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.04 148.02 26.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.12 160.1 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 3.8 ptmt -147.18 29.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.965 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 -62.3 136.79 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.098 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.597 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.527 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.5 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.754 HG21 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.755 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.748 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.585 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.711 HD13 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.589 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.468 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' CG ' ' HE2' ' A' ' 46' ' ' MET . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.597 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.43 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.601 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' CE2' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' ND2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.721 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.721 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.755 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.754 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.473 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.681 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -67.22 168.55 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 19.2 tt0 -170.04 61.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.521 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 102' ' ' LEU . 6.7 mp -74.41 139.73 75.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.868 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 112.94 2.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.199 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.13 -57.95 2.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.67 127.7 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.802 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.6 -50.63 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -148.95 102.86 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.13 122.72 47.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.72 170.16 16.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.2 152.28 22.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -130.04 159.32 37.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -136.48 178.15 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.138 0.494 . . . . 0.0 111.209 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -135.31 11.77 3.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.337 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.769 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -64.58 136.02 56.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.033 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.528 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.588 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.74 HG13 ' HB3' ' A' ' 42' ' ' PHE . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.602 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.503 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.543 ' HG3' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.711 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 55' ' ' PHE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.607 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.555 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.526 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.548 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.518 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.538 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.622 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.588 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -60.76 152.43 26.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -178.88 69.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.379 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.9 mp -74.0 169.38 19.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 102' ' ' LEU . 71.2 Cg_endo -76.29 131.07 12.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.268 1.978 . . . . 0.0 112.728 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -89.7 135.05 33.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.6 mt -103.46 170.87 7.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.585 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 63.6 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.029 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -160.34 -44.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 m80 64.12 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 ttm -113.42 -63.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.788 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -93.56 145.57 24.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.63 156.76 36.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.207 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 144.97 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.519 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 58.8 m95 -143.51 162.03 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.11 26.1 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.898 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 -69.53 133.7 47.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.377 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 46' ' ' MET . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.554 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.671 ' CD1' ' HD2' ' A' ' 25' ' ' PHE . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.755 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.527 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' HB3' HD12 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.496 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.69 ' HG3' HG22 ' A' ' 15' ' ' VAL . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.786 ' HA ' HD11 ' A' ' 59' ' ' ILE . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.786 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.632 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 3.8 m-70 -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.616 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.496 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.407 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.629 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.712 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.712 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.755 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.616 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.459 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.7 ppt_? -70.61 118.38 13.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.11 70.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.64 ' N ' HD13 ' A' ' 102' ' ' LEU . 7.4 mp -74.37 159.31 83.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.196 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 138.18 29.77 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.583 2.189 . . . . 0.0 112.236 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.19 95.28 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -108.59 135.81 49.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.795 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.889 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -121.22 -53.12 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.967 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -159.02 102.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.0 mtp 61.62 154.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.774 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.64 150.34 43.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -121.94 133.63 54.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.016 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.633 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 53.2 m95 -137.72 154.03 49.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.509 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.15 33.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.404 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -73.32 136.4 44.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.291 -178.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.581 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.841 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.74 HG22 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.793 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.661 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 43' ' ' VAL . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.645 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.66 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.834 ' HA ' HD12 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 55' ' ' PHE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 58' ' ' GLY . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.784 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.784 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.527 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.735 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.637 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.637 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.768 HG13 ' HB3' ' A' ' 25' ' ' PHE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.727 ' N ' HG23 ' A' ' 92' ' ' ILE . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.793 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.487 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.841 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 165.92 22.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -168.11 81.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.007 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.664 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.2 mp -75.46 134.52 73.1 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.54 141.33 33.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.269 1.979 . . . . 0.0 112.157 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.19 -48.08 8.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.06 101.16 10.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.925 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -116.33 133.58 55.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 mmt -113.86 144.74 42.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 145.32 53.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.25 153.19 26.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -117.51 134.45 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.532 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 38.6 m95 -139.68 155.73 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 111.546 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -146.72 37.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.54 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 -59.62 140.96 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.819 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.818 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.919 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.724 HG22 ' CG2' ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 89' ' ' LYS . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.742 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.608 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.659 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 52' ' ' ILE . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.815 ' HA ' HD12 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 57' ' ' ASP . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.611 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.455 ' CD2' ' CG ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.56 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.668 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG23 ' CE2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.579 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.436 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.637 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.608 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.71 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.71 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.73 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.85 ' HA ' HG21 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.547 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -74.38 169.13 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.8 106.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.653 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.42 145.61 82.78 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.07 145.68 51.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.41 2.074 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.07 99.35 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 tt -90.03 106.32 18.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.912 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.75 114.76 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.988 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 61.44 92.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -64.17 -57.31 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.092 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.87 126.69 38.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.119 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.29 144.9 53.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.27 158.85 39.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.762 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.527 ' HH2' ' HD2' ' A' ' 20' ' ' ARG . 38.1 m95 -140.09 178.0 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.073 0.463 . . . . 0.0 110.953 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -139.38 13.07 2.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.473 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 -68.8 137.47 54.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.802 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.574 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.648 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.592 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.714 HD12 HG12 ' A' ' 59' ' ' ILE . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.672 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.596 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.772 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.479 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HB3' HD13 ' A' ' 44' ' ' LEU . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.714 HG12 HD12 ' A' ' 23' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.494 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.585 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.566 ' O ' ' O ' ' A' ' 92' ' ' ILE . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.727 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.727 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.751 HG12 ' CB ' ' A' ' 25' ' ' PHE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.696 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.592 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.62 137.47 57.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.22 76.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 7.0 mp -74.23 -55.41 2.95 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.555 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 44.4 Cg_endo -68.05 119.98 6.97 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.241 1.961 . . . . 0.0 112.309 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -40.97 11.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mt -105.54 -179.37 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.917 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 56.29 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -134.34 159.76 40.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.595 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.54 102.19 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -75.78 -45.66 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.716 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.43 148.25 33.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -123.58 159.78 28.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -139.89 174.54 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -139.34 13.1 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.594 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 -67.97 135.53 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.656 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.496 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.682 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.619 HG13 ' CB ' ' A' ' 97' ' ' VAL . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.735 HG13 ' HB3' ' A' ' 42' ' ' PHE . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.631 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.752 HD12 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.575 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.656 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.484 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.463 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.511 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.522 HG21 ' CE2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.528 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.631 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.768 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.55 HD22 ' HA2' ' A' ' 61' ' ' GLY . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.619 ' CB ' HG13 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.682 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? -63.52 153.2 36.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 80.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.54 157.3 84.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.933 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.27 110.73 3.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -55.11 8.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.97 98.72 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.961 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.66 28.55 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -81.41 163.75 22.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.678 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -153.62 -48.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -97.21 120.44 37.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.3 154.55 16.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -110.53 142.84 41.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.05 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -144.55 164.57 30.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.287 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.669 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -146.92 26.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.831 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER -63.26 136.48 57.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.555 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.699 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG13 ' CG2' ' A' ' 97' ' ' VAL . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.852 HG23 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.704 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.673 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.5 ' HG3' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.779 ' HA ' HD11 ' A' ' 59' ' ' ILE . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.46 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.54 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.569 ' CE1' HD23 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.715 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG23 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.699 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.4 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -71.33 161.91 30.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 3.3 tt0 -174.76 83.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.97 139.37 73.09 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.889 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 114.4 3.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.135 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.77 -37.72 40.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.754 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 97.0 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.829 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.085 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -104.36 117.96 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -122.44 141.3 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.048 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.66 135.84 15.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' HG3' ' H ' ' A' ' 6' ' ' ALA . 2.5 pt20 -94.99 -46.96 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 5' ' ' GLN . . . -89.68 148.16 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.028 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -129.72 151.35 50.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.227 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.434 ' HZ3' ' CB ' ' A' ' 20' ' ' ARG . 22.6 m95 -131.8 157.19 44.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 111.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 5.0 mmtt -118.82 12.9 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.687 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 -68.35 139.16 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.787 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.614 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.834 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.68 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 HG22 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.461 HD12 ' CG2' ' A' ' 92' ' ' ILE . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.694 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.563 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 43' ' ' VAL . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.578 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.794 ' HA ' HD12 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.77 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.556 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.476 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 90' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.549 ' CZ ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.421 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.489 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 80' ' ' ALA . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.715 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.715 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.694 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.536 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.834 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.93 133.1 47.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -161.68 75.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.088 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.55 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 5.0 mp -74.53 -55.25 2.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 35.7 Cg_endo -65.46 134.64 39.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.042 1.828 . . . . 0.0 112.194 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.66 121.75 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.825 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.59 136.16 42.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.903 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.61 179.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.03 6.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.3 ttp -157.28 119.37 3.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -95.72 -58.08 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.05 29.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.3 159.46 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' OE2' ' A' ' 10' ' ' GLU . 30.2 m95 -138.97 -178.01 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.394 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.55 20.98 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 -66.2 137.54 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.362 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.614 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.511 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.868 HG23 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.583 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.603 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.603 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.596 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.544 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.548 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.755 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.614 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.436 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.512 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' HD23 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.692 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.692 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.714 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.868 ' HA ' HG23 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 -69.21 156.37 38.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.7 63.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.294 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' LEU . 5.1 mp -74.53 111.34 12.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.136 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.22 102.43 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.326 2.017 . . . . 0.0 112.315 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 111.11 18.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.778 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.36 107.49 18.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.856 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -146.8 162.66 38.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.72 115.13 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -151.66 112.02 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.67 148.3 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -117.5 133.1 56.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.988 0.423 . . . . 0.0 111.11 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -138.93 155.12 48.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.384 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -147.23 32.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.644 178.749 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.79 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 -65.89 138.9 58.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.23 -178.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.646 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.864 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.768 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG11 ' CG2' ' A' ' 97' ' ' VAL . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.616 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.654 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' GLY . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.405 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 58' ' ' GLY . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.515 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.588 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.645 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.864 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.768 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? -74.03 176.5 6.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -165.1 104.11 0.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.722 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.36 119.05 74.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.07 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.18 104.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.342 2.028 . . . . 0.0 112.553 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -85.14 -29.95 24.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.72 117.3 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -123.57 171.11 9.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -67.16 -50.04 62.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.732 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -123.6 77.34 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -56.55 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.53 153.72 27.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -131.26 157.3 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.58 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 22.5 m95 -133.48 178.63 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 4.3 mttt -139.06 10.33 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.748 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.16 148.1 27.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 -178.7 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.58 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.558 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.77 HD11 ' HD2' ' A' ' 42' ' ' PHE . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.675 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.695 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.677 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.442 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' HD1' ' H ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.77 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 43' ' ' VAL . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.494 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.736 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.521 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.508 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CD2' HD23 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.535 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.477 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.694 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.697 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.697 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.675 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.542 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.689 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.03 133.19 54.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -147.93 52.39 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.481 0.658 . . . . 0.0 110.031 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 2.0 tt -104.9 120.49 49.87 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.741 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.41 100.58 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.352 2.035 . . . . 0.0 112.573 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -99.45 -58.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.94 34.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.883 -179.958 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.1 m 59.4 31.29 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -37.16 84.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.53 121.28 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.22 -66.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.15 160.38 29.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.0 m -128.96 153.49 47.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 20' ' ' ARG . 43.2 m95 -141.21 173.84 11.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 0.0 110.815 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -144.43 15.54 1.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.548 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 -67.16 140.23 57.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' CG2' ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.73 HG12 ' HB3' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.693 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 37' ' ' GLY . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.737 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.789 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' O ' HG11 ' A' ' 29' ' ' VAL . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.73 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.749 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 55' ' ' PHE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.545 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG22 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.598 ' CE1' HD23 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.459 ' HB2' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.598 HD23 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.789 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.646 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 72' ' ' VAL . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.693 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.609 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.699 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.403 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.16 163.0 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER 177.8 57.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.088 179.194 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.656 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.3 mp -75.15 -55.54 2.22 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.07 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.656 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 15.9 Cg_exo -68.85 117.0 4.73 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.235 1.957 . . . . 0.0 111.843 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -90.15 -56.6 3.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 mp -95.72 116.03 28.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.95 -179.946 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.87 83.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -114.58 118.49 33.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 mmt -97.09 111.1 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -85.1 152.55 23.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.99 144.07 45.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -106.85 143.5 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -143.13 161.12 39.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.637 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 29.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.565 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 -68.23 141.34 55.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.998 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.963 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' CG2' ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.737 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.541 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 43' ' ' VAL . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.704 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' CD1' ' CG1' ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.711 ' HA ' HD12 ' A' ' 59' ' ' ILE . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.519 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.448 ' CG2' ' HB1' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CE2' HD22 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.421 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.737 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.786 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.963 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -77.47 160.22 28.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -168.6 75.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 5.3 mp -74.27 154.24 88.2 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.94 110.77 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.374 2.049 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.54 139.23 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.09 165.12 11.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.786 -179.864 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.6 p -64.54 109.86 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -70.74 139.46 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 mtt -154.29 151.8 29.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -94.79 146.65 24.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.32 148.64 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 146.23 29.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -143.43 162.94 34.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.83 30.69 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.546 178.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 -62.58 135.22 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.082 -178.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 46' ' ' MET . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.684 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.685 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD11 HG12 ' A' ' 59' ' ' ILE . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.744 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.839 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' N ' HG21 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.611 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 20' ' ' ARG . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.639 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 58' ' ' GLY . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 92' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' CD1' HD11 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' A' ' 90' ' ' PHE . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.596 ' CE1' HD22 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.618 HD13 ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.839 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.744 HG13 ' HB3' ' A' ' 25' ' ' PHE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 21' ' ' VAL . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.684 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.01 172.88 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 178.23 81.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.007 179.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.1 mp -76.67 127.19 84.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.93 105.02 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.395 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.91 -31.96 61.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.22 135.65 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -170.2 157.33 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.327 . . . . 0.0 110.702 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -150.6 130.47 13.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -40.39 2.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.21 148.75 29.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.16 145.66 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -124.4 159.17 31.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.566 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 31.3 m95 -139.31 178.69 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.149 0.5 . . . . 0.0 111.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -145.03 14.42 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.644 179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 -71.56 137.41 48.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.678 HD13 HG12 ' A' ' 59' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.767 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.608 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.58 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.799 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 46' ' ' MET . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.455 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.605 ' CE1' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.491 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.605 HD21 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.767 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.551 ' HA ' HG23 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.99 132.87 44.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.24 74.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 6.1 mp -74.07 -53.2 4.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 56.3 Cg_endo -70.89 107.05 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.361 2.041 . . . . 0.0 112.287 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.28 131.04 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.0 177.62 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.51 164.67 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -147.63 178.88 8.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 ptp -101.76 37.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 -60.73 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.58 152.5 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.05 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -114.91 135.3 54.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.877 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -139.9 154.18 47.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.442 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 33.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.749 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 -70.03 134.06 47.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.08 -178.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.633 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.888 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.75 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG22 ' CG2' ' A' ' 59' ' ' ILE . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 42' ' ' PHE . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.575 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.628 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.719 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.71 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.456 ' CG2' ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.745 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.7 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD11 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 55' ' ' PHE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 58' ' ' GLY . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HG3' ' CD2' ' A' ' 62' ' ' HIS . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.494 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.535 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.749 HG23 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CD2' HD22 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.485 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.495 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.723 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.699 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.73 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.51 ' HB2' ' HE2' ' A' ' 68' ' ' PHE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' HG12 ' A' ' 21' ' ' VAL . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.888 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -66.88 170.85 6.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.04 75.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.056 179.031 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.62 129.32 81.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.069 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.71 127.81 13.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.469 2.113 . . . . 0.0 112.219 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -84.88 -57.8 2.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 mt -106.85 174.23 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.752 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.939 -179.935 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.92 145.09 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -81.23 153.72 27.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.94 89.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.691 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -96.32 157.93 15.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.42 145.7 45.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.095 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -126.55 143.09 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -140.96 161.58 37.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.201 0.524 . . . . 0.0 111.505 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -146.8 19.88 1.29 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 -65.16 142.58 58.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.283 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.584 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.665 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.672 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG11 ' CG2' ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 42' ' ' PHE . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.721 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.663 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 43' ' ' VAL . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.823 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.572 ' HG3' HG23 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.823 ' HB3' HD13 ' A' ' 44' ' ' LEU . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.407 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.546 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 84' ' ' LYS . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.412 ' ND2' HD13 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.639 HD22 ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.735 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.735 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.721 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.511 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' HA ' ' CG2' ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG2' HG11 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.672 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.9 157.53 27.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -167.71 71.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.347 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.627 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.4 mp -77.97 -52.17 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.252 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 24.1 Cg_exo -63.97 115.98 3.43 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.46 122.69 29.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.18 98.91 8.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.862 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.87 136.27 28.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -69.76 176.52 3.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttm -115.52 -55.26 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 141.88 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 153.17 28.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.021 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -110.81 142.04 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.458 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 54.6 m95 -142.42 160.92 39.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.178 0.513 . . . . 0.0 111.291 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 26.38 1.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.175 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -64.64 140.17 58.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.935 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 59' ' ' ILE . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.651 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.572 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.704 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.704 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.763 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.607 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.695 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HA ' HD12 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' A' ' 55' ' ' PHE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 58' ' ' GLY . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.596 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.559 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.603 ' HB ' ' CE2' ' A' ' 90' ' ' PHE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.47 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 73' ' ' THR . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' SER . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.651 HG12 ' CB ' ' A' ' 25' ' ' PHE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.795 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.473 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.5 ' CG2' HG13 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.614 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.935 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.799 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.59 160.59 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.32 67.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.04 0.447 . . . . 0.0 110.722 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.07 138.09 75.84 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.59 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.66 117.85 5.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.484 2.123 . . . . 0.0 112.256 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.52 109.61 19.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -160.1 -46.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.38 141.98 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 -44.84 1.81 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.437 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.95 104.56 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.979 0.418 . . . . 0.0 110.953 -179.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.11 147.79 49.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.072 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.11 146.96 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.846 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -143.74 164.75 29.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.147 0.498 . . . . 0.0 111.319 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.59 21.19 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.968 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 -71.7 138.42 48.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.054 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.562 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.674 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.734 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.488 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.488 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 55' ' ' PHE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.55 ' CD1' HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.506 ' CG ' HD23 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.718 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.734 HG12 ' CB ' ' A' ' 25' ' ' PHE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.733 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 21' ' ' VAL . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -70.54 153.32 43.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.43 63.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.711 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 5.6 mp -74.44 -55.55 2.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.46 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 56.6 Cg_endo -70.56 121.08 7.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.249 1.966 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.04 -60.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.737 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.47 88.94 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.927 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG21 ' SD ' ' A' ' 46' ' ' MET . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG21 HG22 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.002 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.775 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.813 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.757 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.593 HG12 ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.886 HD22 ' CE ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.621 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.886 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.629 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.894 ' HA ' HD13 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.122 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.74 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.568 ' C ' HD23 ' A' ' 94' ' ' LEU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.717 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.926 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.654 ' HE3' HD23 ' A' ' 83' ' ' LEU . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.683 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.683 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.122 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.002 ' HA ' HG22 ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.129 0.49 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.775 HG21 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.644 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.981 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.811 HG23 ' HG2' ' A' ' 38' ' ' LYS . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.743 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HG2' HG23 ' A' ' 26' ' ' THR . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.811 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.775 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.811 ' CD1' HD11 ' A' ' 44' ' ' LEU . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 92' ' ' ILE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.705 ' O ' HD23 ' A' ' 94' ' ' LEU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.547 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 83' ' ' LEU . 10.1 p30 -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.858 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.725 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.981 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.887 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.745 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 38' ' ' LYS . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 26' ' ' THR . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.631 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.41 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.87 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.747 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.681 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.793 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.2 p30 -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.793 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.914 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.722 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.779 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.924 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.695 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 112.68 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.668 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.838 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.865 HD12 HD13 ' A' ' 92' ' ' ILE . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.726 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 38' ' ' LYS . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.776 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.783 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.494 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' HD2' HD11 ' A' ' 23' ' ' ILE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.903 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 92' ' ' ILE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.769 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.675 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.92 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 59' ' ' ILE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.609 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.817 HD12 HG22 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.179 0.514 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE3' ' HA3' ' A' ' 13' ' ' GLY . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 1.001 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.906 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG21 ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.033 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 38' ' ' LYS . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' HD13 ' A' ' 23' ' ' ILE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.906 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.705 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.427 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 44' ' ' LEU . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.617 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.405 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.2 p30 -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.691 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.849 ' CD2' HG21 ' A' ' 72' ' ' VAL . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.019 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.033 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 1.001 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.729 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.2 0.524 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.648 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.593 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.762 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG21 HG22 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.528 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.6 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.648 ' HG3' HG21 ' A' ' 15' ' ' VAL . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.089 HD11 HD12 ' A' ' 92' ' ' ILE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.651 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.445 ' OD1' HD12 ' A' ' 83' ' ' LEU . 4.2 p30 -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.787 ' HB3' ' HE3' ' A' ' 86' ' ' LYS . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.717 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.717 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 59' ' ' ILE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.556 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.641 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.675 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.89 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.744 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.694 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.663 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.663 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HD2' ' A' ' 20' ' ' ARG . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.819 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' O ' HG21 ' A' ' 15' ' ' VAL . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.728 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.878 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.615 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.536 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.69 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.944 HD12 HD11 ' A' ' 59' ' ' ILE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.602 ' N ' HG22 ' A' ' 92' ' ' ILE . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.89 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.637 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.881 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.733 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 38' ' ' LYS . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.739 ' H ' HG13 ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CG ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.587 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.881 HG12 ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.591 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.502 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.566 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.4 ' ND2' HD12 ' A' ' 83' ' ' LEU . 3.0 p-10 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.965 HD12 HD11 ' A' ' 59' ' ' ILE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.951 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.028 0.442 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.713 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.883 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 94' ' ' LEU . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.743 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.76 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.559 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.639 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.518 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.785 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.638 HG23 ' HB2' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 83' ' ' LEU . 2.9 p30 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.829 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.621 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.987 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.713 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.754 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.975 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.009 HG22 ' HA ' ' A' ' 94' ' ' LEU . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.648 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.704 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.12 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.626 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.594 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' OD1' HD12 ' A' ' 83' ' ' LEU . 11.9 p30 -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.12 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.009 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.609 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.686 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.975 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.563 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.113 0.482 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.639 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.899 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.943 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.778 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.735 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.834 ' O ' HD13 ' A' ' 23' ' ' ILE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG12 ' HD2' ' A' ' 20' ' ' ARG . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.639 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.625 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.619 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.703 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.566 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.724 ' HD3' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.612 ' N ' HG22 ' A' ' 92' ' ' ILE . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.943 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.691 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.784 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.597 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.618 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.032 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.565 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.773 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' ' 20' ' ' ARG . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG2' ' HE1' ' A' ' 46' ' ' MET . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.449 ' CD2' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.615 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 52' ' ' ILE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.696 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.601 ' N ' HG22 ' A' ' 92' ' ' ILE . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.032 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.695 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.618 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.945 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.956 HG21 ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.96 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.774 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.769 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.683 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.862 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.945 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.786 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CD1' HD11 ' A' ' 44' ' ' LEU . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.608 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.846 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.103 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.512 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 1.7 ppt_? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.648 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.588 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.887 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.923 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.03 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.803 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.734 ' H ' HG13 ' A' ' 29' ' ' VAL . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.542 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.923 HG22 ' HD2' ' A' ' 20' ' ' ARG . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.668 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.485 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.664 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 46' ' ' MET . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.72 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.543 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.818 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' A' ' 72' ' ' VAL . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.835 HD13 HD11 ' A' ' 70' ' ' ILE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.03 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.887 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.046 0.45 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.875 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.989 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.777 ' HD2' HG22 ' A' ' 43' ' ' VAL . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.868 HG21 HG22 ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.877 HG22 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.759 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 20' ' ' ARG . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.465 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.432 ' OD1' HD12 ' A' ' 83' ' ' LEU . 9.3 p30 -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.772 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.899 HD12 HD11 ' A' ' 59' ' ' ILE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.617 ' N ' HG22 ' A' ' 92' ' ' ILE . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 60' ' ' LYS . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.755 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 94' ' ' LEU . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.772 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.75 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.613 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 15' ' ' VAL . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.832 ' HA ' HD13 ' A' ' 59' ' ' ILE . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HB3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.041 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.649 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.592 ' HA2' HD21 ' A' ' 94' ' ' LEU . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.587 ' CD2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.041 HD12 HD11 ' A' ' 59' ' ' ILE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.961 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.622 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.702 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.789 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 38' ' ' LYS . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.801 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.801 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 26' ' ' THR . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.868 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.062 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.602 HG23 ' HB2' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.434 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.541 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.887 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.062 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.644 ' CB ' HG12 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.871 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.895 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.741 ' H ' HG13 ' A' ' 29' ' ' VAL . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.69 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.871 HG22 ' HD2' ' A' ' 20' ' ' ARG . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.477 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.555 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.411 ' OD1' HD12 ' A' ' 83' ' ' LEU . 10.4 p30 -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.881 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.73 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.831 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.895 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.71 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.146 0.498 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.751 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.975 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.753 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.753 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.882 ' HD2' HD11 ' A' ' 23' ' ' ILE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.776 HG22 ' HG2' ' A' ' 20' ' ' ARG . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.03 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.817 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 55' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.502 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.03 HD12 HD11 ' A' ' 59' ' ' ILE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.589 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.975 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.694 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.886 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.902 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.614 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.614 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.081 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.618 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.432 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 77' ' ' GLU . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.698 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.698 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.081 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.902 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 121.345 0.593 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 99' ' ' GLU . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.924 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.797 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.787 HG21 ' CG2' ' A' ' 59' ' ' ILE . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.076 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 38' ' ' LYS . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.769 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 26' ' ' THR . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.592 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.678 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.014 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.4 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.619 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 52' ' ' ILE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.663 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.9 p30 -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.571 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.076 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.924 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.797 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.586 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' NE ' ' HB2' ' A' ' 45' ' ' ALA . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.969 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.771 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB3' HG23 ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG22 ' HD2' ' A' ' 20' ' ' ARG . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.78 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.716 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.726 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.747 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.744 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.701 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.747 ' CD2' HG21 ' A' ' 72' ' ' VAL . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.61 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.969 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.591 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.628 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.566 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.669 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.707 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.749 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.814 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.637 ' H ' HG13 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' SER . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.744 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.669 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.773 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.057 HD11 HD12 ' A' ' 92' ' ' ILE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.772 HG23 ' HB2' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CG ' HD21 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.814 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.651 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 92' ' ' ILE . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.01 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.604 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.08 0.466 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 1.012 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG12 HG23 ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.763 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.549 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG22 ' HD2' ' A' ' 20' ' ' ARG . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.695 HD12 HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.72 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.446 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.021 HD11 HG13 ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.855 ' CE2' HG11 ' A' ' 72' ' ' VAL . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.566 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 94' ' ' LEU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 52' ' ' ILE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.834 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.763 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.579 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.284 0.564 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.787 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.994 HG22 ' HA ' ' A' ' 94' ' ' LEU . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.769 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 38' ' ' LYS . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.641 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.863 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 23' ' ' ILE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.654 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.725 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.796 ' HA3' HG12 ' A' ' 72' ' ' VAL . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.812 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.687 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.687 ' HD2' ' CE1' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.612 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.796 HG12 ' HA3' ' A' ' 54' ' ' GLY . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.66 ' CD2' HD21 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.532 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.889 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.863 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 70' ' ' ILE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.994 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.856 ' HD2' HG12 ' A' ' 43' ' ' VAL . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.898 HD12 HD13 ' A' ' 92' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.782 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.736 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.661 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.697 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' HG21 ' A' ' 15' ' ' VAL . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.706 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.551 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 59' ' ' ILE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.198 0.523 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.961 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.863 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 97' ' ' VAL . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 94' ' ' LEU . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.752 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.738 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.725 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.85 ' HA ' HD13 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 94' ' ' LEU . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG21 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.403 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.4 p30 -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.925 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.729 ' HE2' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.784 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.709 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HG21 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.012 HD12 HD11 ' A' ' 59' ' ' ILE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.611 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.992 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.775 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.762 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.119 0.485 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.736 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.693 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HD2' HD11 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.763 HD12 HG21 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.592 ' HG3' HG21 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' THR . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' HA ' HD13 ' A' ' 59' ' ' ILE . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.075 HD11 HD12 ' A' ' 92' ' ' ILE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.504 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.713 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.742 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.742 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.036 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.979 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.652 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.826 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 97' ' ' VAL . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.005 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.632 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.785 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.826 HG12 ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.72 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.995 HD11 HG13 ' A' ' 72' ' ' VAL . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.691 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.995 HG13 HD11 ' A' ' 52' ' ' ILE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' OD1' HD12 ' A' ' 83' ' ' LEU . 9.9 p30 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.005 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.729 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.677 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.687 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.884 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.927 HG22 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.748 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' SER . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 23' ' ' ILE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.829 ' HE1' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.829 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CG ' HD21 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.468 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.895 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.659 ' CE ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.724 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.724 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.976 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.607 ' N ' HG22 ' A' ' 92' ' ' ILE . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.927 HD12 HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 112.98 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -153.57 -59.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.9 mtm 59.72 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.59 -58.85 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.68 151.38 39.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -104.87 133.48 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.058 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -140.3 151.76 45.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.082 0.468 . . . . 0.0 111.258 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -147.48 35.15 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.196 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 -73.41 134.02 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.319 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG21 ' SD ' ' A' ' 46' ' ' MET . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG21 HG22 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.002 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.775 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.813 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.757 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.593 HG12 ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.886 HD22 ' CE ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.621 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.886 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.629 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.894 ' HA ' HD13 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.122 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.74 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.568 ' C ' HD23 ' A' ' 94' ' ' LEU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.717 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.926 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.654 ' HE3' HD23 ' A' ' 83' ' ' LEU . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.683 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.683 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.122 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.002 ' HA ' HG22 ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.14 143.37 50.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 5.2 tt0 -150.12 82.08 1.37 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.421 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.6 mp -74.47 -55.43 2.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 97.8 Cg_endo -78.14 139.5 17.03 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.444 2.096 . . . . 0.0 112.108 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.23 121.02 15.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.685 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.13 103.06 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.853 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -164.32 140.68 6.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.0 110.818 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.79 160.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ttt -158.38 95.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.89 101.32 14.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.983 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.8 163.55 18.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -115.58 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -142.58 160.44 40.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.336 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -147.29 38.5 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.916 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 -72.24 131.96 43.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.217 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.775 HG21 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.644 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.981 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.811 HG23 ' HG2' ' A' ' 38' ' ' LYS . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.743 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HG2' HG23 ' A' ' 26' ' ' THR . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.811 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.775 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.811 ' CD1' HD11 ' A' ' 44' ' ' LEU . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 92' ' ' ILE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.705 ' O ' HD23 ' A' ' 94' ' ' LEU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.547 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.447 ' OD1' HD12 ' A' ' 83' ' ' LEU . 10.1 p30 -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.858 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.725 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.981 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.15 164.04 11.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 100.24 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.379 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mt -74.27 116.29 51.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.906 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.95 120.52 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.473 2.116 . . . . 0.0 112.549 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -74.85 -34.5 62.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.873 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -178.42 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.919 -0.073 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 p -103.4 101.89 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -94.46 -35.82 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.254 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 111.11 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -70.53 125.09 25.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.47 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -132.0 156.5 46.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -138.73 176.61 8.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -140.13 16.03 2.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.22 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 -68.53 134.18 49.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.13 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.887 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.745 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 38' ' ' LYS . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 26' ' ' THR . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.631 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.41 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.87 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.681 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.793 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.2 p30 -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.793 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.914 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.722 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.779 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.924 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.695 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -63.57 140.26 58.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.87 68.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.5 mp -75.02 -58.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.295 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 36.7 Cg_endo -65.52 136.68 47.49 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.332 2.021 . . . . 0.0 112.285 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -94.39 116.21 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.6 141.7 37.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.895 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.65 138.63 38.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.375 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -115.96 139.61 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.58 120.45 26.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -92.9 -26.95 17.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.024 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.83 147.93 41.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.196 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -127.05 137.09 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 23.3 m95 -136.44 160.08 39.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -146.64 37.2 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.33 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -72.54 132.71 44.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.68 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.668 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.838 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.865 HD12 HD13 ' A' ' 92' ' ' ILE . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.726 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 38' ' ' LYS . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.776 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.783 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.494 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' HD2' HD11 ' A' ' 23' ' ' ILE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.903 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 92' ' ' ILE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.769 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.675 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.92 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 59' ' ' ILE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.609 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.817 HD12 HG22 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.22 176.28 5.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 177.96 72.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.979 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -104.08 92.64 4.71 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.05 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.07 112.18 2.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.377 2.052 . . . . 0.0 112.538 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 136.68 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.84 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.69 179.42 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.74 149.54 48.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.41 95.57 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.0 138.04 47.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.13 151.18 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.041 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.34 138.38 41.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.275 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.434 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 44.5 m95 -139.29 156.56 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.523 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -147.17 31.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 -70.78 137.19 49.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.201 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE3' ' HA3' ' A' ' 13' ' ' GLY . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 1.001 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.906 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG21 ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.033 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 38' ' ' LYS . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' HD13 ' A' ' 23' ' ' ILE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.906 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.705 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.427 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 44' ' ' LEU . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.617 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.405 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.2 p30 -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.691 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.849 ' CD2' HG21 ' A' ' 72' ' ' VAL . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.019 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.033 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 1.001 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.729 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.77 168.48 13.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -165.69 104.4 0.7 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.668 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 mt -74.41 151.72 87.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.331 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.47 132.3 50.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.195 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -97.39 -69.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.756 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.34 109.55 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.902 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -83.31 147.75 27.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -142.14 143.09 32.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -133.92 158.68 42.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -95.96 -71.78 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.55 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.9 150.94 50.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.633 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 54.8 m95 -144.0 166.86 23.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.227 0.537 . . . . 0.0 111.583 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 8' ' ' TRP . 1.4 mmmt -143.65 16.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.235 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 -65.69 140.74 58.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.298 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.648 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.593 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.762 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG21 HG22 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.528 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.6 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.549 HG11 ' CZ2' ' A' ' 8' ' ' TRP . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.648 ' HG3' HG21 ' A' ' 15' ' ' VAL . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.089 HD11 HD12 ' A' ' 92' ' ' ILE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.651 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.445 ' OD1' HD12 ' A' ' 83' ' ' LEU . 4.2 p30 -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.787 ' HB3' ' HE3' ' A' ' 86' ' ' LYS . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.717 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.717 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 59' ' ' ILE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.556 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.48 139.29 58.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -164.74 84.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.5 mp -74.73 -58.89 1.6 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.164 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 32.1 Cg_exo -57.99 145.65 90.63 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.009 1.806 . . . . 0.0 111.99 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.83 123.07 25.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.97 126.56 47.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.945 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.91 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -98.14 169.21 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.77 -177.73 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 mmm -102.75 161.37 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -55.49 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.12 159.82 28.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.97 150.64 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -145.6 166.16 26.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.23 26.77 1.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 -61.01 139.1 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.977 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.641 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.675 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.89 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.744 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.694 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.663 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.663 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HD2' ' A' ' 20' ' ' ARG . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.819 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' O ' HG21 ' A' ' 15' ' ' VAL . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.728 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.878 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.615 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.536 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.69 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.944 HD12 HD11 ' A' ' 59' ' ' ILE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.602 ' N ' HG22 ' A' ' 92' ' ' ILE . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.89 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.66 166.32 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -171.71 61.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.245 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.429 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 9.6 mp -74.55 148.35 85.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.49 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.38 121.24 8.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.681 2.254 . . . . 0.0 112.231 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.69 96.49 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.21 101.07 13.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.902 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -139.35 -48.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -135.87 160.51 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -120.27 -54.2 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -177.22 4.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.92 23.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -104.92 139.64 39.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 47.2 m95 -139.88 157.1 46.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.633 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -147.12 28.47 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.134 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 -71.99 135.26 46.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.637 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.881 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.733 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 38' ' ' LYS . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.739 ' H ' HG13 ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CG ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.587 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.881 HG12 ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.591 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.502 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.566 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.4 ' ND2' HD12 ' A' ' 83' ' ' LEU . 3.0 p-10 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.965 HD12 HD11 ' A' ' 59' ' ' ILE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.951 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? -65.07 173.79 2.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 173.4 92.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.666 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mt -74.42 143.43 79.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.4 135.66 37.31 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.518 2.145 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.94 -45.12 9.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.56 93.66 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.815 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 m -141.31 165.14 28.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -169.83 128.89 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 tpp -97.95 129.88 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -68.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.97 154.21 36.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.77 149.48 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -144.42 167.32 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.274 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.652 ' HD3' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.87 20.5 1.28 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.17 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 -68.84 139.52 55.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.066 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.713 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.883 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 94' ' ' LEU . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.743 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.76 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.559 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.639 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.785 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.638 HG23 ' HB2' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' HD12 ' A' ' 83' ' ' LEU . 2.9 p30 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.829 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.621 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.987 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.713 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.754 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.61 146.28 44.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -156.01 61.68 0.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.342 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.671 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.5 mp -75.71 -51.09 3.16 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.032 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 20.2 Cg_exo -65.69 130.89 26.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.312 2.008 . . . . 0.0 111.888 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.2 38.82 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.11 -175.49 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.681 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.87 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.92 -38.73 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -107.33 143.29 35.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.64 102.06 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.6 121.69 24.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.025 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.74 155.93 26.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.86 138.57 48.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.766 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -138.45 152.45 48.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.133 0.492 . . . . 0.0 111.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' NZ ' ' HA ' ' A' ' 104' ' ' GLU . 3.5 ptmt -147.42 30.66 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -67.36 142.1 56.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 -178.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.975 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.009 HG22 ' HA ' ' A' ' 94' ' ' LEU . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.648 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.704 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.12 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.626 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.594 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' OD1' HD12 ' A' ' 83' ' ' LEU . 11.9 p30 -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.12 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.009 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.609 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.686 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.975 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.563 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.98 169.45 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.589 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -179.38 112.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.409 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.528 ' HG ' HH12 ' A' ' 100' ' ' ARG . 3.6 mt -74.68 -52.81 3.48 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.033 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 41.6 Cg_endo -67.28 132.8 28.61 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.728 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.604 ' HA ' ' NZ ' ' A' ' 9' ' ' LYS . 3.7 mm-40 -84.73 -53.49 5.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.78 88.94 2.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.785 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 60.5 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -141.34 179.31 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.987 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -141.7 75.06 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -52.14 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.04 148.02 26.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.12 160.1 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 3.8 ptmt -147.18 29.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.965 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 -62.3 136.79 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.098 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.639 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.899 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.943 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.778 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.735 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.834 ' O ' HD13 ' A' ' 23' ' ' ILE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG12 ' HD2' ' A' ' 20' ' ' ARG . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.639 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.625 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.619 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.703 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.566 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.724 ' HD3' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.612 ' N ' HG22 ' A' ' 92' ' ' ILE . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.943 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.691 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -67.22 168.55 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 19.2 tt0 -170.04 61.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.521 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 6.7 mp -74.41 139.73 75.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.868 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 112.94 2.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.199 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.518 ' HB3' HD22 ' A' ' 105' ' ' LEU . 14.6 mm-40 -84.13 -57.95 2.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 104' ' ' GLU . 3.5 mm? -94.67 127.7 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.802 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.6 -50.63 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -148.95 102.86 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.13 122.72 47.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.72 170.16 16.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.2 152.28 22.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -130.04 159.32 37.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -136.48 178.15 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.138 0.494 . . . . 0.0 111.209 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -135.31 11.77 3.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.337 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.784 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -64.58 136.02 56.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.033 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.597 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.618 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.032 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.565 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.773 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' ' 20' ' ' ARG . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG2' ' HE1' ' A' ' 46' ' ' MET . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.449 ' CD2' ' HD2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.615 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 52' ' ' ILE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.696 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.601 ' N ' HG22 ' A' ' 92' ' ' ILE . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.032 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.695 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.618 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -60.76 152.43 26.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -178.88 69.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.379 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.616 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.9 mp -74.0 169.38 19.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 102' ' ' LEU . 71.2 Cg_endo -76.29 131.07 12.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.268 1.978 . . . . 0.0 112.728 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -89.7 135.05 33.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.6 mt -103.46 170.87 7.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.585 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 63.6 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.029 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -160.34 -44.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 m80 64.12 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 ttm -113.42 -63.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.788 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -93.56 145.57 24.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.63 156.76 36.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.207 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 144.97 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.54 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 58.8 m95 -143.51 162.03 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.632 ' HE2' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.11 26.1 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.898 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 -69.53 133.7 47.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.377 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.945 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.956 HG21 ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.96 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.774 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.769 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.683 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.862 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.945 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.786 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CD1' HD11 ' A' ' 44' ' ' LEU . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.608 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.608 ' CE1' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.846 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.103 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.512 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 1.7 ppt_? -70.61 118.38 13.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.11 70.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD12 ' HE2' ' A' ' 9' ' ' LYS . 7.4 mp -74.37 159.31 83.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.196 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 138.18 29.77 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.583 2.189 . . . . 0.0 112.236 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.19 95.28 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -108.59 135.81 49.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.795 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.889 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -121.22 -53.12 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.967 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -159.02 102.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.0 mtp 61.62 154.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.774 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.64 150.34 43.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -121.94 133.63 54.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.016 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 53.2 m95 -137.72 154.03 49.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.509 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.15 33.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.404 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -73.32 136.4 44.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.291 -178.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.648 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.588 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.887 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.923 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.03 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.803 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.734 ' H ' HG13 ' A' ' 29' ' ' VAL . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.542 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.923 HG22 ' HD2' ' A' ' 20' ' ' ARG . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.668 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.485 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.664 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 46' ' ' MET . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.72 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.543 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.818 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.641 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' A' ' 72' ' ' VAL . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.835 HD13 HD11 ' A' ' 70' ' ' ILE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.03 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.887 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.08 165.92 22.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -168.11 81.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.007 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.46 134.52 73.1 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.54 141.33 33.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.269 1.979 . . . . 0.0 112.157 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.19 -48.08 8.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 105' ' ' LEU . 4.4 mm? -104.06 101.16 10.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.925 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -116.33 133.58 55.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 mmt -113.86 144.74 42.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 145.32 53.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.25 153.19 26.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -117.51 134.45 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 38.6 m95 -139.68 155.73 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 111.546 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 4.2 ptpt -146.72 37.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.54 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 -59.62 140.96 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.819 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.875 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.989 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.777 ' HD2' HG22 ' A' ' 43' ' ' VAL . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.868 HG21 HG22 ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.877 HG22 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.759 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 20' ' ' ARG . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.465 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.432 ' OD1' HD12 ' A' ' 83' ' ' LEU . 9.3 p30 -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.772 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.899 HD12 HD11 ' A' ' 59' ' ' ILE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' N ' HG22 ' A' ' 92' ' ' ILE . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -74.38 169.13 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -172.8 106.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.653 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.42 145.61 82.78 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.07 145.68 51.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.41 2.074 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.07 99.35 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 tt -90.03 106.32 18.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.912 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.75 114.76 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.988 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 61.44 92.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -64.17 -57.31 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.092 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.87 126.69 38.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.119 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.29 144.9 53.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.27 158.85 39.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.762 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.511 ' HH2' ' HD2' ' A' ' 20' ' ' ARG . 38.1 m95 -140.09 178.0 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.073 0.463 . . . . 0.0 110.953 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -139.38 13.07 2.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.473 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 -68.8 137.47 54.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.802 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 60' ' ' LYS . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.755 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 94' ' ' LEU . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.772 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.75 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.613 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 15' ' ' VAL . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.832 ' HA ' HD13 ' A' ' 59' ' ' ILE . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HB3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.041 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.649 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.592 ' HA2' HD21 ' A' ' 94' ' ' LEU . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.587 ' CD2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.041 HD12 HD11 ' A' ' 59' ' ' ILE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.961 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.622 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.62 137.47 57.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.22 76.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 7.0 mp -74.23 -55.41 2.95 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.555 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 44.4 Cg_endo -68.05 119.98 6.97 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.241 1.961 . . . . 0.0 112.309 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -40.97 11.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mt -105.54 -179.37 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.917 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 56.29 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -134.34 159.76 40.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.595 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.54 102.19 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -75.78 -45.66 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.716 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.43 148.25 33.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -123.58 159.78 28.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -139.89 174.54 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -139.34 13.1 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.594 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 -67.97 135.53 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.702 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.789 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 38' ' ' LYS . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.801 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.801 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 26' ' ' THR . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.868 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.062 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.602 HG23 ' HB2' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.434 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.541 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.887 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.062 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.644 ' CB ' HG12 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? -63.52 153.2 36.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 80.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.54 157.3 84.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.933 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.27 110.73 3.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -55.11 8.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.97 98.72 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.961 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.66 28.55 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -81.41 163.75 22.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.678 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -153.62 -48.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -97.21 120.44 37.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.3 154.55 16.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -110.53 142.84 41.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.05 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -144.55 164.57 30.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.287 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -146.92 26.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.831 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER -63.26 136.48 57.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.871 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.895 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.741 ' H ' HG13 ' A' ' 29' ' ' VAL . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.69 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.871 HG22 ' HD2' ' A' ' 20' ' ' ARG . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.477 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.555 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.411 ' OD1' HD12 ' A' ' 83' ' ' LEU . 10.4 p30 -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.881 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.73 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.831 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.895 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.71 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -71.33 161.91 30.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 3.3 tt0 -174.76 83.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.97 139.37 73.09 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.889 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 114.4 3.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.135 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.77 -37.72 40.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.754 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 97.0 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.829 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.085 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -104.36 117.96 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -122.44 141.3 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.048 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.66 135.84 15.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 6' ' ' ALA . 2.5 pt20 -94.99 -46.96 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 5' ' ' GLN . . . -89.68 148.16 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.028 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -129.72 151.35 50.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.227 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.437 ' CZ2' HG21 ' A' ' 43' ' ' VAL . 22.6 m95 -131.8 157.19 44.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 111.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 5.0 mmtt -118.82 12.9 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.687 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 -68.35 139.16 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.787 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.751 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.975 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.753 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.753 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.882 ' HD2' HD11 ' A' ' 23' ' ' ILE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.776 HG22 ' HG2' ' A' ' 20' ' ' ARG . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.03 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.817 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 55' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.502 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.03 HD12 HD11 ' A' ' 59' ' ' ILE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.589 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.975 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.694 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.886 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.93 133.1 47.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -161.68 75.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.088 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 5.0 mp -74.53 -55.25 2.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 35.7 Cg_endo -65.46 134.64 39.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.042 1.828 . . . . 0.0 112.194 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.66 121.75 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.825 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.59 136.16 42.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.903 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.61 179.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.03 6.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.3 ttp -157.28 119.37 3.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -95.72 -58.08 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.05 29.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.3 159.46 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' OE2' ' A' ' 10' ' ' GLU . 30.2 m95 -138.97 -178.01 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.394 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.55 20.98 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 -66.2 137.54 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.362 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.902 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.614 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.614 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.081 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.618 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.432 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 77' ' ' GLU . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.698 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.698 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.081 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.902 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 -69.21 156.37 38.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.7 63.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.294 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 5.1 mp -74.53 111.34 12.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.136 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.22 102.43 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.326 2.017 . . . . 0.0 112.315 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 111.11 18.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.778 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.36 107.49 18.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.856 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -146.8 162.66 38.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.72 115.13 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -151.66 112.02 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.67 148.3 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 103' ' ' PRO . 10.3 t -117.5 133.1 56.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.988 0.423 . . . . 0.0 111.11 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -138.93 155.12 48.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.384 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -147.23 32.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.644 178.749 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 -65.89 138.9 58.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.23 -178.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 99' ' ' GLU . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.924 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.797 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.787 HG21 ' CG2' ' A' ' 59' ' ' ILE . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.076 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 38' ' ' LYS . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.769 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 26' ' ' THR . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.592 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.678 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.014 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.4 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.619 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 52' ' ' ILE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.663 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.9 p30 -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.571 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.076 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.924 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.797 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? -74.03 176.5 6.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -165.1 104.11 0.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.722 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.36 119.05 74.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.07 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' A' ' 7' ' ' THR . 73.5 Cg_exo -49.18 104.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.342 2.028 . . . . 0.0 112.553 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -85.14 -29.95 24.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.72 117.3 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -123.57 171.11 9.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -67.16 -50.04 62.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.732 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -123.6 77.34 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -56.55 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.53 153.72 27.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.7 m -131.26 157.3 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.671 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.607 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 22.5 m95 -133.48 178.63 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 4.3 mttt -139.06 10.33 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.748 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.16 148.1 27.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 -178.7 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.586 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' NE ' ' HB2' ' A' ' 45' ' ' ALA . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.969 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.771 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB3' HG23 ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG22 ' HD2' ' A' ' 20' ' ' ARG . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.78 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.716 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.726 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.747 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.744 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.701 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.747 ' CD2' HG21 ' A' ' 72' ' ' VAL . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.61 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.969 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.591 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.628 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.03 133.19 54.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -147.93 52.39 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.481 0.658 . . . . 0.0 110.031 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 2.0 tt -104.9 120.49 49.87 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.741 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.41 100.58 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.352 2.035 . . . . 0.0 112.573 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -99.45 -58.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.94 34.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.883 -179.958 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.1 m 59.4 31.29 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -37.16 84.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.53 121.28 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.22 -66.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.15 160.38 29.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.646 ' O ' HD21 ' A' ' 102' ' ' LEU . 45.0 m -128.96 153.49 47.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.629 ' HA ' HD11 ' A' ' 102' ' ' LEU . 43.2 m95 -141.21 173.84 11.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 0.0 110.815 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -144.43 15.54 1.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.548 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 -67.16 140.23 57.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.669 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.707 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.749 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.814 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.637 ' H ' HG13 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' SER . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.744 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.669 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.773 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.057 HD11 HD12 ' A' ' 92' ' ' ILE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.772 HG23 ' HB2' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CG ' HD21 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.814 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.651 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 92' ' ' ILE . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.01 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.604 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -75.16 163.0 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER 177.8 57.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.088 179.194 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.3 mp -75.15 -55.54 2.22 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.07 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 15.9 Cg_exo -68.85 117.0 4.73 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.235 1.957 . . . . 0.0 111.843 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -90.15 -56.6 3.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 mp -95.72 116.03 28.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.95 -179.946 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.87 83.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -114.58 118.49 33.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 mmt -97.09 111.1 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -85.1 152.55 23.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.99 144.07 45.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -106.85 143.5 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -143.13 161.12 39.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.637 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 29.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.565 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 -68.23 141.34 55.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.998 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 1.012 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG12 HG23 ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.763 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.549 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG22 ' HD2' ' A' ' 20' ' ' ARG . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.695 HD12 HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.72 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.446 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.021 HD11 HG13 ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.855 ' CE2' HG11 ' A' ' 72' ' ' VAL . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.566 ' CE1' ' HD3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 94' ' ' LEU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 52' ' ' ILE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.834 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.763 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.579 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -77.47 160.22 28.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -168.6 75.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 5.3 mp -74.27 154.24 88.2 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.94 110.77 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.374 2.049 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.54 139.23 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.09 165.12 11.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.786 -179.864 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.6 p -64.54 109.86 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -70.74 139.46 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 mtt -154.29 151.8 29.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -94.79 146.65 24.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.32 148.64 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 146.23 29.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -143.43 162.94 34.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.83 30.69 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.546 178.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 -62.58 135.22 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.082 -178.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.787 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.994 HG22 ' HA ' ' A' ' 94' ' ' LEU . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.769 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 38' ' ' LYS . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.641 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.863 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 23' ' ' ILE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.654 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.725 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.796 ' HA3' HG12 ' A' ' 72' ' ' VAL . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.812 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.687 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.687 ' HD2' ' CE1' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.796 HG12 ' HA3' ' A' ' 54' ' ' GLY . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.66 ' CD2' HD21 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.532 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.889 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.863 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 70' ' ' ILE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.994 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.01 172.88 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 178.23 81.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.007 179.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.67 127.19 84.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.93 105.02 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.395 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.91 -31.96 61.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -105.22 135.65 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -170.2 157.33 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.327 . . . . 0.0 110.702 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -150.6 130.47 13.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -40.39 2.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.21 148.75 29.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.16 145.66 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -124.4 159.17 31.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.592 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 31.3 m95 -139.31 178.69 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.149 0.5 . . . . 0.0 111.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -145.03 14.42 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.644 179.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 -71.56 137.41 48.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.856 ' HD2' HG12 ' A' ' 43' ' ' VAL . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.898 HD12 HD13 ' A' ' 92' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.782 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.736 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.661 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.697 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' HG21 ' A' ' 15' ' ' VAL . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.706 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.551 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 59' ' ' ILE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.99 132.87 44.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.24 74.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 6.1 mp -74.07 -53.2 4.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 56.3 Cg_endo -70.89 107.05 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.361 2.041 . . . . 0.0 112.287 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.28 131.04 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.0 177.62 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.51 164.67 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -147.63 178.88 8.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 ptp -101.76 37.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 -60.73 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.58 152.5 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.05 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -114.91 135.3 54.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.877 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -139.9 154.18 47.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.442 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 33.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 -70.03 134.06 47.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.08 -178.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.961 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.863 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 97' ' ' VAL . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 94' ' ' LEU . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.752 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.738 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.725 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.85 ' HA ' HD13 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.66 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 94' ' ' LEU . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG21 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' OD1' HD12 ' A' ' 83' ' ' LEU . 12.4 p30 -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.925 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.729 ' HE2' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.784 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.709 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HG21 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.012 HD12 HD11 ' A' ' 59' ' ' ILE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.611 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.992 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.775 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.762 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -66.88 170.85 6.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.04 75.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.056 179.031 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.562 HD13 ' HD2' ' A' ' 100' ' ' ARG . 5.1 mp -75.62 129.32 81.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.069 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.71 127.81 13.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.469 2.113 . . . . 0.0 112.219 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -84.88 -57.8 2.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 mt -106.85 174.23 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.752 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.939 -179.935 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.92 145.09 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -81.23 153.72 27.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.94 89.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.691 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -96.32 157.93 15.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.42 145.7 45.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.095 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -126.55 143.09 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CH2' HG21 ' A' ' 43' ' ' VAL . 53.8 m95 -140.96 161.58 37.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.201 0.524 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -146.8 19.88 1.29 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 -65.16 142.58 58.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.283 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.736 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.693 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HD2' HD11 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.763 HD12 HG21 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.592 ' HG3' HG21 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' THR . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' HA ' HD13 ' A' ' 59' ' ' ILE . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.075 HD11 HD12 ' A' ' 92' ' ' ILE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.504 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.713 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.742 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.742 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.036 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.9 157.53 27.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -167.71 71.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.347 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.657 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.4 mp -77.97 -52.17 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.252 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 24.1 Cg_exo -63.97 115.98 3.43 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.46 122.69 29.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.18 98.91 8.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.862 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.87 136.27 28.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -69.76 176.52 3.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttm -115.52 -55.26 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 141.88 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 153.17 28.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.021 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -110.81 142.04 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 54.6 m95 -142.42 160.92 39.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.178 0.513 . . . . 0.0 111.291 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 26.38 1.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.175 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -64.64 140.17 58.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.979 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.652 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.826 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 97' ' ' VAL . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.005 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.632 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.785 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.826 HG12 ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.72 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.995 HD11 HG13 ' A' ' 72' ' ' VAL . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.411 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.691 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.995 HG13 HD11 ' A' ' 52' ' ' ILE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' OD1' HD12 ' A' ' 83' ' ' LEU . 9.9 p30 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.005 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.729 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.59 160.59 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.32 67.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.04 0.447 . . . . 0.0 110.722 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.07 138.09 75.84 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.59 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.66 117.85 5.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.484 2.123 . . . . 0.0 112.256 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.52 109.61 19.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -160.1 -46.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.38 141.98 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 -44.84 1.81 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.437 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.95 104.56 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.979 0.418 . . . . 0.0 110.953 -179.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.11 147.79 49.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.072 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.11 146.96 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.846 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -143.74 164.75 29.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.147 0.498 . . . . 0.0 111.319 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.59 21.19 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.968 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 -71.7 138.42 48.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.054 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.677 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.687 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.884 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.927 HG22 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.748 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' SER . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 23' ' ' ILE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.829 ' HE1' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.829 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CG ' HD21 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.468 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.895 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.659 ' CE ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.724 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.724 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.976 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.607 ' N ' HG22 ' A' ' 92' ' ' ILE . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.927 HD12 HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -70.54 153.32 43.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.43 63.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.711 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 5.6 mp -74.44 -55.55 2.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.46 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 56.6 Cg_endo -70.56 121.08 7.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.249 1.966 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.04 -60.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.737 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.47 88.94 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.927 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.688 HG21 ' SD ' ' A' ' 46' ' ' MET . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG21 HG22 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.002 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.775 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.813 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.757 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.593 HG12 ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.886 HD22 ' CE ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.621 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.886 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.629 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.894 ' HA ' HD13 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.122 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.74 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.421 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.568 ' C ' HD23 ' A' ' 94' ' ' LEU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.717 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.492 HD21 HD12 ' A' ' 83' ' ' LEU . 1.7 p-10 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.926 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.654 ' HE3' HD23 ' A' ' 83' ' ' LEU . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.683 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.683 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.122 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.002 ' HA ' HG22 ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.129 0.49 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.775 HG21 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.644 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.981 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.811 HG23 ' HG2' ' A' ' 38' ' ' LYS . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.743 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.518 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HG2' HG23 ' A' ' 26' ' ' THR . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.811 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.775 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.811 ' CD1' HD11 ' A' ' 44' ' ' LEU . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 92' ' ' ILE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.52 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.705 ' O ' HD23 ' A' ' 94' ' ' LEU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.547 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.597 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.858 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.725 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.981 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.887 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.745 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 38' ' ' LYS . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 26' ' ' THR . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.631 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.41 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.87 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.41 ' H ' ' CD2' ' A' ' 62' ' ' HIS . 0.4 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.747 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.681 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.779 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.793 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.57 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.793 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.914 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.722 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.779 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.924 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.695 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 112.68 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.668 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.838 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.865 HD12 HD13 ' A' ' 92' ' ' ILE . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.726 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 38' ' ' LYS . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.776 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.783 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.494 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' HD2' HD11 ' A' ' 23' ' ' ILE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.903 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 92' ' ' ILE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.406 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.769 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.675 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.92 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 59' ' ' ILE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.609 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.817 HD12 HG22 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.179 0.514 . . . . 0.0 112.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE3' ' HA3' ' A' ' 13' ' ' GLY . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 1.001 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.906 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG21 ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.033 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 38' ' ' LYS . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' HD13 ' A' ' 23' ' ' ILE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.906 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.705 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.427 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 44' ' ' LEU . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.617 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.691 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.849 ' CD2' HG21 ' A' ' 72' ' ' VAL . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.019 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.033 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 1.001 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.729 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.2 0.524 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.648 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.593 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.762 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG21 HG22 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.528 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.6 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.648 ' HG3' HG21 ' A' ' 15' ' ' VAL . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.089 HD11 HD12 ' A' ' 92' ' ' ILE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.651 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.59 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.787 ' HB3' ' HE3' ' A' ' 86' ' ' LYS . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.717 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.717 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 59' ' ' ILE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.583 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.556 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.994 0.426 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.641 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.675 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.89 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.744 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.694 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.663 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.663 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HD2' ' A' ' 20' ' ' ARG . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.819 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' O ' HG21 ' A' ' 15' ' ' VAL . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.728 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.878 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.615 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.536 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.69 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.944 HD12 HD11 ' A' ' 59' ' ' ILE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.602 ' N ' HG22 ' A' ' 92' ' ' ILE . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.89 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.637 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.881 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.733 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 38' ' ' LYS . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.739 ' H ' HG13 ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CG ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.587 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.881 HG12 ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.591 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.502 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.566 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.439 ' ND2' HD12 ' A' ' 83' ' ' LEU . 4.7 p30 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.965 HD12 HD11 ' A' ' 59' ' ' ILE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.951 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.028 0.442 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.713 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.883 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 94' ' ' LEU . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.743 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.76 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.559 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.639 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.518 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.785 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.638 HG23 ' HB2' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.609 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.2 p-10 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.829 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.621 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.987 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.713 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.754 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.975 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.009 HG22 ' HA ' ' A' ' 94' ' ' LEU . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.648 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.704 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.12 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.626 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.594 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.556 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.12 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.009 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.609 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.686 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.975 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.563 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 121.113 0.482 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.639 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.899 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.943 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.778 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.735 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.834 ' O ' HD13 ' A' ' 23' ' ' ILE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG12 ' HD2' ' A' ' 20' ' ' ARG . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.639 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.619 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.703 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.566 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.538 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.724 ' HD3' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.612 ' N ' HG22 ' A' ' 92' ' ' ILE . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.943 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.691 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.784 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 112.033 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.597 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.618 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.032 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.565 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.773 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' ' 20' ' ' ARG . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG2' ' HE1' ' A' ' 46' ' ' MET . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.615 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 52' ' ' ILE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.696 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.551 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.601 ' N ' HG22 ' A' ' 92' ' ' ILE . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.032 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.695 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.618 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.945 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.956 HG21 ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.96 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.774 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.769 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.683 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.862 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.945 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.786 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CD1' HD11 ' A' ' 44' ' ' LEU . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.631 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 3.8 m-70 -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.544 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.846 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.103 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.512 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 1.7 ppt_? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.648 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.588 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.887 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.923 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.03 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.803 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.734 ' H ' HG13 ' A' ' 29' ' ' VAL . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.542 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.923 HG22 ' HD2' ' A' ' 20' ' ' ARG . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.668 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.485 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.664 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 46' ' ' MET . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.72 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.417 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.543 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.545 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.818 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.641 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' A' ' 72' ' ' VAL . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.835 HD13 HD11 ' A' ' 70' ' ' ILE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.03 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.887 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.046 0.45 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.875 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.989 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.777 ' HD2' HG22 ' A' ' 43' ' ' VAL . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.868 HG21 HG22 ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.877 HG22 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.759 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 20' ' ' ARG . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.465 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.772 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.899 HD12 HD11 ' A' ' 59' ' ' ILE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.617 ' N ' HG22 ' A' ' 92' ' ' ILE . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 60' ' ' LYS . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.755 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 94' ' ' LEU . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.772 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.75 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.613 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 15' ' ' VAL . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.832 ' HA ' HD13 ' A' ' 59' ' ' ILE . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HB3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.041 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.649 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.592 ' HA2' HD21 ' A' ' 94' ' ' LEU . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.498 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.041 HD12 HD11 ' A' ' 59' ' ' ILE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.961 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.622 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.702 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.789 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 38' ' ' LYS . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.801 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.801 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 26' ' ' THR . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.868 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.062 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.489 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.602 HG23 ' HB2' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.434 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.541 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.445 ' ND2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.887 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.062 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.644 ' CB ' HG12 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.871 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.895 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.741 ' H ' HG13 ' A' ' 29' ' ' VAL . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.69 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.871 HG22 ' HD2' ' A' ' 20' ' ' ARG . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.477 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.555 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.561 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.881 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.73 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.831 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.895 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.71 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.146 0.498 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.751 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.975 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.753 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.753 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.882 ' HD2' HD11 ' A' ' 23' ' ' ILE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.776 HG22 ' HG2' ' A' ' 20' ' ' ARG . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.03 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.817 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 55' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.502 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.03 HD12 HD11 ' A' ' 59' ' ' ILE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.589 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.975 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.694 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.886 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 . . . . . 0 C--O 1.23 0.054 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.902 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.614 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.614 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.081 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.618 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.432 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 77' ' ' GLU . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.551 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.2 p-10 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.698 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.698 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.081 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.902 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 121.345 0.593 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 99' ' ' GLU . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.924 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.797 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.787 HG21 ' CG2' ' A' ' 59' ' ' ILE . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.076 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 38' ' ' LYS . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.769 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 26' ' ' THR . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.592 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.678 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.014 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.4 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.619 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 52' ' ' ILE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.663 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.563 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.571 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.076 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.924 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.797 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.586 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' NE ' ' HB2' ' A' ' 45' ' ' ALA . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.969 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.771 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB3' HG23 ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.633 HG22 ' HD2' ' A' ' 20' ' ' ARG . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.78 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.716 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.726 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.747 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.744 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.701 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.747 ' CD2' HG21 ' A' ' 72' ' ' VAL . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.61 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.969 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.591 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.628 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.566 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.669 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.707 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.749 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.814 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.637 ' H ' HG13 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' SER . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.744 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.669 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.773 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.057 HD11 HD12 ' A' ' 92' ' ' ILE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.772 HG23 ' HB2' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CG ' HD21 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.814 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.651 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 92' ' ' ILE . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.01 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.604 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 121.08 0.466 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 1.012 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG12 HG23 ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.763 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.549 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG22 ' HD2' ' A' ' 20' ' ' ARG . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.695 HD12 HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.72 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.446 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.021 HD11 HG13 ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.855 ' CE2' HG11 ' A' ' 72' ' ' VAL . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.437 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 94' ' ' LEU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 52' ' ' ILE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.49 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.834 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.763 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.579 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.284 0.564 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.787 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.994 HG22 ' HA ' ' A' ' 94' ' ' LEU . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.769 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 38' ' ' LYS . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.641 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.863 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 23' ' ' ILE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.654 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.725 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.796 ' HA3' HG12 ' A' ' 72' ' ' VAL . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.812 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.492 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HD2' ' NE2' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.612 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.796 HG12 ' HA3' ' A' ' 54' ' ' GLY . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.66 ' CD2' HD21 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.532 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.889 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.863 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 70' ' ' ILE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.994 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.856 ' HD2' HG12 ' A' ' 43' ' ' VAL . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.898 HD12 HD13 ' A' ' 92' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.782 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.736 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.661 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.697 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' HG21 ' A' ' 15' ' ' VAL . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.483 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.706 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.551 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 59' ' ' ILE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.762 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.198 0.523 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.961 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.863 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 97' ' ' VAL . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 94' ' ' LEU . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.752 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.738 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.725 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.85 ' HA ' HD13 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 94' ' ' LEU . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG21 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.553 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.925 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.729 ' HE2' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.784 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.709 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HG21 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.012 HD12 HD11 ' A' ' 59' ' ' ILE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.611 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.992 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.775 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.762 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.119 0.485 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.736 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.693 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HD2' HD11 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.763 HD12 HG21 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.592 ' HG3' HG21 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' THR . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' HA ' HD13 ' A' ' 59' ' ' ILE . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.075 HD11 HD12 ' A' ' 92' ' ' ILE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.713 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.742 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.742 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.036 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.979 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.652 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.826 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 97' ' ' VAL . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.005 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.632 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.785 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.826 HG12 ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.72 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.995 HD11 HG13 ' A' ' 72' ' ' VAL . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.461 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.691 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.995 HG13 HD11 ' A' ' 52' ' ' ILE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.588 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.005 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.729 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.179 0.514 . . . . 0.0 112.054 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.677 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.687 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.884 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.927 HG22 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.748 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' SER . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 23' ' ' ILE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.829 ' HE1' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.829 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.415 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.4 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CG ' HD21 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.468 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.895 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.659 ' CE ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.724 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.724 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.976 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.607 ' N ' HG22 ' A' ' 92' ' ' ILE . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.927 HD12 HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.52 112.98 23.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -153.57 -59.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.9 mtm 59.72 92.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.59 -58.85 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.68 151.38 39.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -104.87 133.48 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.058 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -140.3 151.76 45.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.082 0.468 . . . . 0.0 111.258 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -147.48 35.15 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.196 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pt-20 -73.41 134.02 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.319 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -69.1 -152.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.815 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -129.27 25.42 5.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 -157.64 23.11 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.435 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.38 -174.57 1.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.688 HG21 ' SD ' ' A' ' 46' ' ' MET . 11.9 p -68.06 149.8 11.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.268 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.4 mt-10 -136.51 163.73 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.65 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.559 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 46' ' ' MET . 41.0 mt-10 -118.3 71.71 0.84 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.941 0.4 . . . . 0.0 112.068 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.659 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 8.9 m-20 -100.19 -173.35 2.41 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -140.65 112.82 7.81 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.207 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG21 HG22 ' A' ' 59' ' ' ILE . 30.4 m -94.08 166.15 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -117.46 112.85 21.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.002 HG22 ' HA ' ' A' ' 94' ' ' LEU . 10.8 pt -130.33 150.15 34.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.0 p-10 -119.61 125.52 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.775 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.1 p90 -141.93 168.96 18.51 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 45.7 m -151.69 114.94 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.61 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -154.92 172.43 33.28 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.658 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.2 p -112.87 -82.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.284 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.813 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.11 39.71 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 -4.11 62.64 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.612 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.1 mm-40 -135.27 116.11 14.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 111.155 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.757 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 14.7 pt-20 -58.94 118.69 6.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.273 0.559 . . . . 0.0 110.973 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' A' ' 86' ' ' LYS . 10.4 p90 -84.01 -133.83 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.22 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -70.41 -60.87 2.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.319 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.3 13.17 28.58 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.217 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -59.83 -6.14 4.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.766 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 121.12 7.29 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.077 0.465 . . . . 0.0 110.864 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.52 145.76 50.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 63.8 p -114.93 -60.13 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 111.121 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -102.94 70.78 1.11 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.735 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.7 t80 -91.34 108.31 19.8 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.949 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.593 HG12 ' HG2' ' A' ' 20' ' ' ARG . 34.8 t -84.67 100.46 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.118 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.886 HD22 ' CE ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -94.69 136.38 35.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.734 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -98.14 104.18 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.394 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.79 92.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.62 26.1 12.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.759 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.621 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.3 tt0 -131.01 -56.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.82 55.41 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.629 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER 41.68 54.53 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.309 . . . . 0.0 111.757 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.886 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -51.49 94.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.109 0.48 . . . . 0.0 109.814 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -68.29 166.59 23.72 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.184 -178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.629 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 5.4 Cg_endo -49.26 -24.16 7.89 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.928 2.418 . . . . 0.0 111.899 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -75.26 -58.45 3.94 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.452 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.894 ' HA ' HD13 ' A' ' 59' ' ' ILE . 48.5 m-85 -69.87 -42.07 73.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.138 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 2.8 pt-20 -59.94 -17.28 36.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.641 0.258 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -76.83 0.21 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.484 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.72 -52.15 21.69 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.381 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.122 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -78.45 40.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 121.903 0.858 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -50.96 -53.64 31.23 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.74 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.95 43.79 1.08 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.381 -1.736 . . . . 0.0 109.36 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.421 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -125.87 -17.61 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.224 -0.988 . . . . 0.0 112.462 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.568 ' C ' HD23 ' A' ' 94' ' ' LEU . 7.8 mmtt -118.49 81.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 111.418 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.45 97.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.0 33.3 4.08 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -98.01 163.68 12.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.067 0.147 . . . . 0.0 111.105 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -129.72 106.26 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -137.37 166.77 23.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.981 0.42 . . . . 0.0 111.518 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 14.3 m -127.02 124.02 38.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.717 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.07 166.22 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.971 0.415 . . . . 0.0 111.185 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -146.38 133.54 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.441 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -146.99 124.69 11.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -84.7 139.14 37.75 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.716 0.293 . . . . 0.0 111.438 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 38.0 Cg_endo -66.95 -176.09 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.809 2.339 . . . . 0.0 112.873 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -18.67 58.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.522 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -85.99 -37.9 18.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.62 59.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' C ' ' HB3' ' A' ' 84' ' ' LYS . 18.2 m170 -99.94 76.83 1.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.059 0.457 . . . . 0.0 111.239 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.42 137.01 36.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.264 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.59 -18.4 1.13 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.492 HD21 HD12 ' A' ' 83' ' ' LEU . 1.7 p-10 -93.8 -43.01 8.82 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.926 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.31 14.4 3.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' HB3' ' C ' ' A' ' 79' ' ' HIS . 3.1 pttp -34.63 136.5 0.15 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.02 50.19 7.6 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.04 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.654 ' HE3' HD23 ' A' ' 83' ' ' LEU . 2.9 ttmm -89.75 85.12 6.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.877 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.98 92.55 7.86 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.574 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.81 -167.91 2.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.683 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.6 ttpp -128.29 141.98 51.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.683 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.8 m-30 -136.72 156.17 48.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.3 103.37 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 175.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.122 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -102.53 161.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.8 t30 -135.6 104.17 5.71 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.768 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.002 ' HA ' HG22 ' A' ' 23' ' ' ILE . 27.0 tp -66.46 156.79 33.77 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -149.79 -107.3 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.317 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.2 102.85 3.73 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.74 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.7 p -111.63 108.76 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.526 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 7.7 mm-40 -126.47 179.02 5.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.385 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -102.66 85.29 2.55 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.766 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.14 143.37 50.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.978 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 5.2 tt0 -150.12 82.08 1.37 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.434 . . . . 0.0 110.421 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.6 mp -74.47 -55.43 2.75 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 97.8 Cg_endo -78.14 139.5 17.03 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.444 2.096 . . . . 0.0 112.108 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.23 121.02 15.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.685 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.13 103.06 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.853 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -164.32 140.68 6.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.0 110.818 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.79 160.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ttt -158.38 95.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.89 101.32 14.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.983 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.8 163.55 18.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -115.58 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -142.58 160.44 40.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.336 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -147.29 38.5 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.916 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.5 mt-10 -72.24 131.96 43.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.217 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -69.27 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.232 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -127.09 20.18 6.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.666 0.27 . . . . 0.0 111.524 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.42 -161.89 29.24 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.73 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -172.65 0.49 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 111.626 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.775 HG21 ' HG3' ' A' ' 46' ' ' MET . 12.8 p -67.99 151.75 10.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.003 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -135.78 163.19 30.76 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.74 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.432 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.1 mt-10 -118.08 72.85 0.87 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.006 0.432 . . . . 0.0 111.577 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.644 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.9 m-20 -100.08 -171.62 2.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.638 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -145.15 109.58 4.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.718 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 97' ' ' VAL . 29.3 m -93.73 173.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 111.789 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -119.67 115.15 23.36 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.981 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.2 pt -129.93 153.47 38.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.55 125.38 45.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.723 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.2 p90 -141.77 166.64 24.18 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.811 HG23 ' HG2' ' A' ' 38' ' ' LYS . 8.3 m -147.44 117.79 7.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.72 164.08 35.58 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.291 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -109.46 169.12 8.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.941 0.401 . . . . 0.0 111.372 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -100.85 -80.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.743 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.2 p30 -95.38 36.99 1.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.748 0.309 . . . . 0.0 110.527 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -4.47 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -134.74 111.69 10.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -56.84 117.71 4.21 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.1 p90 -82.71 -136.38 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.273 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 15.9 mm-40 -69.96 -56.38 7.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.682 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.46 14.37 23.66 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.938 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -61.25 -10.29 20.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.744 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HG2' HG23 ' A' ' 26' ' ' THR . 28.9 mtmt -148.52 124.98 10.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.454 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.93 144.89 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 4.4 m -115.93 -61.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -102.8 70.44 1.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.658 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.6 t80 -92.46 107.39 19.18 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.215 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.4 p -80.68 100.45 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.986 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.811 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -91.93 135.09 34.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.0 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -96.91 104.48 16.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.184 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.775 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -65.51 84.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.805 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 65.49 1.21 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.079 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -122.16 -62.84 1.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.968 0.413 . . . . 0.0 110.146 179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -98.37 -54.13 1.19 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.762 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 176.85 67.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.847 0.356 . . . . 0.0 110.937 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.31 109.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.09 160.98 76.07 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.526 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 51.3 Cg_exo -54.34 -23.0 28.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.114 1.876 . . . . 0.0 111.516 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.89 -64.68 3.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.62 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.811 ' CD1' HD11 ' A' ' 44' ' ' LEU . 56.8 m-85 -70.29 -45.46 66.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.091 0.472 . . . . 0.0 110.268 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 0.9 OUTLIER -53.18 -24.0 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.269 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 24.4 t0 -80.65 -74.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.564 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.75 -59.31 8.85 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.714 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.004 HD11 HD12 ' A' ' 92' ' ' ILE . 3.3 mp -75.02 39.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.849 0.833 . . . . 0.0 110.946 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.7 mmtp -51.29 -52.92 40.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.58 37.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.875 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.52 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -124.39 16.69 8.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.94 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.705 ' O ' HD23 ' A' ' 94' ' ' LEU . 12.6 mttt -146.42 78.65 1.52 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 0.0 110.759 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.88 97.72 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.98 36.22 4.8 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.041 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -99.45 163.37 12.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.548 0.213 . . . . 0.0 111.279 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 tt0 -127.93 105.41 8.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.801 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 37.9 p90 -135.63 167.0 21.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 93.0 m -127.51 129.47 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.511 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.81 168.35 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.159 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.7 p-10 -93.01 147.04 23.17 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.73 129.6 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.272 179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.3 m -148.99 122.39 9.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.547 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.61 132.51 44.29 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.66 0.267 . . . . 0.0 111.604 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.62 174.89 6.81 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.657 2.238 . . . . 0.0 112.724 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 mt-10 -71.68 -14.12 61.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.068 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -87.36 -33.15 19.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.362 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 7.5 t80 -64.93 -69.84 0.27 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 110.102 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 22.4 m170 36.66 75.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.13 150.0 28.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 110.473 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.31 -27.98 39.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.597 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.3 -36.54 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.858 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.34 19.45 3.38 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.5 pttp -32.36 127.59 0.25 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.27 53.75 9.13 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.481 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.26 92.83 5.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -80.15 100.19 8.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.85 -173.67 3.7 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 14.8 mtmt -121.37 140.07 52.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.031 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.725 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.0 m-30 -136.59 153.27 51.0 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.63 103.71 8.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.004 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -102.27 161.83 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 5.2 t30 -135.38 104.06 5.72 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.773 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.981 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.43 155.33 37.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.6 mtmm -147.69 -109.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.276 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -72.19 103.16 3.25 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.01 106.12 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.755 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 10' ' ' GLU . 36.5 mt-10 -125.67 -173.98 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.928 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 2.0 tm-20 -109.38 89.29 2.96 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.633 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.15 164.04 11.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.883 178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 100.24 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.379 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mt -74.27 116.29 51.38 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.906 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.95 120.52 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.473 2.116 . . . . 0.0 112.549 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -74.85 -34.5 62.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.873 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -178.42 3.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.85 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.919 -0.073 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.1 p -103.4 101.89 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -94.46 -35.82 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.254 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 111.11 3.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.981 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -70.53 125.09 25.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.47 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -132.0 156.5 46.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -138.73 176.61 8.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -140.13 16.03 2.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.22 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.9 pt-20 -68.53 134.18 49.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.13 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -63.45 -150.19 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.623 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -135.95 21.58 3.28 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.692 0.282 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.91 -159.47 25.52 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.919 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.2 -174.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.99 149.59 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.663 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.546 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 17.4 mt-10 -136.38 165.76 25.04 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.87 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.311 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.2 mt-10 -117.99 71.67 0.83 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.922 0.391 . . . . 0.0 111.942 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-20 -99.98 -172.18 2.18 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -141.93 113.72 7.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.429 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.887 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.4 m -94.27 165.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 90.6 m -119.28 112.92 20.07 Favored 'General case' 0 N--CA 1.458 -0.058 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.924 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.0 pt -130.26 157.28 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -125.11 125.17 43.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.745 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.8 p90 -141.66 167.82 21.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 38' ' ' LYS . 91.3 m -146.76 116.47 7.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.738 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.542 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -162.79 165.31 36.27 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.282 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.13 175.17 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.836 0.35 . . . . 0.0 111.549 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -111.78 -73.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.714 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.63 33.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 110.17 179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -8.11 66.36 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.181 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' C ' ' HB3' ' A' ' 28' ' ' SER . 1.1 mt-10 -132.22 114.33 14.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.994 0.426 . . . . 0.0 110.163 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.93 118.89 5.41 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.666 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -82.48 -136.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.438 -178.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 32.8 mt-10 -69.81 -56.88 5.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.014 0.435 . . . . 0.0 110.518 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 11.36 34.78 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.574 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.25 -11.07 8.35 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.931 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 26' ' ' THR . 1.6 ttmt -149.63 121.33 8.07 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.967 0.413 . . . . 0.0 110.561 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.57 144.64 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.649 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -114.37 -58.38 2.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.838 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -102.94 70.55 1.1 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.631 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.8 t80 -89.59 108.12 19.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.7 t -86.94 95.75 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.52 133.8 34.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.179 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -95.91 104.45 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.532 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 2.2 mmm -67.72 81.28 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 75.95 1.16 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.165 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -132.44 -65.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.335 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.92 -56.73 0.94 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.844 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.14 67.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.41 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.86 112.35 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.19 158.8 83.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.6 Cg_endo -58.37 -21.53 53.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.394 2.062 . . . . 0.0 111.669 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.95 -61.31 5.63 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.743 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.87 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.4 m-85 -69.87 -43.96 70.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.112 0.482 . . . . 0.0 110.446 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 2.7 tt0 -54.69 -20.54 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -80.25 -75.31 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.626 0.251 . . . . 0.0 110.992 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.96 -55.61 18.52 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.294 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.106 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -77.43 40.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.862 0.839 . . . . 0.0 110.687 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -51.11 -54.12 28.04 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 44.88 0.99 Allowed Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.368 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.41 ' H ' ' CD2' ' A' ' 62' ' ' HIS . 0.4 OUTLIER -124.16 -17.28 6.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.09 -1.055 . . . . 0.0 112.419 -178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' C ' HD23 ' A' ' 94' ' ' LEU . 1.1 mtpp -118.4 81.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.86 98.33 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.43 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 99.99 36.68 4.12 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.155 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -98.31 170.07 9.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.027 0.441 . . . . 0.0 111.97 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.8 pt-20 -135.27 103.11 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.809 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.681 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 31.2 p90 -136.25 166.99 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.131 0.491 . . . . 0.0 111.646 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 75.5 m -125.34 124.82 42.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.04 166.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.646 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.4 p-10 -94.39 150.16 20.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.779 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.2 m -145.17 132.82 16.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.969 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.2 m -150.23 121.38 7.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.58 130.41 51.25 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.415 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 41.2 Cg_endo -68.05 -178.42 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.853 2.368 . . . . 0.0 113.14 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 9.2 mp0 -77.08 -9.78 58.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.436 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -89.94 -32.53 16.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.413 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.05 -69.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.146 0.498 . . . . 0.0 110.127 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.9 m170 35.51 71.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.02 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.793 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.55 146.83 31.08 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.988 0.423 . . . . 0.0 110.268 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.53 -25.03 15.1 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.57 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.31 -37.83 10.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.793 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.37 18.71 3.37 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -31.81 127.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.05 53.9 8.69 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.497 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.13 92.09 5.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.914 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -79.95 99.75 7.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.38 -172.99 3.41 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.722 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 10.0 mtmt -124.05 139.59 53.8 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.617 -1.628 . . . . 0.0 107.829 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.779 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.5 m-30 -136.59 153.9 50.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.662 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.29 103.75 8.4 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.106 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -103.0 163.47 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -173.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.0 m-20 -135.61 104.31 5.75 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.87 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.924 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -63.1 157.41 22.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.726 0.298 . . . . 0.0 111.747 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 22' ' ' THR . 4.3 mtpm? -150.98 -110.56 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.19 103.52 3.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.25 105.41 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.685 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 1.5 mt-10 -128.04 170.0 13.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.738 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -92.0 84.45 5.32 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.695 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -63.57 140.26 58.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.124 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.87 68.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.5 mp -75.02 -58.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.295 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 36.7 Cg_endo -65.52 136.68 47.49 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.332 2.021 . . . . 0.0 112.285 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -94.39 116.21 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.6 141.7 37.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.895 -179.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.65 138.63 38.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.375 . . . . 0.0 110.778 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -115.96 139.61 50.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.58 120.45 26.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.76 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -92.9 -26.95 17.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.024 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.83 147.93 41.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.196 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -127.05 137.09 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 23.3 m95 -136.44 160.08 39.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.85 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -146.64 37.2 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.33 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -72.54 132.71 44.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.68 -178.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.46 -149.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.718 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -135.38 19.03 3.36 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.721 0.296 . . . . 0.0 111.519 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.48 -162.73 29.28 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.794 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.78 -171.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 0.0 111.593 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.6 p -67.81 148.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.641 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -136.11 166.28 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.326 177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.866 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.2 pt-20 -118.37 70.21 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.031 0.443 . . . . 0.0 111.529 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.668 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.2 m-20 -99.88 -175.81 3.07 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.068 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -141.94 116.36 9.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.279 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.838 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.81 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.889 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -119.52 113.28 20.49 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.865 HD12 HD13 ' A' ' 92' ' ' ILE . 21.7 pt -127.15 158.37 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -127.36 123.88 37.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.726 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -141.69 169.23 17.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 38' ' ' LYS . 96.1 m -148.86 117.25 6.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.419 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -159.26 171.23 35.73 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.517 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.776 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.39 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.061 0.457 . . . . 0.0 111.61 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -117.57 -75.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.788 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.783 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.7 t70 -95.81 38.32 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.944 0.402 . . . . 0.0 109.964 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.76 65.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.975 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -132.19 122.63 25.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.997 0.427 . . . . 0.0 110.662 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -57.2 120.06 7.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.042 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.494 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 2.6 p90 -83.07 -135.96 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.163 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.4 mt-10 -70.15 -53.73 16.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.005 0.431 . . . . 0.0 110.93 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.28 12.2 39.84 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.59 -9.97 5.53 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.155 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.3 OUTLIER -149.54 122.52 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 111.175 179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.69 143.52 48.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.239 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.3 t -113.61 -60.57 1.86 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -102.88 71.0 1.13 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' HD2' HD11 ' A' ' 23' ' ' ILE . 10.4 t80 -91.12 106.49 18.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.903 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.4 p -80.13 97.96 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.594 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.89 130.8 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -95.64 104.9 16.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.263 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -70.07 83.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 111.372 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.61 66.18 0.84 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.066 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -66.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.59 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.75 -55.94 0.98 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.088 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.57 66.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 110.294 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.48 113.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.302 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pt -68.62 162.63 61.34 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.681 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 23.0 Cg_endo -60.71 -17.58 50.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.346 2.031 . . . . 0.0 111.852 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.73 -59.69 4.29 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.634 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.843 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.1 m-85 -71.29 -49.96 37.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -49.96 -22.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.076 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 12.8 t0 -79.7 -76.15 0.22 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.64 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.37 -52.45 43.59 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.448 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 92' ' ' ILE . 2.4 mp -81.62 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-O 121.518 0.675 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.3 ptmt -51.22 -51.13 56.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.9 48.35 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.163 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.15 -12.36 7.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.689 -0.755 . . . . 0.0 113.022 -178.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 24.1 mmtp -127.0 87.76 2.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.698 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.54 97.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.139 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.18 37.2 3.17 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.528 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 21.0 tp10 -98.47 164.06 12.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.6 tt0 -130.65 105.4 7.8 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.1 p90 -138.89 166.91 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 111.395 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 37.0 m -126.74 126.79 44.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.679 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.14 168.19 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.13 0.491 . . . . 0.0 111.168 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -93.38 149.83 20.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -146.46 129.56 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.067 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 4.6 m -149.12 123.01 9.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.3 m-85 -84.8 129.94 54.76 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -178.19 2.82 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.955 2.437 . . . . 0.0 113.257 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 6.2 pt-20 -76.63 -10.23 59.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.186 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.43 -37.06 18.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.371 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.1 t80 -67.2 -69.39 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.4 m170 32.81 73.98 0.06 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.34 140.13 30.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.998 0.428 . . . . 0.0 110.432 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -24.68 0.42 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.516 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.07 -39.28 10.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.769 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.11 17.52 3.45 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -34.93 130.89 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.54 48.14 28.68 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.451 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 95.31 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -82.54 104.58 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.3 -171.71 3.03 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.675 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.87 139.2 52.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.218 177.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.92 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.65 155.07 50.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.793 0.33 . . . . 0.0 111.697 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.13 103.38 8.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.042 HD12 HD11 ' A' ' 59' ' ' ILE . 4.3 mt -101.99 162.77 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.609 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.69 104.58 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.818 -1.537 . . . . 0.0 109.068 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.817 HD12 HG22 ' A' ' 23' ' ' ILE . 16.0 tp -66.41 156.74 33.76 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 79.5 mttt -150.46 -106.35 0.07 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.346 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.58 105.54 19.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.508 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.8 mp0 -126.03 -176.62 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.254 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.804 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -107.67 89.74 3.09 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.22 176.28 5.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.964 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 177.96 72.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.979 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -104.08 92.64 4.71 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.05 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.07 112.18 2.88 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.377 2.052 . . . . 0.0 112.538 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 136.68 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.84 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 85.36 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.98 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -164.69 179.42 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.74 149.54 48.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.41 95.57 3.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.793 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -72.0 138.04 47.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.13 151.18 27.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.041 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.34 138.38 41.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.275 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.434 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 44.5 m95 -139.29 156.56 46.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.523 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -147.17 31.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.209 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.0 pt-20 -70.78 137.19 49.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.201 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE3' ' HA3' ' A' ' 13' ' ' GLY . 2.2 pttt -65.78 -158.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.887 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -128.58 25.13 5.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.627 0.251 . . . . 0.0 111.54 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 97' ' ' VAL . . . -110.79 -153.58 13.29 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.897 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 -173.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.015 0.436 . . . . 0.0 111.982 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.8 p -66.46 155.38 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.113 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 8.4 mt-10 -135.42 158.88 43.26 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.2 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.883 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 46' ' ' MET . 21.8 mt-10 -117.69 68.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.19 0.519 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 1.001 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.61 -170.91 1.92 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.514 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.906 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -140.1 117.53 11.42 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.776 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG21 ' CG2' ' A' ' 59' ' ' ILE . 20.7 m -93.55 165.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.926 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 96.3 m -120.22 112.86 19.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.033 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -131.12 155.79 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.4 p-10 -121.67 127.34 50.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.72 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.5 p90 -141.82 167.06 23.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.776 HG23 ' HG3' ' A' ' 38' ' ' LYS . 63.5 m -148.01 113.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.858 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.18 172.52 34.67 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.808 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 178.26 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.227 -0.486 . . . . 0.0 111.428 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.4 p -114.57 -80.38 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.807 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.28 40.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.052 0.453 . . . . 0.0 110.051 179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -10.54 66.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.211 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -134.85 120.77 19.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.019 0.438 . . . . 0.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -58.15 120.16 8.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.344 0.593 . . . . 0.0 111.038 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 8.1 p90 -83.4 -135.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.107 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -70.39 -58.76 3.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.165 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.79 14.02 21.22 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.285 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.83 -6.94 7.28 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.823 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.776 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.0 OUTLIER -146.53 121.63 10.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.963 0.411 . . . . 0.0 111.205 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.19 143.44 47.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.565 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -114.57 -60.34 1.9 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.13 0.49 . . . . 0.0 110.581 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.14 71.41 1.12 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' O ' HD13 ' A' ' 23' ' ' ILE . 13.5 t80 -90.3 110.14 21.22 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.071 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.906 HG22 ' HG2' ' A' ' 20' ' ' ARG . 9.3 p -85.38 98.37 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.804 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -91.03 134.59 34.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.052 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.79 104.68 16.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.705 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -68.89 84.76 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.133 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.98 67.8 0.98 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.073 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.32 -64.65 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.48 0.91 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.747 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.427 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.15 69.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.0 110.547 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.404 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.76 112.93 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.238 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.39 161.95 65.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.58 -21.17 61.09 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.624 2.216 . . . . 0.0 112.373 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.82 -57.46 5.34 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.804 ' CD1' HD11 ' A' ' 44' ' ' LEU . 40.6 m-85 -70.46 -42.65 71.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.998 0.428 . . . . 0.0 110.006 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 15.9 tt0 -58.8 -17.39 23.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.605 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -77.87 0.16 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.218 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -71.66 -50.94 17.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.109 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.47 36.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.467 0.651 . . . . 0.0 111.632 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' GLY . 1.4 mttt -48.43 -53.07 19.17 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.617 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.4 44.12 1.02 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 113.609 -1.632 . . . . 0.0 109.944 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.1 -9.64 7.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.465 -0.868 . . . . 0.0 112.333 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -123.38 81.3 1.87 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.56 93.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.774 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.33 38.08 2.17 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.501 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -97.67 167.84 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.292 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -136.12 99.78 4.23 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.799 178.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -136.07 167.13 21.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 0.0 111.897 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 4.0 t -124.58 127.33 47.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.37 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.28 165.29 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 120.89 0.376 . . . . 0.0 110.715 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.0 t70 -94.69 150.34 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.849 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.9 134.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.188 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 87' ' ' ALA . 29.3 m -145.7 123.18 11.71 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.3 m-85 -85.35 127.71 62.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 44.9 Cg_endo -68.13 176.28 5.65 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.725 2.283 . . . . 0.0 112.959 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.1 pt-20 -71.42 -12.61 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.445 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -86.23 -33.49 20.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.691 0.282 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.443 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -67.23 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.026 0.441 . . . . 0.0 110.296 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.3 m170 34.41 73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.06 151.34 25.02 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.903 0.383 . . . . 0.0 110.681 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -54.39 -27.34 35.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.17 -36.62 11.4 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.46 17.76 3.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.93 125.35 0.27 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.67 51.76 32.0 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.736 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -99.07 91.79 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.96 97.74 5.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -136.81 -172.71 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.691 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.43 139.95 53.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.787 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.849 ' CD2' HG21 ' A' ' 72' ' ' VAL . 11.7 m-30 -136.91 156.46 48.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.914 0.388 . . . . 0.0 111.701 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.75 103.64 8.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.019 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -101.93 163.01 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 38.8 m-20 -135.44 104.82 5.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.301 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.033 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -65.51 155.83 34.43 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 27.7 mttp -151.77 -104.98 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.132 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 103.44 6.02 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.05 106.42 20.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.72 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 7.7 mt-10 -133.42 168.25 18.96 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.381 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 1.001 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.0 tt0 -92.53 91.69 7.71 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.729 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.77 168.48 13.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.111 178.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -165.69 104.4 0.7 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.668 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 mt -74.41 151.72 87.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.331 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.47 132.3 50.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.386 2.057 . . . . 0.0 112.195 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -97.39 -69.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.756 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.34 109.55 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.902 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -83.31 147.75 27.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -142.14 143.09 32.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.972 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -133.92 158.68 42.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -95.96 -71.78 0.66 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.55 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.9 150.94 50.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.633 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 54.8 m95 -144.0 166.86 23.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.227 0.537 . . . . 0.0 111.583 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 8' ' ' TRP . 1.4 mmmt -143.65 16.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.235 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 15.3 pt-20 -65.69 140.74 58.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.298 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -66.18 -150.13 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -133.81 20.03 3.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -161.04 29.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.841 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.44 -171.93 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.901 0.382 . . . . 0.0 111.696 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.648 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.8 152.49 9.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.25 164.22 28.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.82 -74.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.318 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 46' ' ' MET . 51.1 mt-10 -118.05 70.09 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.108 0.48 . . . . 0.0 111.571 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.593 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.3 m-20 -99.73 -170.8 1.95 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.287 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.762 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 20.9 mtt85 -145.44 116.54 7.87 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.795 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG21 HG22 ' A' ' 59' ' ' ILE . 13.6 m -93.08 169.19 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.082 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 46.9 m -122.37 114.09 20.27 Favored 'General case' 0 C--O 1.228 -0.043 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -134.61 154.67 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -119.81 128.87 54.11 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' CB ' HG12 ' A' ' 92' ' ' ILE . 17.0 p90 -144.25 166.92 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -148.06 114.2 5.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.416 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.57 169.63 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.183 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.1 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.904 0.383 . . . . 0.0 111.313 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.766 HG22 ' HB2' ' A' ' 88' ' ' ALA . 21.5 t -109.44 -81.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -95.47 40.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.934 0.397 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -14.1 64.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.123 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -129.87 120.86 25.6 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.996 0.427 . . . . 0.0 110.323 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.1 pt-20 -63.16 122.25 15.65 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.451 0.643 . . . . 0.0 111.205 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.528 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -82.29 -137.2 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.555 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 35.7 mm-40 -70.34 -54.13 13.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.076 0.465 . . . . 0.0 110.646 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.82 13.5 24.0 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.85 -10.04 7.95 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.148 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.72 123.24 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.161 0.505 . . . . 0.0 111.004 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.75 144.5 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.103 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 71.0 p -114.5 -57.09 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.017 0.437 . . . . 0.0 110.878 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.15 70.5 1.07 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.6 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.7 t80 -87.66 117.07 26.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.549 HG11 ' CZ2' ' A' ' 8' ' ' TRP . 60.7 t -94.65 95.76 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 110.156 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.25 141.82 28.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.938 -178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -104.86 104.35 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.266 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.648 ' HG3' HG21 ' A' ' 15' ' ' VAL . 7.3 mmm -68.69 79.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.047 0.451 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.88 73.44 0.91 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.846 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -130.37 -68.11 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.01 -57.19 0.92 Allowed Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.081 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.8 65.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 110.087 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HG2' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -46.36 112.95 0.55 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.282 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.3 pt -68.55 161.54 69.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.748 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.0 Cg_endo -60.18 -17.03 43.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.255 1.97 . . . . 0.0 111.769 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.52 -60.55 4.98 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.188 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.829 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.9 -45.25 61.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.786 0.327 . . . . 0.0 110.835 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' ' HG2' ' A' ' 51' ' ' MET . 1.9 tt0 -54.73 -20.69 8.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 26.1 t70 -80.08 -77.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.921 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.49 -54.28 27.19 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.632 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.089 HD11 HD12 ' A' ' 92' ' ' ILE . 1.7 mp -80.63 38.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.653 0.739 . . . . 0.0 111.011 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -51.76 -52.21 50.47 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.42 57.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.434 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -123.62 -38.33 2.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -115.86 96.01 5.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.321 0.581 . . . . 0.0 110.552 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.42 103.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.522 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 106.86 36.27 2.6 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HB2' ' CG ' ' A' ' 63' ' ' LYS . 30.5 tt0 -94.67 165.74 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 111.944 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 7.6 pt-20 -135.84 103.31 5.35 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.541 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.2 p90 -138.8 167.17 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.077 0.465 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.0 m -124.92 122.8 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.598 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.03 165.84 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.887 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.69 148.76 21.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -145.95 133.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.737 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 18.6 m -147.77 122.26 9.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.49 128.15 60.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.573 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 36.0 Cg_endo -65.95 176.04 4.1 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.562 2.174 . . . . 0.0 112.827 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 23.0 tt0 -71.18 -13.75 62.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.428 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.75 -33.34 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.224 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.7 t80 -66.34 -69.97 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.118 0.485 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 32.64 79.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.271 -0.877 . . . . 0.0 113.263 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.651 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -86.85 149.08 25.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.986 0.422 . . . . 0.0 110.355 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.47 -26.04 7.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.59 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.38 -40.73 9.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -132.63 18.82 4.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 5.5 pttt -34.15 127.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.0 52.36 26.67 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.434 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -98.68 96.96 8.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -85.17 87.27 7.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.787 ' HB3' ' HE3' ' A' ' 86' ' ' LYS . . . -126.99 -175.9 3.55 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.717 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 9.5 mtmt -121.28 139.2 53.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.086 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.717 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.7 154.2 50.67 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.79 103.69 8.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 59' ' ' ILE . 4.9 mt -104.22 164.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.619 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.1 m-80 -135.35 104.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.588 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.3 tp -62.36 152.44 33.99 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.6 mtmp? -147.88 -110.26 0.08 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.059 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 10.5 mttt -72.79 103.18 3.59 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.583 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.73 110.23 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.009 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 2.4 mp0 -137.13 178.66 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.308 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.7 tm-20 -100.17 85.86 3.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.556 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.48 139.29 58.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.764 178.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -164.74 84.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 5.5 mp -74.73 -58.89 1.6 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.164 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.767 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 32.1 Cg_exo -57.99 145.65 90.63 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.009 1.806 . . . . 0.0 111.99 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.83 123.07 25.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.97 126.56 47.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.945 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.91 -179.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -98.14 169.21 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -142.77 -177.73 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 mmm -102.75 161.37 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -55.49 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.12 159.82 28.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.97 150.64 25.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -145.6 166.16 26.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.23 26.77 1.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.024 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.4 mt-10 -61.01 139.1 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.977 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -156.79 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.74 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.44 19.86 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.556 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.43 -160.42 26.07 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.941 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.97 -169.57 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.947 0.403 . . . . 0.0 111.748 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.9 p -67.82 149.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 13.6 mt-10 -136.18 165.03 26.69 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.61 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 46' ' ' MET . 17.2 mt-10 -118.25 71.41 0.83 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.912 0.387 . . . . 0.0 111.73 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.641 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 12.3 m-20 -99.92 -172.89 2.31 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.675 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.1 mmt180 -142.26 114.04 8.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.212 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.3 m -93.74 167.91 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.8 m -118.61 113.1 20.72 Favored 'General case' 0 N--CA 1.46 0.042 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.89 HG22 ' HA ' ' A' ' 94' ' ' LEU . 17.4 pt -128.49 156.31 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.5 p-10 -124.69 123.6 40.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.744 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.8 p90 -141.91 169.84 16.83 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -151.18 118.17 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.929 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.02 171.27 36.29 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.485 -0.865 . . . . 0.0 113.282 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.2 168.47 9.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 111.596 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.3 p -115.42 -66.15 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.028 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.694 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.77 35.77 1.35 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 -14.16 64.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.808 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.32 131.55 36.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.58 116.9 3.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.652 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.663 ' CD2' ' HG3' ' A' ' 35' ' ' GLU . 1.6 p90 -83.23 -135.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.663 ' HG3' ' CD2' ' A' ' 34' ' ' PHE . 2.6 pp20? -70.9 -51.03 28.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.886 0.374 . . . . 0.0 111.059 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.2 13.39 59.92 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.393 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.96 -9.32 10.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.182 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.41 121.48 7.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.211 0.529 . . . . 0.0 110.612 179.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.43 146.66 51.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 25.4 p -115.05 -58.65 2.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.12 70.93 1.09 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 6.4 t80 -90.19 107.71 19.3 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.235 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HD2' ' A' ' 20' ' ' ARG . 40.9 t -84.5 96.42 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.581 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.81 138.44 31.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -99.36 104.66 16.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.93 80.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.048 -179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.21 69.99 0.88 Allowed Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.788 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -127.14 -67.9 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 110.497 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.11 -54.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.843 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' NE ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.01 67.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.597 179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.24 110.76 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.712 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.87 156.45 91.27 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 50.9 Cg_exo -52.18 -24.18 19.71 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.211 1.941 . . . . 0.0 111.613 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.41 -62.36 4.92 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.919 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.819 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.2 m-85 -69.99 -42.26 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.996 0.427 . . . . 0.0 110.716 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 3.3 tt0 -55.18 -23.05 19.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 1.5 t70 -80.18 -74.94 0.28 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.491 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.79 -54.44 28.37 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.398 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -81.31 38.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.65 0.738 . . . . 0.0 111.477 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' O ' HG21 ' A' ' 15' ' ' VAL . 13.7 mttt -51.66 -51.61 54.48 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.728 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.01 40.1 1.46 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.12 14.36 8.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.334 -0.933 . . . . 0.0 111.907 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.878 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 11.0 mmtt -146.68 81.12 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.811 0.338 . . . . 0.0 111.633 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.46 95.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.77 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.03 4.19 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.096 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.878 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 5.0 tp10 -99.25 159.3 15.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.458 0.171 . . . . 0.0 111.121 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 34.7 tt0 -124.57 108.5 12.14 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 24.1 p90 -138.49 166.66 23.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.435 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 8.8 m -126.29 130.62 51.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -138.99 165.75 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.108 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.9 p30 -94.95 147.72 23.08 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -144.92 134.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.815 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.5 m -148.91 122.72 9.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.615 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -85.33 129.98 53.41 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.711 0.291 . . . . 0.0 111.687 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.536 ' HG3' ' NE ' ' A' ' 50' ' ' ARG . 42.4 Cg_endo -70.16 -174.91 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.818 2.346 . . . . 0.0 113.445 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 15.9 mt-10 -77.11 -13.59 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.944 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.27 -32.83 19.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.645 0.259 . . . . 0.0 111.035 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 2.7 t80 -67.09 -69.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.426 . . . . 0.0 110.042 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.0 m170 34.12 62.49 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.678 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -73.35 147.56 44.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -52.98 -26.01 13.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.23 -38.22 10.66 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.64 18.22 3.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.4 pttp -30.0 125.23 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.07 54.35 12.42 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.648 -0.706 . . . . 0.0 114.349 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -99.36 92.84 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 73' ' ' THR . . . -78.94 91.24 4.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.69 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -127.34 -174.18 3.1 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.716 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.93 139.14 53.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.797 -1.547 . . . . 0.0 107.599 178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 16.5 m-30 -137.25 156.12 48.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.72 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.944 HD12 HD11 ' A' ' 59' ' ' ILE . 2.7 mt -103.05 161.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.602 ' N ' HG22 ' A' ' 92' ' ' ILE . 4.3 t30 -135.6 104.39 5.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.011 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.89 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.2 tp -65.61 157.1 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.1 mmmm -148.76 -108.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.4 103.11 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.9 p -111.5 105.74 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.437 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.3 mp0 -122.53 -167.9 1.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.098 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -117.74 90.37 3.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.841 -179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.66 166.32 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.523 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -171.71 61.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.245 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.429 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 9.6 mp -74.55 148.35 85.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.49 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.38 121.24 8.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.681 2.254 . . . . 0.0 112.231 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.69 96.49 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.21 101.07 13.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.902 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -139.35 -48.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -135.87 160.51 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.707 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -120.27 -54.2 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.77 -177.22 4.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.762 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.92 23.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.152 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -104.92 139.64 39.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.617 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 47.2 m95 -139.88 157.1 46.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.633 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -147.12 28.47 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.134 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 8.4 pt-20 -71.99 135.26 46.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.279 0.561 . . . . 0.0 112.181 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -68.02 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.753 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -139.15 20.07 2.61 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.599 0.237 . . . . 0.0 111.376 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.04 -161.6 30.73 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.779 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 -173.76 0.59 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.861 0.362 . . . . 0.0 111.762 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.591 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.9 p -67.82 149.53 11.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.473 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 12.9 mt-10 -135.74 165.63 25.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.153 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.3 pt-20 -118.65 72.01 0.86 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.951 0.405 . . . . 0.0 111.856 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.637 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 23.7 m-20 -100.31 -171.68 2.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.881 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -146.46 111.79 5.48 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.908 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 97' ' ' VAL . 21.3 m -93.84 171.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.8 m -118.17 112.76 20.57 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.5 pt -127.6 153.16 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.5 p-10 -122.44 125.36 45.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.733 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.9 p90 -141.79 167.96 20.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.515 HG23 ' CG ' ' A' ' 38' ' ' LYS . 3.4 m -149.22 117.51 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.932 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -160.17 172.63 36.67 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.376 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.4 p -110.2 167.72 9.98 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 112.057 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -109.83 -70.91 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.011 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.739 ' H ' HG13 ' A' ' 29' ' ' VAL . 12.4 p-10 -95.69 37.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.173 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -11.69 66.67 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.756 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -135.23 129.41 33.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.756 0.313 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.06 116.56 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.79 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.16 -135.11 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.655 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.3 -57.48 4.82 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 14.04 46.89 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.048 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . . . -62.5 -6.83 12.19 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.463 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' CG ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -145.35 119.82 9.69 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.899 0.38 . . . . 0.0 110.463 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.62 144.83 49.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 22.8 t -116.2 -60.19 1.89 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -103.23 70.22 1.05 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.587 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.9 t80 -92.48 106.3 18.32 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.943 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.881 HG12 ' HD2' ' A' ' 20' ' ' ARG . 25.4 t -84.22 97.32 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.151 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.54 144.62 25.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.848 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.627 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -106.22 104.75 14.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.591 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.59 77.98 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.796 0.332 . . . . 0.0 110.805 179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 105.12 59.78 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.103 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.87 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.17 -53.34 1.09 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.234 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.27 70.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.33 . . . . 0.0 110.518 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.45 109.71 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -68.72 159.01 84.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.74 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.3 Cg_exo -55.3 -19.77 22.91 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.106 1.871 . . . . 0.0 111.418 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.59 -62.87 3.62 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.756 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 59' ' ' ILE . 56.8 m-85 -71.28 -47.47 56.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.862 0.363 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -50.01 -26.3 4.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.248 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 21.4 t0 -78.91 -74.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.382 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.47 -56.51 22.93 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.433 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -80.21 39.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.549 0.69 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.66 -51.26 57.25 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 176.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.68 47.28 0.85 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.276 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.502 ' NE2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -124.36 -18.19 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -118.38 85.61 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.976 -179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.5 95.35 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.283 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.89 34.36 3.51 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.843 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 6.2 tp10 -99.62 162.09 13.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 2.9 tt0 -127.57 106.6 9.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.606 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.566 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 33.9 p90 -138.0 166.81 23.15 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.391 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.2 m -126.83 128.03 45.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.902 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.47 167.51 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.043 0.449 . . . . 0.0 111.108 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 7.2 p-10 -94.62 148.6 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -145.56 131.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.232 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 87' ' ' ALA . 15.8 m -149.26 123.76 9.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.9 m-85 -85.02 126.02 68.95 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.696 0.284 . . . . 0.0 111.583 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.2 Cg_endo -64.87 -179.96 1.18 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.766 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 17.5 pt-20 -76.63 -9.39 58.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.192 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -86.22 -30.67 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.91 -70.77 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.239 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.7 m170 33.6 73.72 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -89.97 144.6 25.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.593 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -14.44 0.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.439 ' ND2' HD12 ' A' ' 83' ' ' LEU . 4.7 p30 -94.93 -48.4 6.01 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.24 18.5 3.41 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -29.22 125.15 0.12 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.85 54.28 14.77 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.249 -0.887 . . . . 0.0 114.187 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.09 90.23 4.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.047 0.423 . . . . 0.0 111.753 179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -77.61 92.06 4.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -126.85 -172.11 2.57 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -129.09 139.85 51.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.639 178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -137.24 156.95 47.67 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.59 103.52 8.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.965 HD12 HD11 ' A' ' 59' ' ' ILE . 2.3 mt -101.77 162.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 t30 -135.68 104.92 5.95 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.494 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.951 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.0 tp -67.66 153.4 43.78 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -147.68 -106.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.861 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 102.83 3.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.03 105.45 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.505 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.7 mt-10 -126.56 -172.36 2.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.33 -0.148 . . . . 0.0 111.325 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 3.5 tt0 -107.92 83.26 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 3.3 ppt_? -65.07 173.79 2.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.139 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 173.4 92.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.666 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mt -74.42 143.43 79.48 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.307 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.4 135.66 37.31 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.518 2.145 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.94 -45.12 9.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.055 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -103.56 93.66 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.996 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.815 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.2 m -141.31 165.14 28.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.4 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -169.83 128.89 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.7 tpp -97.95 129.88 44.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -68.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.97 154.21 36.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.77 149.48 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -144.42 167.32 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.274 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.652 ' HD3' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.87 20.5 1.28 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.17 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.7 pt-20 -68.84 139.52 55.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.066 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -153.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.735 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.66 20.09 6.11 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.684 0.278 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.95 -163.97 33.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.924 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -170.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.547 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 46' ' ' MET . 7.6 p -67.67 149.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.752 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.5 mp0 -136.32 164.62 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.89 -73.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mp0 -118.26 71.14 0.82 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.713 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 24.9 m-20 -99.95 -170.9 1.95 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.34 115.22 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.05 178.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.883 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.5 m -93.59 167.41 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.6 m -118.6 112.86 20.39 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 94' ' ' LEU . 37.0 pt -130.74 154.35 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -123.12 124.33 42.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.743 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.0 p90 -141.71 169.53 17.43 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 18.8 m -150.47 116.91 5.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -159.09 166.76 34.71 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.572 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.23 167.69 10.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.5 p -102.77 -79.28 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.823 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.76 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.6 t70 -95.21 38.04 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 0.0 110.324 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.34 -7.13 66.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.248 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -134.88 114.87 12.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.069 0.462 . . . . 0.0 110.419 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -57.1 119.77 6.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.694 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.559 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 1.1 p90 -82.48 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.368 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.4 mm-40 -70.23 -54.42 12.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.9 10.43 47.15 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.813 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.25 -10.03 4.97 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.042 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.28 122.48 7.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.68 145.6 50.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.302 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 2.1 p -114.15 -59.57 2.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -103.03 71.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.814 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.6 t80 -89.53 107.72 19.24 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.4 t -85.09 96.87 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.106 0.479 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.8 134.83 33.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.923 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.82 105.32 17.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.282 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 30.2 mmt -65.49 86.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.475 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 55.94 1.36 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.797 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -134.67 -67.9 0.55 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.372 . . . . 0.0 110.401 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.13 66.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.058 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.95 60.64 1.66 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 111.866 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.639 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 3.6 mtp -48.97 113.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pt -67.57 161.33 66.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.57 -31.71 92.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.446 2.098 . . . . 0.0 111.628 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -55.38 -60.31 9.03 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.611 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 43.7 m-85 -68.62 -44.19 74.76 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.4 . . . . 0.0 110.253 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.85 -19.66 12.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.015 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -78.28 -76.24 0.2 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.823 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -69.41 -53.11 18.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.697 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 1.8 mp -79.84 38.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.583 0.706 . . . . 0.0 111.264 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' GLY . 4.0 mtpt -50.44 -51.96 42.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.58 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.98 45.29 0.96 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 113.755 -1.566 . . . . 0.0 109.865 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.17 -15.74 6.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.435 -0.882 . . . . 0.0 112.604 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtp -120.19 84.05 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.48 96.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.244 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.78 35.72 3.68 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.763 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.789 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 47.9 tt0 -99.0 166.84 11.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.937 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 5.7 tt0 -131.96 105.57 7.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.578 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 25.4 p90 -137.67 167.06 22.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.084 0.469 . . . . 0.0 111.231 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 72.0 m -126.33 125.3 42.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.54 168.14 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.96 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.518 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.2 p-10 -93.99 150.36 20.41 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.785 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.4 m -145.55 130.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.958 0.409 . . . . 0.0 110.993 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.638 HG23 ' HB2' ' A' ' 87' ' ' ALA . 23.8 m -150.03 122.45 8.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.2 m-85 -84.78 135.88 39.74 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.07 -175.28 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.738 2.292 . . . . 0.0 112.66 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.09 -17.68 58.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -86.22 -37.95 18.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.916 0.388 . . . . 0.0 110.134 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -76.61 71.94 3.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.411 178.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.9 m170 -110.77 79.05 1.16 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.899 0.38 . . . . 0.0 111.475 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -82.72 139.89 33.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.48 -19.56 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.609 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.2 p-10 -92.5 -44.9 8.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.849 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.4 17.0 3.4 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -33.9 127.57 0.39 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.36 54.92 7.06 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.152 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.95 95.55 7.24 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.829 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -84.7 99.08 10.6 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -137.97 -174.27 3.74 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.711 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -120.94 139.62 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 113.979 -1.464 . . . . 0.0 108.084 178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' CD2' HG21 ' A' ' 72' ' ' VAL . 14.5 m-30 -136.53 152.38 50.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.75 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.38 103.81 8.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -102.47 164.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -173.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.621 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.6 m-80 -135.05 104.67 6.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.942 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.987 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.9 tp -66.55 156.11 35.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.688 0.28 . . . . 0.0 111.511 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 5.1 mttm -150.32 -107.98 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.445 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.67 102.83 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -112.07 107.41 22.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.508 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 14.3 mp0 -123.2 -167.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.433 0.16 . . . . 0.0 111.433 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.713 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -115.46 87.55 2.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.95 0.405 . . . . 0.0 111.929 -179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.754 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.61 146.28 44.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.999 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -156.01 61.68 0.58 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.342 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.671 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.5 mp -75.71 -51.09 3.16 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.032 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 20.2 Cg_exo -65.69 130.89 26.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.312 2.008 . . . . 0.0 111.888 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.2 38.82 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.11 -175.49 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.681 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.87 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.92 -38.73 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -107.33 143.29 35.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.64 102.06 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.6 121.69 24.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.025 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.74 155.93 26.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.86 138.57 48.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.766 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -138.45 152.45 48.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.133 0.492 . . . . 0.0 111.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' NZ ' ' HA ' ' A' ' 104' ' ' GLU . 3.5 ptmt -147.42 30.66 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -67.36 142.1 56.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.347 0.594 . . . . 0.0 112.353 -178.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.5 pttt -69.04 -160.59 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 23.49 7.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . -106.53 -156.75 21.31 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -169.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.107 0.479 . . . . 0.0 112.291 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.1 p -67.19 152.31 9.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.42 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 4.5 mt-10 -135.12 160.08 39.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -73.17 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.636 0.585 . . . . 0.0 111.918 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' MET . 48.9 mt-10 -118.09 68.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.767 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.975 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -100.69 -170.46 1.86 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.695 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -140.28 114.07 8.84 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.342 -179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.8 m -94.42 164.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.2 m -116.03 113.69 23.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.009 HG22 ' HA ' ' A' ' 94' ' ' LEU . 4.9 pt -130.25 152.13 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.648 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -120.84 124.92 46.21 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.704 ' CB ' HG12 ' A' ' 92' ' ' ILE . 14.3 p90 -141.99 168.83 18.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.7 m -150.49 116.82 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.36 166.65 35.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.288 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -110.09 172.26 6.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.05 0.452 . . . . 0.0 111.538 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -110.92 -72.32 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.988 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -95.59 33.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.565 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.29 -8.25 66.91 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.059 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' C ' ' HB3' ' A' ' 28' ' ' SER . 37.4 mt-10 -135.18 117.25 15.38 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.09 0.471 . . . . 0.0 110.35 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -56.92 120.09 7.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -82.7 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.251 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 22.6 mt-10 -70.34 -55.61 8.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 0.0 110.79 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.22 10.66 41.04 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.703 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.91 -9.58 3.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.074 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 121.27 7.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.078 0.466 . . . . 0.0 110.658 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 144.63 49.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.409 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 28.7 m -113.19 -59.16 2.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.452 . . . . 0.0 111.008 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.98 71.16 1.12 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.5 t80 -91.36 107.2 19.04 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 20' ' ' ARG . 21.9 t -83.45 98.46 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.67 134.08 34.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.401 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -99.88 104.66 16.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.096 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 11.0 mmm -71.78 87.12 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.16 54.38 0.76 Allowed Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.862 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.82 -71.31 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.08 67.87 0.54 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 38.37 67.69 0.39 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.034 0.445 . . . . 0.0 111.709 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.3 114.54 0.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -68.9 159.7 81.38 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.753 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.5 Cg_endo -58.56 -19.29 44.04 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.247 1.965 . . . . 0.0 111.76 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.96 -61.91 4.6 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.753 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.0 m-85 -72.86 -44.32 61.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.942 0.401 . . . . 0.0 110.549 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 11.5 tt0 -53.93 -22.74 10.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.049 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 11.3 t0 -80.19 -75.69 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.213 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.13 -56.04 22.79 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.232 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.12 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -77.51 39.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.908 0.861 . . . . 0.0 110.817 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.7 mmtt -49.41 -54.62 16.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.626 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 48.04 0.81 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 113.507 -1.678 . . . . 0.0 109.563 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -124.05 -19.49 5.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.312 -0.944 . . . . 0.0 112.387 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -117.78 84.09 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.94 97.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.065 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 102.59 34.86 3.98 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.51 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 43.0 tt0 -98.76 165.67 11.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.658 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 13.1 pt-20 -131.37 107.66 9.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -139.89 166.92 23.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.003 0.43 . . . . 0.0 111.441 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.6 m -125.94 125.72 43.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.51 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.756 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.53 167.17 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.775 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 14.9 p-10 -94.38 151.26 19.53 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.2 m -145.83 132.15 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.938 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.671 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.8 m -152.86 122.51 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 83' ' ' LEU . 3.8 m-85 -84.7 130.81 51.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.513 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.4 177.61 2.03 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.7 tt0 -76.51 -6.49 52.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -32.7 14.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 6.0 t80 -64.04 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.109 0.48 . . . . 0.0 110.27 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.6 m170 35.08 74.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.594 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.18 151.72 22.94 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.095 0.474 . . . . 0.0 110.758 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -50.92 -29.76 12.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.556 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.29 -37.21 11.09 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.91 17.53 3.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 1.5 ptmt -30.54 124.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.14 54.07 16.58 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.576 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.06 89.33 4.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.89 103.02 7.57 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -138.17 -173.34 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.725 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.5 mtmp? -127.15 139.85 52.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.019 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.725 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.5 m-30 -136.75 154.62 50.52 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.58 103.25 8.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.12 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -102.25 164.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -173.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 92' ' ' ILE . 55.5 m-20 -136.03 104.81 5.82 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.244 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.009 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -63.33 154.46 31.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.609 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 15.4 mmtt -147.62 -114.37 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.934 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -71.63 103.75 3.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.686 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.69 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.776 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.7 mp0 -135.51 166.55 22.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.165 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.975 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tm-20 -92.26 95.55 9.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.563 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -72.98 169.45 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 178.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.589 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -179.38 112.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.409 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.528 ' HG ' HH12 ' A' ' 100' ' ' ARG . 3.6 mt -74.68 -52.81 3.48 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.033 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 41.6 Cg_endo -67.28 132.8 28.61 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.728 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.604 ' HA ' ' NZ ' ' A' ' 9' ' ' LYS . 3.7 mm-40 -84.73 -53.49 5.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.234 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -108.78 88.94 2.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.78 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.785 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 60.5 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -141.34 179.31 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.987 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -141.7 75.06 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -52.14 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.04 148.02 26.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -143.12 160.1 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 3.8 ptmt -147.18 29.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.965 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.0 mt-10 -62.3 136.79 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.098 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.72 -156.95 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.944 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 18.77 6.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.522 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.82 -160.35 25.67 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.837 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.71 -170.63 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 12.0 p -67.89 150.19 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.821 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.4 mt-10 -136.33 163.92 29.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.68 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.331 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 mm-40 -118.11 70.28 0.8 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 111.489 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.691 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.1 m-20 -100.16 -172.31 2.19 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.639 ' HD2' HG12 ' A' ' 43' ' ' VAL . 4.4 mmt180 -142.65 114.37 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.384 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.899 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.99 169.08 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 87.6 m -122.01 113.68 19.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.943 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -132.49 154.51 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.5 p-10 -120.13 125.12 47.45 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.778 ' CB ' HG12 ' A' ' 92' ' ' ILE . 21.0 p90 -142.09 168.82 18.85 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.25 114.96 4.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.014 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -156.95 169.73 34.17 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.129 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.0 168.16 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.998 0.428 . . . . 0.0 111.124 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.735 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 11.6 t -97.65 -84.05 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.064 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.17 44.06 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.15 0.5 . . . . 0.0 109.759 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.81 -11.52 66.23 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.56 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.22 132.19 48.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.558 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 54.2 mt-10 -72.99 116.5 13.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.441 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.42 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.448 -178.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.9 mt-10 -69.84 -55.59 9.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.73 13.49 29.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.688 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.77 -10.13 7.95 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.889 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -152.58 122.99 7.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.083 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.38 50.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.381 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 26.7 t -114.48 -58.31 2.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.009 0.433 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -103.02 71.21 1.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.834 ' O ' HD13 ' A' ' 23' ' ' ILE . 9.6 t80 -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.793 0.33 . . . . 0.0 110.285 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG12 ' HD2' ' A' ' 20' ' ' ARG . 38.4 t -89.78 96.31 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.097 0.475 . . . . 0.0 110.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.25 135.17 33.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.031 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.41 104.49 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.37 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.88 78.43 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 0.0 110.803 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.06 73.93 0.93 Allowed Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.005 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 2.0 mm-40 -129.53 -66.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.367 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.95 -55.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 178.56 68.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.39 . . . . 0.0 110.441 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.85 112.57 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.313 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.4 pt -68.43 159.78 79.37 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.621 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.8 Cg_endo -59.33 -15.69 30.77 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.278 1.986 . . . . 0.0 111.817 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -71.56 -60.95 4.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.638 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 59' ' ' ILE . 58.3 m-85 -71.46 -43.67 66.22 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.006 0.431 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.1 tt0 -54.74 -21.64 11.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.923 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 5.1 t70 -80.1 -75.78 0.25 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.16 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.36 -52.95 35.56 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.406 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.047 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -81.68 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.684 0.754 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.33 -51.39 54.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 176.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.639 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 47.09 0.86 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.555 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -124.1 -15.36 6.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.868 -0.666 . . . . 0.0 112.54 -178.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.619 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mmtt -119.78 84.74 2.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.808 0.337 . . . . 0.0 111.481 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 95.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.771 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.09 36.76 2.85 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.52 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tp10 -97.98 168.44 10.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.0 111.891 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 pt-20 -135.58 106.54 6.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.421 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.9 p90 -140.39 167.04 23.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.627 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 10.5 m -125.26 124.77 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.658 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.702 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.44 166.34 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.0 110.768 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.8 p30 -94.46 150.43 20.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.703 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -145.22 131.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.721 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 87' ' ' ALA . 9.6 m -150.47 122.06 8.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.566 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -85.4 131.19 48.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.763 0.316 . . . . 0.0 111.648 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 37.4 Cg_endo -67.04 -179.14 1.6 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.62 2.214 . . . . 0.0 112.9 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 24.9 tt0 -76.86 -9.58 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.317 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -89.82 -29.26 18.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.583 0.23 . . . . 0.0 111.152 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.1 t80 -70.16 -70.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.3 m170 35.56 71.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.149 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.71 150.77 27.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.019 0.438 . . . . 0.0 110.765 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.38 -29.95 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.538 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.16 -36.2 11.57 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 19.16 3.42 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.23 127.03 0.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.98 53.88 13.33 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.317 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.724 ' HD3' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -98.9 92.25 5.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -82.66 94.7 7.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -132.76 -175.23 3.7 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.183 178.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 13.6 m-30 -136.56 152.57 50.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.54 103.95 8.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.047 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -104.74 164.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -173.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.612 ' N ' HG22 ' A' ' 92' ' ' ILE . 39.6 m-20 -135.54 104.66 5.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.292 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.943 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -64.18 153.39 38.01 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 mmmt -147.72 -107.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.988 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.97 103.4 5.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.44 106.29 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.642 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 6.2 mt-10 -125.78 -176.02 3.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.276 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.691 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.7 tt0 -108.05 88.14 2.66 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -67.22 168.55 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.598 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 19.2 tt0 -170.04 61.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.521 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.444 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 6.7 mp -74.41 139.73 75.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.868 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 112.94 2.98 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.199 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.518 ' HB3' HD22 ' A' ' 105' ' ' LEU . 14.6 mm-40 -84.13 -57.95 2.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.104 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 104' ' ' GLU . 3.5 mm? -94.67 127.7 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.796 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.802 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.6 -50.63 4.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -148.95 102.86 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.857 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.13 122.72 47.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.899 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.72 170.16 16.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.2 152.28 22.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -130.04 159.32 37.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -136.48 178.15 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.138 0.494 . . . . 0.0 111.209 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -135.31 11.77 3.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.337 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.784 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.7 pt-20 -64.58 136.02 56.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.033 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -63.6 -151.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.603 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -134.7 20.33 3.56 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.634 0.254 . . . . 0.0 111.463 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.91 -161.37 28.68 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.949 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.4 -171.96 0.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.828 0.347 . . . . 0.0 111.712 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.76 148.2 12.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.819 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.83 165.56 25.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.67 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.282 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 31.7 mt-10 -118.48 71.04 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.597 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 3.9 m-20 -99.99 -172.33 2.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.618 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 4.5 mmt180 -142.6 113.17 7.33 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.306 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 ' CG2' ' A' ' 59' ' ' ILE . 35.3 m -93.57 166.23 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 93.5 m -115.85 113.69 23.71 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.032 HG22 ' HA ' ' A' ' 94' ' ' LEU . 9.5 pt -129.29 150.76 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.62 ' HB3' ' O ' ' A' ' 40' ' ' SER . 8.9 p-10 -120.05 125.75 49.09 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.638 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.3 p90 -143.02 169.89 16.72 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -152.22 118.04 5.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.17 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.43 174.27 39.65 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.882 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -110.45 174.07 6.03 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.006 0.431 . . . . 0.0 111.49 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.4 p -108.05 -80.85 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.996 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.29 41.91 1.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.6 -10.87 66.81 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.917 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -131.3 127.36 37.55 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.791 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 41.4 mt-10 -67.1 116.02 7.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.651 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.565 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.64 -136.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 3.1 mt-10 -69.97 -55.37 9.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.962 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.12 13.61 31.49 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.895 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.44 -10.96 8.5 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.023 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.39 121.76 8.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.204 0.526 . . . . 0.0 110.928 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.58 144.94 49.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.279 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 3.0 p -116.02 -56.99 2.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.661 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.21 70.9 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.773 ' HB3' HG13 ' A' ' 23' ' ' ILE . 6.3 t80 -92.42 106.43 18.42 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.049 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.528 HG12 ' HD2' ' A' ' 20' ' ' ARG . 46.7 t -84.81 97.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.595 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.639 HD11 ' CG ' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -88.79 140.65 29.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.463 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -100.45 104.82 16.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.679 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.46 78.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.109 0.48 . . . . 0.0 111.245 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 69.45 0.78 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -126.18 -66.59 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.023 0.44 . . . . 0.0 110.382 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.93 -54.11 1.07 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.966 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 77' ' ' GLU . 0.5 OUTLIER 175.32 69.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.38 112.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.898 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.025 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -68.84 164.07 49.97 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 52' ' ' ILE . 21.1 Cg_endo -60.21 -16.58 41.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.249 1.966 . . . . 0.0 111.87 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -74.22 -63.97 2.52 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.434 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.772 ' HA ' HD13 ' A' ' 59' ' ' ILE . 25.5 m-85 -65.87 -48.6 70.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.179 0.514 . . . . 0.0 109.66 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HG2' ' HE1' ' A' ' 46' ' ' MET . 5.2 tm-20 -53.13 -22.9 6.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.682 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -76.08 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -74.68 -49.14 11.27 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.189 -178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.032 HD11 HD12 ' A' ' 92' ' ' ILE . 3.5 mp -76.86 35.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.504 0.669 . . . . 0.0 111.418 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.566 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -52.28 -51.68 57.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 176.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.38 48.81 0.74 Allowed Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.068 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.2 -20.84 5.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.418 -0.891 . . . . 0.0 112.425 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.2 mmtt -116.42 83.72 2.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.717 0.294 . . . . 0.0 111.614 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.51 97.49 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.693 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.15 39.52 2.84 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -97.96 166.97 11.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 112.083 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.1 pt-20 -135.84 101.64 4.81 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 33.2 p90 -134.78 167.33 21.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.097 0.475 . . . . 0.0 112.027 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 25.7 m -124.56 116.58 22.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.16 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.667 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.89 165.04 32.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.14 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.615 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 10.5 t0 -95.94 151.23 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.025 HG13 HD11 ' A' ' 52' ' ' ILE . 18.6 t -146.6 131.69 11.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 87' ' ' ALA . 4.0 m -145.62 124.47 12.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -84.64 132.06 47.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.665 0.269 . . . . 0.0 111.36 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.8 178.99 2.94 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.712 2.275 . . . . 0.0 112.95 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 5.5 tt0 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.014 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -86.7 -32.83 20.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.28 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -63.57 -69.01 0.3 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.283 0.563 . . . . 0.0 109.746 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.1 m170 35.42 75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.39 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.696 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.99 145.75 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -49.45 -28.42 5.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.551 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.24 -37.14 11.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.829 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.08 17.94 3.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.4 pttp -33.13 123.84 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.79 53.17 30.82 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.7 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -99.06 88.19 3.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -75.99 94.8 3.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.52 -171.62 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.406 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 3.4 mppt? -134.79 139.68 45.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.05 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.8 OUTLIER -139.1 164.81 28.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.509 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.42 103.81 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.032 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -100.82 163.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.601 ' N ' HG22 ' A' ' 92' ' ' ILE . 12.7 m-20 -135.74 105.0 5.96 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.668 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.032 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.9 tp -64.02 155.99 29.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.868 0.366 . . . . 0.0 111.535 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.8 mtpt -150.38 -110.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.092 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 103.62 3.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.695 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.02 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.403 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.556 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 17.0 mt-10 -132.38 167.45 19.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.335 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.5 tm-20 -91.65 89.13 7.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.618 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -60.76 152.43 26.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.867 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -178.88 69.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.379 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.616 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 6.9 mp -74.0 169.38 19.21 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 102' ' ' LEU . 71.2 Cg_endo -76.29 131.07 12.5 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.268 1.978 . . . . 0.0 112.728 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -89.7 135.05 33.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.6 mt -103.46 170.87 7.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.585 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 63.6 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.029 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.576 -0.209 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -160.34 -44.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 m80 64.12 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 ttm -113.42 -63.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.788 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -93.56 145.57 24.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.63 156.76 36.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.207 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 144.97 37.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.95 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.54 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 58.8 m95 -143.51 162.03 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.632 ' HE2' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -147.11 26.1 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.898 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 3.1 pt-20 -69.53 133.7 47.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.377 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 38.9 mttm -63.27 -153.08 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.723 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -133.22 21.51 4.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.365 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.09 -161.08 28.46 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.675 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -174.21 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.83 0.347 . . . . 0.0 111.479 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 13.1 p -67.7 150.11 11.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.566 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -136.48 166.02 24.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.721 0.296 . . . . 0.0 110.342 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.91 -74.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.127 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 mp0 -118.27 71.87 0.85 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.845 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 8.2 m-20 -100.26 -173.11 2.34 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.945 ' HD2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -141.44 113.98 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.406 178.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.956 HG21 ' CG2' ' A' ' 59' ' ' ILE . 29.9 m -93.86 166.61 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.673 0.273 . . . . 0.0 111.63 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 97.2 m -120.28 114.49 21.96 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.96 HG22 ' HA ' ' A' ' 94' ' ' LEU . 2.4 pp -134.01 153.44 36.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.0 p-10 -120.52 126.24 49.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.472 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.774 ' CB ' HG12 ' A' ' 92' ' ' ILE . 15.2 p90 -142.62 168.89 18.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 m -149.1 116.29 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.32 168.15 34.63 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.421 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -110.43 171.68 7.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.9 0.381 . . . . 0.0 111.514 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -109.57 -75.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.795 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.769 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.4 m-20 -95.66 40.12 1.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.853 0.359 . . . . 0.0 110.289 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.61 67.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.839 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -133.7 127.52 33.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.919 0.39 . . . . 0.0 110.613 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -64.06 121.05 13.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.203 0.525 . . . . 0.0 110.615 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.5 p90 -83.23 -134.83 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.035 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.95 -57.95 4.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.65 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.83 10.6 38.53 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.743 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.683 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.0 -9.23 3.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.155 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.36 121.52 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.949 0.404 . . . . 0.0 110.659 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.16 146.41 51.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.271 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 5.0 p -115.16 -57.49 2.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.071 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.94 70.3 1.08 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.862 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.5 t80 -89.69 108.32 19.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.798 0.333 . . . . 0.0 110.249 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.945 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.8 t -87.12 96.21 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.786 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -89.97 138.07 31.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.154 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -103.17 104.58 14.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.696 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 15.9 mmm -67.9 81.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.85 64.78 0.67 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.664 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -120.92 -69.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.951 0.405 . . . . 0.0 110.306 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.87 -53.95 1.08 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.953 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.06 70.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.451 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.05 110.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.285 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.53 161.55 69.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.628 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.9 Cg_endo -59.2 -20.96 57.51 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.209 1.939 . . . . 0.0 111.429 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.63 -61.31 5.73 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.398 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.786 ' CD1' HD11 ' A' ' 44' ' ' LEU . 70.6 m-85 -72.09 -46.63 56.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.75 -25.81 3.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.239 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -79.44 -75.76 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 68' ' ' PHE . . . -61.21 -57.98 15.76 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.207 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -81.65 41.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 122.036 0.922 . . . . 0.0 110.744 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 3.9 pttt -51.57 -51.37 56.02 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.25 0.84 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.312 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.631 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 3.8 m-70 -125.67 -19.24 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 7.4 mmtt -116.09 84.89 2.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.938 0.399 . . . . 0.0 111.761 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.26 96.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.833 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.88 35.41 3.23 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.995 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.1 tt0 -98.37 164.92 12.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.702 0.251 . . . . 0.0 111.449 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -130.65 101.72 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HE1' ' HB2' ' A' ' 94' ' ' LEU . 42.8 p90 -133.91 166.73 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.825 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.4 m -126.13 126.39 44.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.76 167.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.261 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.4 p30 -94.5 148.19 22.5 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.5 m -145.77 132.25 14.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.098 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 87' ' ' ALA . 51.4 m -147.88 121.84 9.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.26 131.32 48.63 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.769 0.319 . . . . 0.0 111.615 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 43.0 Cg_endo -68.49 177.24 4.86 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.682 2.255 . . . . 0.0 112.849 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 2.2 pt-20 -74.39 -9.07 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.31 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 1.3 pt-20 -88.61 -35.0 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.701 0.286 . . . . 0.0 110.763 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 3.7 t80 -64.9 -70.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.033 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.0 m170 35.88 73.2 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.35 148.97 25.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 110.655 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.72 -27.78 12.93 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.544 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.05 -37.36 11.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.846 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.15 18.43 3.43 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 7.9 pttp -32.35 125.36 0.3 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.41 54.42 10.51 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.596 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.29 91.78 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.53 97.68 5.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.81 -171.63 2.9 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -125.21 139.87 53.35 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.889 178.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.0 m-30 -136.79 154.21 50.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.41 103.7 8.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.103 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -102.39 162.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -135.08 104.08 5.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.843 177.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.96 ' HA ' HG22 ' A' ' 23' ' ' ILE . 16.3 tp -64.45 152.74 40.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.605 0.241 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -146.65 -108.47 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.163 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -73.89 102.8 4.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.64 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.512 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 12.4 mp0 -123.93 -164.85 1.28 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.391 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.706 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 43.4 tt0 -116.79 83.73 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' CB ' ' A' ' 20' ' ' ARG . 1.7 ppt_? -70.61 118.38 13.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.11 70.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD12 ' HE2' ' A' ' 9' ' ' LYS . 7.4 mp -74.37 159.31 83.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.196 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 138.18 29.77 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.583 2.189 . . . . 0.0 112.236 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.19 95.28 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.071 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -108.59 135.81 49.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.795 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.889 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -121.22 -53.12 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.967 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -159.02 102.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.0 mtp 61.62 154.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.774 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.64 150.34 43.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -121.94 133.63 54.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.016 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 53.2 m95 -137.72 154.03 49.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.509 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.15 33.81 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.404 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -73.32 136.4 44.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.291 -178.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 6.1 pttt -69.37 -156.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.896 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -127.11 22.3 6.66 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 111.582 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.648 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -103.0 -157.08 25.22 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.52 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.38 -170.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.047 0.451 . . . . 0.0 112.042 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.588 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.4 p -66.81 155.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.455 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.41 160.42 38.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.09 -74.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.884 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.0 OUTLIER -117.96 69.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 110.88 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.887 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.29 -165.74 1.25 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.923 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -145.97 115.26 7.09 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.027 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.7 m -93.14 171.97 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.568 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.0 m -120.86 113.73 20.56 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.03 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.9 pt -128.65 156.66 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 24' ' ' ASP . 4.1 t0 -122.91 125.62 45.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.803 ' HB3' HG13 ' A' ' 92' ' ' ILE . 3.0 p90 -141.27 163.9 31.7 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 99.3 m -146.88 114.65 6.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.08 168.77 37.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.168 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.26 173.98 6.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.119 0.485 . . . . 0.0 111.729 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.3 p -109.21 -79.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.637 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.734 ' H ' HG13 ' A' ' 29' ' ' VAL . 19.4 p30 -95.17 40.15 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.942 0.401 . . . . 0.0 110.384 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.45 -11.92 66.66 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.235 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HB3' ' A' ' 28' ' ' SER . 3.4 mm-40 -134.09 120.01 19.64 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.371 . . . . 0.0 110.426 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.0 pt-20 -57.2 120.75 8.64 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.248 0.547 . . . . 0.0 110.836 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.542 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -82.51 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.319 -178.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -70.48 -57.98 4.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.139 0.495 . . . . 0.0 110.557 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.02 23.73 10.37 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.987 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.42 -49.34 69.6 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.279 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.64 132.73 54.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 0.0 111.324 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -113.85 -58.17 2.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 0.0 111.402 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 p30 -103.03 71.64 1.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.5 t80 -91.82 104.77 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.923 HG22 ' HD2' ' A' ' 20' ' ' ARG . 15.0 p -81.74 97.71 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.159 0.504 . . . . 0.0 111.186 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.84 139.53 30.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.27 104.7 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.692 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.668 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -70.1 92.02 0.73 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.014 0.435 . . . . 0.0 111.331 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.51 64.61 1.27 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.678 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.485 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 2.7 tt0 -123.59 -64.8 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.552 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.77 -58.65 0.88 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.786 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -179.3 66.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.664 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 13.4 ttm -46.16 114.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 52' ' ' ILE . 1.2 pt -69.08 159.59 82.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.198 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.4 Cg_endo -54.95 -23.06 33.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.91 2.407 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.78 -56.63 8.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.249 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 54.2 m-85 -70.7 -45.86 64.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 51' ' ' MET . 7.0 pt-20 -53.81 -22.78 10.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 110.714 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.44 -77.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.92 -52.04 30.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.642 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.9 mp -83.13 40.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.64 0.733 . . . . 0.0 111.601 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 46' ' ' MET . 2.4 mtmm -51.37 -52.34 46.61 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 176.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.72 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.8 45.06 0.99 Allowed Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.735 -178.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.417 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -124.34 -20.45 5.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.199 -1.0 . . . . 0.0 112.661 -178.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mttm -117.85 83.92 2.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.3 . . . . 0.0 111.622 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.09 96.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.035 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.78 33.8 2.98 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.734 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 63.6 tt0 -98.57 161.06 13.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.698 0.285 . . . . 0.0 111.652 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 2.0 pm0 -129.44 109.45 11.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.569 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.543 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 21.4 p90 -141.57 166.83 23.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.505 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 7.4 m -125.34 128.79 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.94 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -134.75 165.13 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.152 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.7 p30 -95.16 145.3 25.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.3 m -146.94 135.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.612 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.8 m -148.57 123.6 10.07 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -84.91 129.67 55.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.652 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 51.0 Cg_endo -68.88 179.97 2.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.764 2.31 . . . . 0.0 112.976 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -75.62 -11.44 60.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.211 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.42 -31.67 19.93 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.751 0.31 . . . . 0.0 111.056 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.407 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.2 t80 -69.77 -69.6 0.34 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.2 m170 35.38 75.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.226 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.32 142.1 29.58 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.959 0.409 . . . . 0.0 110.662 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.98 -28.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.545 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.21 -37.18 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.818 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.23 20.0 3.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -36.42 130.86 0.68 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.47 49.25 20.97 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.177 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 97.75 8.81 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -86.99 105.27 17.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -143.82 -169.41 3.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.641 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.62 138.97 53.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.693 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' A' ' 72' ' ' VAL . 10.1 m-30 -137.48 158.76 43.7 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.088 0.471 . . . . 0.0 111.844 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.91 102.45 7.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.835 HD13 HD11 ' A' ' 70' ' ' ILE . 1.6 mp -96.18 154.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.781 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 79.0 m-20 -127.85 104.27 7.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.531 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.03 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.6 tp -63.72 152.69 38.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -148.73 -109.34 0.08 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.006 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -74.0 103.44 4.48 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.72 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.52 108.63 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.734 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 4.4 mt-10 -133.66 167.52 20.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.702 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.887 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -92.07 92.25 8.18 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.304 0.574 . . . . 0.0 112.289 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.08 165.92 22.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.082 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -168.11 81.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.007 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.46 134.52 73.1 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -50.54 141.33 33.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.269 1.979 . . . . 0.0 112.157 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.19 -48.08 8.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 105' ' ' LEU . 4.4 mm? -104.06 101.16 10.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.925 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -116.33 133.58 55.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 mmt -113.86 144.74 42.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.37 145.32 53.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.779 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.25 153.19 26.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -117.51 134.45 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.557 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 38.6 m95 -139.68 155.73 47.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.12 0.486 . . . . 0.0 111.546 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 4.2 ptpt -146.72 37.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.54 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.6 pm0 -59.62 140.96 55.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.819 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.875 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 1.2 mmtp -68.32 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -130.81 19.95 5.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.71 -150.78 9.4 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.914 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -169.02 0.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 8.9 p -67.56 152.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.532 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -135.2 161.46 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.19 -74.03 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.042 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 46' ' ' MET . 9.1 mp0 -118.03 68.64 0.77 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.989 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.32 -169.91 1.79 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.777 ' HD2' HG22 ' A' ' 43' ' ' VAL . 3.4 mmt180 -142.94 115.53 8.61 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.509 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.868 HG21 HG22 ' A' ' 59' ' ' ILE . 22.5 m -93.75 167.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.704 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.0 m -118.19 113.79 22.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.877 HG22 ' HA ' ' A' ' 94' ' ' LEU . 42.0 pt -130.62 154.58 40.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.4 p-10 -123.25 125.44 45.08 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' CB ' HG12 ' A' ' 92' ' ' ILE . 12.2 p90 -143.3 170.45 15.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.7 m -151.41 116.95 5.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.503 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.02 170.71 34.35 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.498 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.749 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -110.46 169.48 8.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 111.762 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.2 p -110.78 -72.92 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.529 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.759 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.95 37.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 109.961 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.47 66.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.129 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' C ' ' HB3' ' A' ' 28' ' ' SER . 34.0 mt-10 -134.0 122.56 23.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -56.99 121.77 10.73 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -179.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.636 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 11.2 p90 -83.02 -135.0 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.636 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -58.13 4.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.089 0.471 . . . . 0.0 110.415 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.41 34.44 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.842 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.92 -9.28 3.69 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.043 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -151.3 121.89 7.43 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.222 0.534 . . . . 0.0 110.867 179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.59 146.92 51.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.359 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.1 p -114.75 -58.87 2.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.036 0.446 . . . . 0.0 110.755 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -103.14 71.39 1.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.694 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.5 t80 -91.82 102.85 15.45 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 20' ' ' ARG . 8.4 p -80.89 97.49 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.3 0.572 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.743 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -89.58 140.61 29.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.271 -179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' ' CD ' ' A' ' 20' ' ' ARG . . . -105.3 104.75 14.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.834 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 42.6 mmm -71.41 87.15 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.0 63.4 0.88 Allowed Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.667 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.496 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.6 tt0 -122.26 -68.38 0.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.868 0.366 . . . . 0.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.94 -55.35 1.06 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.836 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.58 63.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 110.143 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -45.56 112.91 0.51 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.57 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.99 160.55 73.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 21.3 Cg_endo -60.68 -20.31 64.72 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.353 2.036 . . . . 0.0 111.68 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -67.78 -59.19 6.76 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.205 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 49.5 m-85 -71.55 -45.65 61.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 120.859 0.361 . . . . 0.0 110.603 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.39 -21.4 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -79.83 -78.49 0.16 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.359 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.29 -53.35 36.8 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.398 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -80.55 36.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.399 0.619 . . . . 0.0 111.209 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG21 ' A' ' 15' ' ' VAL . 3.6 ptmt -51.86 -50.96 59.92 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.83 47.15 0.85 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.386 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.465 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -124.15 6.18 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.691 -0.754 . . . . 0.0 112.351 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.3 mmtt -142.31 85.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.643 0.258 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.01 96.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.263 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 101.72 37.35 3.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.572 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 4.1 tp10 -98.74 167.32 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 111.827 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 8.3 pt-20 -133.45 108.12 8.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.876 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.69 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -140.38 166.91 23.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.139 0.495 . . . . 0.0 111.412 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.6 m -125.5 128.32 47.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.54 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.613 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.85 167.87 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -94.22 149.49 21.19 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.3 m -145.46 132.17 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.205 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -149.15 120.88 8.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.3 m-85 -85.15 130.01 53.68 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.753 0.311 . . . . 0.0 111.673 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 50' ' ' ARG . 54.5 Cg_endo -69.65 173.12 11.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.776 2.317 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.97 -11.38 60.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.187 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -35.73 19.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.991 0.424 . . . . 0.0 110.608 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -67.51 -69.47 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.54 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 7.5 m170 32.58 77.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.08 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.37 148.5 27.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.088 0.47 . . . . 0.0 110.715 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -53.05 -26.1 14.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.584 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.17 -37.92 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.804 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.22 18.87 3.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 9.7 pttt -33.76 125.57 0.43 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.77 53.85 24.22 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.623 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.636 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -99.06 91.07 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.87 95.52 4.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -134.55 -172.58 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.718 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.43 139.46 53.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.602 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.772 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.6 m-30 -136.62 153.87 50.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.56 103.63 8.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.899 HD12 HD11 ' A' ' 59' ' ' ILE . 2.9 mt -103.0 163.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' N ' HG22 ' A' ' 92' ' ' ILE . 11.3 m-20 -135.11 104.6 5.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.993 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.877 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.5 tp -63.7 156.19 27.71 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 44.7 mttt -150.07 -110.55 0.06 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.006 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -72.49 103.52 3.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.702 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.18 109.97 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.078 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.7 mp0 -138.89 163.13 33.1 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.993 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 9.0 tm-20 -91.79 97.51 11.04 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -74.38 169.13 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.876 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -172.8 106.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.653 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mt -74.42 145.61 82.78 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.07 145.68 51.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.41 2.074 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.07 99.35 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 tt -90.03 106.32 18.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.912 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.75 114.76 4.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.348 . . . . 0.0 110.988 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 61.44 92.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -64.17 -57.31 9.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.092 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.87 126.69 38.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.119 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.29 144.9 53.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.282 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.27 158.85 39.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.762 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.511 ' HH2' ' HD2' ' A' ' 20' ' ' ARG . 38.1 m95 -140.09 178.0 7.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.073 0.463 . . . . 0.0 110.953 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -139.38 13.07 2.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.473 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 11.6 pt-20 -68.8 137.47 54.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.802 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 31.5 mttt -66.05 -141.13 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.249 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -141.44 21.92 2.19 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.607 0.241 . . . . 0.0 111.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.17 -163.9 33.49 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.791 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.76 -173.43 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.762 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 60' ' ' LYS . 13.4 p -67.5 147.5 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.375 177.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 17' ' ' ALA . 5.3 mt-10 -135.6 164.32 28.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.26 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.957 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 mt-10 -118.16 71.91 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 111.447 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.659 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 15.4 m-20 -100.26 -175.33 2.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 3.7 mmt180 -142.93 112.12 6.63 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.438 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.755 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.2 m -93.59 168.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.713 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 92.0 m -117.67 115.17 24.52 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 94' ' ' LEU . 20.8 pt -127.84 156.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.6 p-10 -126.79 122.3 34.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.772 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.7 p90 -141.34 170.87 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.7 m -152.1 117.87 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.029 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.73 169.09 36.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.112 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -109.94 177.45 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.676 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.1 p -115.53 -73.24 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.75 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.5 m-20 -95.95 37.85 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 109.992 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.3 -11.08 67.36 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.693 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -131.85 127.77 37.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.106 0.479 . . . . 0.0 111.195 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -62.92 118.08 7.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.634 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 5.5 p90 -83.45 -134.59 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.44 -57.04 5.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 110.705 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.49 17.85 22.41 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.014 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -64.31 -8.06 29.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.681 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.1 120.79 6.99 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.48 51.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.351 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 20.8 t -115.1 -59.76 1.97 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.063 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.3 70.46 1.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.613 ' HB3' HG13 ' A' ' 23' ' ' ILE . 12.2 t80 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.9 p -80.23 98.74 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.976 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.33 136.68 32.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.949 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -99.62 104.98 16.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.871 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.561 ' HG3' HG21 ' A' ' 15' ' ' VAL . 3.7 mmm -68.56 78.7 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.799 0.333 . . . . 0.0 110.52 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.98 63.96 0.66 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.264 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -116.8 -71.3 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.001 0.429 . . . . 0.0 109.917 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.34 -55.81 1.08 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.886 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -178.98 69.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.52 113.39 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.5 pt -68.49 157.84 86.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.946 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.5 Cg_endo -53.89 -19.2 14.58 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 112.877 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.91 -57.59 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.349 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.832 ' HA ' HD13 ' A' ' 59' ' ' ILE . 26.1 m-85 -68.5 -44.46 74.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 120.89 0.376 . . . . 0.0 110.243 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 5.0 pt-20 -61.77 -11.47 12.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.42 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HB3' HG21 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -80.67 -77.14 0.21 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.814 179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.01 -48.41 40.47 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.189 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.041 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -80.04 38.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.618 0.723 . . . . 0.0 111.197 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.649 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -50.91 -53.34 33.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.592 ' HA2' HD21 ' A' ' 94' ' ' LEU . . . 109.49 43.02 1.19 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.203 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.498 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.46 10.48 8.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.374 -0.913 . . . . 0.0 112.346 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 15.5 mttp -146.47 84.3 1.62 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.92 0.391 . . . . 0.0 110.95 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.99 98.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.36 38.76 3.65 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.711 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 63' ' ' LYS . 7.9 tp10 -98.25 166.21 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 111.907 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 36.9 tt0 -133.52 101.89 5.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.649 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 27.5 p90 -135.42 167.58 20.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -127.1 131.51 50.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.332 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' H ' HD12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -139.48 172.32 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.563 0.697 . . . . 0.0 111.596 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.568 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 6.6 p-10 -94.85 150.6 20.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.651 -1.158 . . . . 0.0 109.0 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.722 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.7 m -145.71 132.11 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.958 0.409 . . . . 0.0 110.777 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.4 m -150.51 122.79 8.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.6 m-85 -85.32 128.56 59.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.712 0.292 . . . . 0.0 111.737 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 -179.32 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.787 2.325 . . . . 0.0 113.35 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -77.17 -9.16 58.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.601 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -92.26 -30.8 15.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.72 0.295 . . . . 0.0 110.976 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.9 t80 -67.01 -68.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 23.9 m170 34.48 74.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.23 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.29 147.77 27.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.906 0.384 . . . . 0.0 110.542 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -52.0 -27.41 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.535 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -94.97 -36.81 11.43 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.35 17.28 3.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -31.54 120.57 0.25 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.19 53.96 34.6 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.81 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.5 91.99 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.816 0.308 . . . . 0.0 111.787 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.825 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.01 99.89 6.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -134.58 -172.72 3.09 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.731 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -126.83 139.25 53.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.741 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.731 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.7 m-30 -136.8 155.02 50.36 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.11 103.62 8.38 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.041 HD12 HD11 ' A' ' 59' ' ' ILE . 7.2 mt -103.06 162.92 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.9 m-20 -135.58 105.16 6.07 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.59 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.961 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.9 tp -66.7 152.52 45.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.531 0.205 . . . . 0.0 111.519 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' THR . 2.3 mmtp -145.49 -107.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.099 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.6 103.08 4.08 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 21' ' ' VAL . 1.5 p -109.43 117.72 55.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 8.3 mp0 -139.69 -177.97 5.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.588 0.232 . . . . 0.0 111.55 -178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 24.1 mt-10 -105.09 87.18 2.58 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.622 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.62 137.47 57.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 111.342 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.22 76.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 7.0 mp -74.23 -55.41 2.95 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.555 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 44.4 Cg_endo -68.05 119.98 6.97 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.241 1.961 . . . . 0.0 112.309 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -40.97 11.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mt -105.54 -179.37 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.917 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 56.29 96.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.842 0.353 . . . . 0.0 110.974 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -134.34 159.76 40.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.595 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.54 102.19 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -75.78 -45.66 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.716 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.43 148.25 33.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -123.58 159.78 28.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -139.89 174.54 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.105 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -139.34 13.1 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.594 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 7.4 pt-20 -67.97 135.53 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.256 0.55 . . . . 0.0 112.006 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -65.04 -150.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.498 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.24 19.64 4.87 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.769 0.319 . . . . 0.0 111.271 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.58 -163.32 34.14 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -171.91 0.4 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 111.678 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.9 p -67.95 151.69 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.568 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER -136.26 163.74 29.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.79 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.31 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.0 mt-10 -117.86 72.21 0.85 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 0.0 111.619 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.557 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 6.2 m-20 -99.94 -168.8 1.65 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.702 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.7 ttt180 -148.4 112.56 5.21 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.065 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG21 ' CG2' ' A' ' 59' ' ' ILE . 19.1 m -93.81 171.8 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 86.9 m -121.55 112.81 18.94 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 ' HA ' ' A' ' 94' ' ' LEU . 35.3 pt -128.95 155.67 41.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -124.12 124.38 42.37 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.789 ' CB ' HG12 ' A' ' 92' ' ' ILE . 13.9 p90 -142.18 168.43 19.76 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 38' ' ' LYS . 53.2 m -148.79 115.72 6.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.43 169.01 34.32 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.353 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.794 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.15 169.85 8.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.386 . . . . 0.0 111.704 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.801 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.1 p -106.39 -78.69 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.78 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.801 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -95.62 41.48 1.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.083 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.15 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -135.03 121.88 21.03 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 10.3 pt-20 -57.64 120.16 7.85 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.444 0.64 . . . . 0.0 111.233 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 10.9 p90 -83.27 -134.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.816 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -69.95 -56.17 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.687 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.77 10.64 37.9 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.959 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.75 -10.98 5.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.228 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.586 ' HG3' HG23 ' A' ' 26' ' ' THR . 5.7 mtpt -148.22 128.39 13.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.896 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.07 145.12 35.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.252 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 30.8 t -117.39 -58.53 2.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.723 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -103.2 70.38 1.06 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' ILE . 7.6 t80 -90.41 108.01 19.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 20' ' ' ARG . 45.2 t -84.49 96.25 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.685 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.6 139.93 30.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.843 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -107.21 105.05 14.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.851 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -65.88 81.44 0.07 Allowed 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.632 0.254 . . . . 0.0 111.53 179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 57.97 0.69 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.821 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.86 -72.17 0.73 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.948 0.404 . . . . 0.0 110.167 179.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.08 -52.29 1.18 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.874 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 179.39 68.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.527 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.54 111.73 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.324 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 1.9 pt -68.55 159.7 80.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.4 Cg_endo -57.8 -20.53 43.93 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.488 2.125 . . . . 0.0 111.78 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.64 -59.96 5.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.421 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.868 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.7 m-85 -71.64 -46.45 59.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.948 0.404 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -52.65 -22.06 4.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.98 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 37.5 t0 -80.11 -75.88 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.615 0.245 . . . . 0.0 111.207 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.44 -54.93 26.16 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.47 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.062 HD11 HD12 ' A' ' 92' ' ' ILE . 2.3 mp -79.33 39.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.835 0.826 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' HG21 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -51.65 -52.36 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.69 46.32 0.91 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.26 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.489 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -130.38 6.22 4.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.274 -0.963 . . . . 0.0 112.839 -178.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 2.7 mtpm? -146.49 83.54 1.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 111.088 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.66 99.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.646 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.09 31.44 5.64 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.865 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 12.9 tp10 -99.98 143.12 30.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.924 -0.162 . . . . 0.0 111.311 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 11.3 mt-10 -108.41 110.16 21.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.749 0.309 . . . . 0.0 110.289 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 29.9 p90 -136.55 166.22 24.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 0.0 111.298 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 19.2 m -125.58 122.65 37.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.792 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.13 165.25 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.918 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.3 m-20 -94.24 149.54 21.14 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.1 m -144.72 133.39 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.918 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.602 HG23 ' HB2' ' A' ' 87' ' ' ALA . 52.3 m -147.72 122.33 9.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.659 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.7 m-85 -85.03 126.85 66.72 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.304 . . . . 0.0 111.522 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 33.6 Cg_endo -65.79 -177.36 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.638 2.225 . . . . 0.0 113.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.541 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 21.5 mm-40 -77.08 -10.92 59.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.476 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -86.45 -35.67 19.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.655 0.264 . . . . 0.0 110.997 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.434 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -64.26 -70.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.541 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 26.1 m170 35.2 70.3 0.14 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -85.98 147.78 26.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.59 -14.64 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.445 ' ND2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -94.98 -48.7 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.887 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.6 27.05 3.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -37.41 124.36 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.42 54.12 17.53 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.692 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.21 92.43 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.48 101.72 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -138.42 -173.16 3.46 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.726 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -125.14 139.54 53.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.624 -1.625 . . . . 0.0 107.752 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.726 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.0 m-30 -136.41 153.37 51.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -123.97 103.66 8.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.062 HD12 HD11 ' A' ' 59' ' ' ILE . 4.2 mt -104.74 162.27 4.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 33.7 t30 -135.76 104.1 5.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.772 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.031 ' HA ' HG22 ' A' ' 23' ' ' ILE . 20.9 tp -66.36 159.34 27.04 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 mttt -151.28 -106.77 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.336 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -72.12 103.3 3.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.644 ' CB ' HG12 ' A' ' 21' ' ' VAL . 1.8 p -111.57 109.24 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.233 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.565 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mt-10 -132.52 178.71 6.63 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.558 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -99.43 83.92 2.9 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 1.2 ppt_? -63.52 153.2 36.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.524 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.73 80.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.607 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.54 157.3 84.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.933 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.27 110.73 3.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.97 -55.11 8.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.97 98.72 9.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.961 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 61.66 28.55 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -81.41 163.75 22.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.678 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -153.62 -48.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -97.21 120.44 37.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.3 154.55 16.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -110.53 142.84 41.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.05 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -144.55 164.57 30.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.287 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -146.92 26.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.831 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.6 OUTLIER -63.26 136.48 57.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -68.94 -152.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.179 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -131.74 20.99 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.601 0.239 . . . . 0.0 111.378 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.9 -162.05 27.74 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.016 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.22 -170.04 0.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 112.063 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.7 p -67.81 148.43 11.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -136.26 165.12 26.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.48 -74.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.021 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -118.38 71.49 0.84 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.535 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.71 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 10.9 m-20 -99.38 -176.15 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.871 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.3 mmt180 -139.72 112.92 8.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.363 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.6 m -93.51 163.5 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.763 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 99.0 m -114.72 113.15 23.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.895 HG22 ' HA ' ' A' ' 94' ' ' LEU . 5.7 pt -128.16 152.12 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 40' ' ' SER . 7.9 p-10 -122.69 123.68 41.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' CB ' HG12 ' A' ' 92' ' ' ILE . 10.1 p90 -142.19 170.62 15.36 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 12.5 m -151.7 117.69 5.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.641 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.21 171.35 35.11 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.508 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.47 170.0 8.37 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 111.93 -179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -112.26 -73.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.943 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.741 ' H ' HG13 ' A' ' 29' ' ' VAL . 5.7 t70 -95.47 38.58 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.034 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 -13.46 65.84 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.799 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.69 125.27 26.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.891 0.377 . . . . 0.0 110.411 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.765 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -57.83 121.92 11.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.996 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 12.2 p90 -83.22 -135.18 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.806 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.1 -56.89 5.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.558 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.09 36.47 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.963 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -56.56 -9.49 3.52 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.127 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 122.91 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.183 0.515 . . . . 0.0 110.656 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.09 145.0 48.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.267 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.2 m -114.11 -59.8 1.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -103.03 70.92 1.1 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.69 ' HB3' HG13 ' A' ' 23' ' ' ILE . 8.7 t80 -92.3 104.58 16.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.86 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.871 HG22 ' HD2' ' A' ' 20' ' ' ARG . 13.5 p -79.69 98.04 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.905 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -89.93 137.2 32.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.984 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' CA ' ' HD3' ' A' ' 20' ' ' ARG . . . -101.16 104.89 15.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.568 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -69.5 80.62 0.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 111.453 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.97 65.01 0.78 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.237 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -121.96 -64.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.33 179.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.76 -53.55 1.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.876 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' NH1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 177.14 65.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.751 0.31 . . . . 0.0 110.633 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.66 111.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 111.058 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pt -68.54 156.33 90.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.624 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.54 -24.41 28.75 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.264 1.976 . . . . 0.0 111.546 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -64.82 -60.9 6.36 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.764 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -71.44 -47.37 56.24 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.676 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.16 -23.91 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.898 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.63 -78.93 0.14 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.245 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.98 38.59 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.707 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -82.12 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 121.571 0.701 . . . . 0.0 111.281 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -49.65 -51.99 33.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 176.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.583 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.51 43.28 1.16 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.994 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.477 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.28 9.74 8.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.679 -0.761 . . . . 0.0 112.236 -178.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.7 mmtt -144.27 84.41 1.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.55 94.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.581 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.13 36.25 3.2 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.977 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 18.8 tp10 -98.79 166.2 11.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.375 . . . . 0.0 111.813 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 10.4 mt-10 -132.12 107.85 8.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.73 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.567 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.6 p90 -141.05 167.15 22.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.194 0.521 . . . . 0.0 111.395 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 40.1 m -126.26 127.94 46.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.15 168.58 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.069 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.555 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.2 m-20 -94.06 150.2 20.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.831 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.0 OUTLIER -146.08 131.26 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.054 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 8.2 m -149.73 121.02 7.84 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.0 m-85 -85.78 130.72 49.65 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.69 0.281 . . . . 0.0 111.444 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.72 174.66 7.25 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 0.0 112.995 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -70.73 -13.99 62.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.139 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.88 -32.42 20.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.54 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HE1' ' HB2' ' A' ' 80' ' ' ALA . 5.6 t80 -65.93 -69.91 0.27 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.144 0.497 . . . . 0.0 110.19 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 37.43 73.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -80.07 148.27 31.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.263 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -53.98 -27.8 33.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.561 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.18 -36.84 11.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.881 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.32 19.54 3.68 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.2 pttp -32.36 124.47 0.32 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.61 55.44 11.04 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.722 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -99.23 90.35 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.66 96.36 4.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.47 -171.78 2.92 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.73 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -125.78 139.44 53.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.773 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.831 ' CD2' HG21 ' A' ' 72' ' ' VAL . 15.3 m-30 -136.94 154.37 50.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.83 103.51 8.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.013 HD12 HD11 ' A' ' 59' ' ' ILE . 3.0 mt -103.3 164.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.614 ' N ' HG22 ' A' ' 92' ' ' ILE . 68.9 m-20 -135.93 105.34 6.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.313 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.895 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.27 153.23 41.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 3.9 mmtt -145.6 -108.55 0.1 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -74.95 103.28 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG23 HG12 ' A' ' 21' ' ' VAL . 2.0 p -111.3 109.47 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.355 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 1.2 mt-10 -130.81 -179.04 5.07 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.71 ' HA ' ' CG ' ' A' ' 19' ' ' ASP . 1.8 tt0 -104.53 89.49 3.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -71.33 161.91 30.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.048 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 3.3 tt0 -174.76 83.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.97 139.37 73.09 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.889 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 114.4 3.82 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.502 2.135 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.77 -37.72 40.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.754 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 97.0 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.829 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.085 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -104.36 117.96 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -122.44 141.3 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.048 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -152.66 135.84 15.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.637 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 6' ' ' ALA . 2.5 pt20 -94.99 -46.96 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.715 0.293 . . . . 0.0 110.874 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 5' ' ' GLN . . . -89.68 148.16 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.028 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -129.72 151.35 50.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.227 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.437 ' CZ2' HG21 ' A' ' 43' ' ' VAL . 22.6 m95 -131.8 157.19 44.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 111.335 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HG3' ' HA ' ' A' ' 102' ' ' LEU . 5.0 mmtt -118.82 12.9 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.687 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 12.9 pt-20 -68.35 139.16 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.787 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.62 -163.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.43 25.5 8.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.583 0.23 . . . . 0.0 111.465 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.33 -155.11 17.78 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.984 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' OE1' ' A' ' 16' ' ' GLU . . . -69.8 -170.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.645 0.26 . . . . 0.0 111.518 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.1 p -67.28 156.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.578 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 17' ' ' ALA . 24.4 mp0 -135.68 159.67 40.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.3 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.979 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.0 mt-10 -117.82 70.28 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.001 0.429 . . . . 0.0 111.019 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.886 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.12 -168.23 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -144.17 113.52 6.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.945 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.751 HG21 ' CG2' ' A' ' 59' ' ' ILE . 34.2 m -93.82 168.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.717 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 m -116.66 112.41 21.21 Favored 'General case' 0 CA--C 1.523 -0.068 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.975 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.2 pp -130.65 151.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.4 p-10 -119.33 130.43 55.36 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CB ' HG12 ' A' ' 92' ' ' ILE . 9.1 p90 -142.34 161.82 37.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 58.1 m -141.45 115.03 8.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.345 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -162.94 168.17 37.64 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.837 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.35 172.09 7.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.37 -0.415 . . . . 0.0 112.055 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.753 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.5 p -111.71 -72.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.937 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.753 ' H ' HG13 ' A' ' 29' ' ' VAL . 3.6 t70 -95.9 37.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.944 0.402 . . . . 0.0 110.265 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.48 -11.81 66.66 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.192 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 28' ' ' SER . 33.7 mt-10 -135.19 125.56 26.5 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.77 0.319 . . . . 0.0 110.379 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.1 pt-20 -57.27 120.32 7.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.373 0.606 . . . . 0.0 110.644 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 13.0 p90 -82.7 -136.48 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.618 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -70.54 -59.9 2.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.81 24.48 7.68 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.039 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.34 -45.82 88.01 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.221 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 7.9 ttpp -121.79 141.78 50.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 0.0 111.191 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.29 154.86 44.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.154 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.608 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -117.28 -57.74 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.932 0.396 . . . . 0.0 111.431 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -103.51 70.83 1.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.882 ' HD2' HD11 ' A' ' 23' ' ' ILE . 5.4 t80 -92.4 107.01 18.9 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.401 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.776 HG22 ' HG2' ' A' ' 20' ' ' ARG . 12.6 p -81.13 97.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.454 0.645 . . . . 0.0 110.652 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.06 141.48 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.73 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -105.86 105.14 15.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 32.9 mmm -70.55 82.46 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.746 0.308 . . . . 0.0 110.838 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.34 56.68 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.834 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -110.31 -73.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.326 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.58 1.47 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.6 OUTLIER 178.91 65.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.793 0.33 . . . . 0.0 111.022 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.67 108.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.944 0.402 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.07 162.68 51.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.13 -24.57 67.17 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.359 2.039 . . . . 0.0 111.714 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -65.32 -60.38 6.79 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.642 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 59' ' ' ILE . 60.9 m-85 -72.19 -41.71 66.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.293 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.2 tt0 -55.48 -21.87 18.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.738 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -78.17 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.302 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.506 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -64.21 -55.05 26.02 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.949 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.03 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -78.21 37.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.73 0.776 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -50.65 -52.53 38.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 176.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.76 44.81 1.01 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.929 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.18 -14.79 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.223 -0.989 . . . . 0.0 112.491 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 4.1 mttt -119.97 81.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.734 0.302 . . . . 0.0 111.424 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 96.68 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.246 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.98 35.53 3.95 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.798 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.817 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 10.7 tp10 -99.42 163.47 12.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -128.29 106.49 9.06 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.955 178.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 34.4 p90 -138.97 166.47 24.41 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.415 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 32.4 m -126.59 128.62 47.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.077 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -136.11 164.82 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.815 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.5 p30 -95.52 147.3 23.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 55' ' ' PHE . 2.6 m -146.34 136.62 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.2 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 5.1 m -146.75 125.17 12.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.637 ' CD2' HD21 ' A' ' 83' ' ' LEU . 4.7 m-85 -85.35 129.62 54.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.684 0.278 . . . . 0.0 111.577 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.47 -178.5 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.48 2.12 . . . . 0.0 112.916 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 16.1 tt0 -76.8 -7.2 54.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.21 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 1.4 mt-10 -88.45 -37.05 16.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.704 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.4 t80 -63.74 -70.87 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.23 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.502 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 21.5 m170 36.21 65.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.695 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -80.29 149.7 30.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -15.08 16.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 82' ' ' ASN . 0.0 OUTLIER -94.85 -48.31 6.07 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.25 25.46 3.52 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 16.5 ptpt -32.95 125.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.03 55.51 8.47 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.676 -0.693 . . . . 0.0 113.632 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 1.5 tppt? -99.2 90.02 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -76.92 97.46 4.61 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.52 -174.68 3.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -125.71 139.88 53.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.511 -1.677 . . . . 0.0 107.586 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.9 m-30 -136.99 157.61 46.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 0.0 111.794 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.5 103.69 8.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.03 HD12 HD11 ' A' ' 59' ' ' ILE . 2.8 mt -101.71 161.18 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.589 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.1 t30 -135.66 104.44 5.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 113.897 -1.501 . . . . 0.0 108.718 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.975 ' HA ' HG22 ' A' ' 23' ' ' ILE . 18.8 tp -64.37 157.33 26.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 11.0 mtpt -150.5 -111.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.18 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.23 103.67 3.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.694 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.3 p -108.83 114.13 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.735 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.8 mt-10 -141.74 165.26 27.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.38 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.886 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -92.04 93.47 8.77 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.93 133.1 47.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.778 178.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -161.68 75.49 0.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.088 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 5.0 mp -74.53 -55.25 2.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 35.7 Cg_endo -65.46 134.64 39.33 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.042 1.828 . . . . 0.0 112.194 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.66 121.75 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.825 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.59 136.16 42.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.903 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.61 179.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.721 0.296 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.03 6.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.3 ttp -157.28 119.37 3.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.705 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -95.72 -58.08 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.05 29.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.3 159.46 23.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.457 ' CE3' ' OE2' ' A' ' 10' ' ' GLU . 30.2 m95 -138.97 -178.01 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.394 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.55 20.98 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 mt-10 -66.2 137.54 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.362 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' CB ' ' A' ' 99' ' ' GLU . 23.3 pttt -69.09 -157.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.639 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -125.51 20.69 7.92 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.491 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.22 -162.8 29.55 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.035 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.24 -171.91 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.002 0.429 . . . . 0.0 111.93 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.8 p -67.96 148.69 11.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -135.93 165.29 25.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.74 0.305 . . . . 0.0 110.277 178.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.81 -72.89 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.395 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.1 mt-10 -118.23 70.53 0.81 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 111.752 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.3 m-20 -99.89 -171.59 2.08 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 43' ' ' VAL . 1.3 ttt180 -146.14 111.93 5.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.147 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG21 ' CG2' ' A' ' 59' ' ' ILE . 31.3 m -93.34 170.59 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -122.51 113.49 19.38 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.902 HG22 ' HA ' ' A' ' 94' ' ' LEU . 6.8 pt -124.99 164.13 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 7.3 t0 -130.03 118.69 21.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.729 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.19 168.57 19.45 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -151.1 116.31 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.777 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.605 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -160.25 167.93 35.7 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.231 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.614 ' HB3' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.58 173.8 6.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.691 0.282 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG13 ' H ' ' A' ' 30' ' ' ASP . 1.7 p -108.53 -78.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.228 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 16.1 t0 -95.29 36.79 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 110.532 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.07 65.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.262 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -132.53 116.25 16.5 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.887 0.375 . . . . 0.0 110.429 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.614 ' N ' ' HB3' ' A' ' 28' ' ' SER . 6.2 pt-20 -60.87 118.06 6.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.59 -137.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.627 -178.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 52.2 mt-10 -70.25 -52.91 19.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.146 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.85 13.41 24.68 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.444 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -57.42 -12.87 9.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.715 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 124.23 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.127 0.489 . . . . 0.0 110.504 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.34 143.73 49.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -112.0 -60.55 1.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.037 0.446 . . . . 0.0 111.13 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -103.32 70.92 1.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 23' ' ' ILE . 11.0 t80 -89.57 108.98 19.98 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 20' ' ' ARG . 24.9 t -83.91 97.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.93 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -89.56 132.22 35.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.86 -179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -97.91 104.66 16.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.26 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.643 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -67.35 78.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 110.994 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.01 66.45 0.69 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.635 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -120.46 -71.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.39 -53.44 1.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.426 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.551 ' HE ' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER 175.46 68.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.132 0.491 . . . . 0.0 110.109 179.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 46' ' ' MET . 6.3 mtp -53.92 115.27 1.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.23 162.39 55.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.048 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.4 -27.15 74.56 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.315 2.01 . . . . 0.0 111.25 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -58.54 -60.55 8.72 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.458 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.818 ' HA ' HD13 ' A' ' 59' ' ' ILE . 35.4 m-85 -70.4 -45.46 65.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.9 0.381 . . . . 0.0 110.374 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -20.4 8.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -78.11 -76.94 0.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.962 179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -67.0 -50.93 42.95 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 120.38 -0.915 . . . . 0.0 112.482 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.081 HD11 HD12 ' A' ' 92' ' ' ILE . 2.0 mp -83.08 38.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.57 0.7 . . . . 0.0 111.392 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.618 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -51.56 -51.03 58.77 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 176.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.7 47.42 0.85 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.208 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.432 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -124.1 -12.43 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -0.656 . . . . 0.0 112.666 -178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -122.29 84.99 2.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.828 0.347 . . . . 0.0 111.574 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.83 94.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 105.27 38.06 2.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.608 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.7 tt0 -97.96 168.4 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 112.181 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.7 mp0 -136.03 99.81 4.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.421 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 32.4 p90 -134.33 167.13 21.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.047 0.451 . . . . 0.0 111.732 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 43.7 m -124.84 123.79 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.747 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -132.02 167.55 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.042 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 5.9 m-20 -94.32 151.16 19.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -143.83 132.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.936 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 16.7 m -151.37 122.45 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.595 ' CG ' HD21 ' A' ' 83' ' ' LEU . 4.2 m-85 -85.11 133.42 42.96 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.817 0.342 . . . . 0.0 111.874 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HB2' ' OE2' ' A' ' 77' ' ' GLU . 56.5 Cg_endo -70.26 176.82 6.63 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.805 2.337 . . . . 0.0 112.838 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -73.59 -13.78 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.233 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.551 ' HG3' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -86.71 -32.61 20.38 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.123 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -65.28 -67.81 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.2 0.524 . . . . 0.0 109.771 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.4 m170 32.46 73.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.44 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.4 140.14 30.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.44 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -43.67 -25.92 0.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.2 p-10 -95.19 -40.21 9.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.25 16.51 4.1 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -29.7 127.09 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.66 53.68 8.3 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.705 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.739 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.36 94.09 6.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.42 98.56 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -130.59 -174.42 3.35 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.698 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -127.85 139.27 52.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.955 178.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.698 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.88 155.1 50.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.081 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.67 164.29 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -173.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.604 ' N ' HG22 ' A' ' 92' ' ' ILE . 62.0 m-20 -135.78 104.51 5.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.351 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.902 ' HA ' HG22 ' A' ' 23' ' ' ILE . 13.0 tp -65.32 156.51 31.84 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.2 mtmm -151.05 -104.63 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -76.58 103.1 6.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.95 110.08 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.4 mt-10 -127.27 -169.55 2.06 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 6.7 tm-20 -114.96 90.13 3.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HD3' ' HD3' ' A' ' 20' ' ' ARG . 3.8 ptt180 -69.21 156.37 38.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.391 . . . . 0.0 111.168 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.7 63.24 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.294 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 5.1 mp -74.53 111.34 12.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.136 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.22 102.43 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.326 2.017 . . . . 0.0 112.315 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.66 111.11 18.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.778 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.36 107.49 18.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.856 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -146.8 162.66 38.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 110.951 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.72 115.13 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -151.66 112.02 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -63.76 1.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.67 148.3 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 103' ' ' PRO . 10.3 t -117.5 133.1 56.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.988 0.423 . . . . 0.0 111.11 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -138.93 155.12 48.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.384 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -147.23 32.51 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.644 178.749 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.9 pt-20 -65.89 138.9 58.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.23 -178.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -63.74 -160.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.942 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -130.08 23.33 5.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.198 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.88 -154.22 12.53 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.807 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.47 -170.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 111.402 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.66 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 9.5 p -67.49 155.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.613 177.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 99' ' ' GLU . 42.3 mp0 -134.99 159.64 40.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.59 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.232 -177.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 46' ' ' MET . 47.9 mt-10 -117.65 69.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.423 . . . . 0.0 110.985 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.924 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.81 -168.87 1.63 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.797 ' HB2' ' HG2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -143.0 112.9 7.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.657 179.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.787 HG21 ' CG2' ' A' ' 59' ' ' ILE . 26.9 m -92.87 166.88 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.664 0.268 . . . . 0.0 111.412 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 91.7 m -114.46 113.02 23.91 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.076 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.7 pt -130.42 149.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -118.32 129.25 55.34 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.9 p90 -143.58 167.8 21.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 38' ' ' LYS . 80.6 m -148.54 116.77 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.945 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.57 171.47 40.05 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.485 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.769 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -110.27 -176.44 2.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 111.192 179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -119.21 -76.91 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.896 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -95.38 39.17 1.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.126 179.201 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.13 63.31 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.863 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.66 125.44 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.965 0.412 . . . . 0.0 110.491 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.714 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 4.3 pt-20 -67.51 119.38 12.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.593 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.67 -136.29 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.656 -178.078 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 30.0 mt-10 -70.38 -54.12 13.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.5 13.13 23.92 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.87 -11.5 5.86 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.082 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 26' ' ' THR . 3.0 mppt? -147.06 129.7 16.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 110.806 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.62 142.3 37.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.53 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 53.6 p -116.21 -59.27 2.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.177 0.513 . . . . 0.0 110.788 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -103.36 70.46 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.592 ' HD2' HD11 ' A' ' 23' ' ' ILE . 7.2 t80 -93.24 104.62 16.79 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.04 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.669 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.6 p -79.24 99.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.039 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.89 139.3 30.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.238 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . . . -104.1 105.76 16.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.17 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.678 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 4.2 mmm -70.93 85.38 0.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.49 65.12 0.77 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.744 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -124.3 -67.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.498 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.67 -57.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.995 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.8 OUTLIER 178.56 68.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.588 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.41 112.82 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.078 -179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.014 HD11 HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -69.06 164.17 50.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.783 179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.0 Cg_endo -61.0 -13.66 28.75 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.228 1.952 . . . . 0.0 112.182 179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -77.69 -63.23 2.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.5 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 59' ' ' ILE . 22.6 m-85 -66.38 -50.56 63.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.179 0.514 . . . . 0.0 110.222 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.11 -22.83 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.511 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -71.24 -77.26 0.09 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -71.25 -48.74 29.74 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.744 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD11 HD12 ' A' ' 92' ' ' ILE . 3.1 mp -78.8 35.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 111.32 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 15' ' ' VAL . 5.9 ptmt -52.22 -51.1 60.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.66 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 109.97 47.03 0.85 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.501 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.4 ' NE2' ' HD3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -124.06 -13.55 7.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.707 -0.747 . . . . 0.0 112.152 -179.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' O ' HD23 ' A' ' 94' ' ' LEU . 8.4 mmtt -121.01 81.98 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.741 0.305 . . . . 0.0 111.22 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.4 97.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.588 178.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.29 38.58 3.03 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.133 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.9 tt0 -97.94 165.7 11.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 111.874 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -135.72 104.59 5.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.383 178.582 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 28.2 p90 -136.79 167.55 21.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.65 -177.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 84.8 m -124.52 116.96 23.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.822 179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -130.54 164.32 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.0 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.619 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.8 t0 -95.95 150.54 20.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 52' ' ' ILE . 12.5 t -146.62 134.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 87' ' ' ALA . 6.4 m -148.94 124.91 10.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.65 129.89 55.33 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.633 0.254 . . . . 0.0 111.536 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.23 177.5 3.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.464 2.11 . . . . 0.0 112.886 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.7 pm0 -75.16 -7.45 53.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.077 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 5.1 mm-40 -89.05 -36.28 15.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.021 0.438 . . . . 0.0 110.551 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 4.7 t80 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 21.6 m170 35.83 75.9 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.663 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.26 147.13 25.67 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 121.063 0.459 . . . . 0.0 110.463 178.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -48.95 -27.91 3.48 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -178.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.563 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.53 -37.73 10.74 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.646 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.765 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.3 19.29 3.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.199 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 13.9 pttp -34.12 127.78 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.12 52.51 12.41 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.104 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 88.42 3.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.778 0.323 . . . . 0.0 111.831 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.92 102.11 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -137.64 -169.48 2.54 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 5.2 mtmt -134.89 139.15 44.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.968 -1.469 . . . . 0.0 108.068 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.571 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -138.95 165.47 27.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 111.324 176.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.5 103.53 7.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.048 HD12 HD11 ' A' ' 59' ' ' ILE . 3.6 mt -99.66 162.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 57.1 m-20 -135.5 104.59 5.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.368 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.076 ' HA ' HG22 ' A' ' 23' ' ' ILE . 23.1 tp -63.8 154.74 32.51 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.8 mtpp -148.61 -112.13 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.189 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -73.04 103.87 3.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -109.15 106.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.829 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 1.2 mt-10 -132.44 165.9 23.24 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.234 -179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.924 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 2.3 tt0 -92.25 93.72 8.81 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.797 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 2.4 ppt_? -74.03 176.5 6.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.188 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -165.1 104.11 0.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.722 179.253 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.36 119.05 74.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.07 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' A' ' 7' ' ' THR . 73.5 Cg_exo -49.18 104.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.342 2.028 . . . . 0.0 112.553 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -85.14 -29.95 24.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.72 117.3 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -123.57 171.11 9.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -67.16 -50.04 62.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.732 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -123.6 77.34 1.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -56.55 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.758 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.53 153.72 27.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.7 m -131.26 157.3 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.671 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.607 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 22.5 m95 -133.48 178.63 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 4.3 mttt -139.06 10.33 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.748 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.16 148.1 27.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.199 0.523 . . . . 0.0 111.965 -178.7 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.23 -156.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.407 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.62 19.29 5.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.284 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.05 -158.03 23.19 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.904 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.27 -170.81 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.586 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 10.2 p -68.08 150.89 10.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 177.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.483 ' O ' ' C ' ' A' ' 17' ' ' ALA . 15.7 mt-10 -136.5 164.39 28.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.71 -73.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.376 -177.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 13.8 mt-10 -118.29 72.15 0.86 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.567 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 7.9 m-20 -99.85 -169.03 1.68 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' NE ' ' HB2' ' A' ' 45' ' ' ALA . 5.0 mmt180 -148.45 110.49 4.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.225 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 59' ' ' ILE . 33.1 m -93.41 166.49 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 64.4 m -112.98 113.6 25.72 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.969 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.1 pt -130.93 148.75 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.7 p30 -116.72 130.81 56.95 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 92' ' ' ILE . 8.3 p90 -144.53 166.63 24.62 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 38' ' ' LYS . 97.2 m -147.56 115.54 6.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.897 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -163.66 168.98 38.49 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.498 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.57 173.97 6.08 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.16 0.505 . . . . 0.0 111.678 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -105.88 -82.65 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.737 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.771 ' H ' HG13 ' A' ' 29' ' ' VAL . 1.8 p30 -95.45 39.2 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.411 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.7 -6.15 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.322 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.15 111.78 9.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.836 0.351 . . . . 0.0 110.409 179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 1.4 pt-20 -56.68 118.35 4.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.193 0.521 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -82.46 -137.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.6 -177.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 1.1 mm-40 -70.54 -58.3 3.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.165 0.507 . . . . 0.0 110.873 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.44 22.59 12.53 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.188 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.33 -49.62 67.45 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.996 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB3' HG23 ' A' ' 26' ' ' THR . 2.3 ptmt -122.52 131.32 53.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 111.35 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . -133.46 157.13 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.206 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 1.5 t -114.03 -59.13 2.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 111.375 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -102.85 71.4 1.15 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 23' ' ' ILE . 8.7 t80 -92.65 103.62 15.99 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.854 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.633 HG22 ' HD2' ' A' ' 20' ' ' ARG . 14.3 p -79.85 98.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.743 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -89.23 139.54 30.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.467 -179.328 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.7 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -101.97 104.73 15.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.92 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -68.44 78.33 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.959 0.409 . . . . 0.0 111.091 -179.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.82 71.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.479 -0.782 . . . . 0.0 113.047 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -127.0 -68.36 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.472 179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.43 -55.41 1.03 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.841 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 179.77 70.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.05 0.452 . . . . 0.0 110.716 179.608 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.5 110.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.66 156.71 90.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.79 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 9.4 Cg_endo -52.65 -20.47 12.49 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.58 2.187 . . . . 0.0 112.163 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -72.23 -59.95 4.36 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.468 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.78 ' HA ' HD13 ' A' ' 59' ' ' ILE . 39.8 m-85 -69.68 -48.96 57.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.743 0.271 . . . . 0.0 110.984 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 53' ' ' PRO . 7.1 pt-20 -52.27 -20.79 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.183 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -77.94 0.17 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -61.99 -53.3 43.91 Favored Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.971 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 92' ' ' ILE . 2.2 mp -83.52 40.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.741 0.781 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 3.3 mttt -50.92 -52.69 39.65 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 176.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.716 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.28 45.96 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.822 -178.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -124.56 -19.37 5.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.175 -178.379 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmtm -118.04 84.54 2.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.762 0.315 . . . . 0.0 111.625 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 99.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 35.97 4.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.579 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' CB ' ' A' ' 63' ' ' LYS . 9.6 tp10 -98.27 164.78 12.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 111.709 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.89 105.63 7.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.59 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.2 p90 -138.71 166.87 23.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.432 . . . . 0.0 111.52 -177.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 48.4 m -127.26 127.1 43.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.723 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.726 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.27 166.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 120.853 0.359 . . . . 0.0 110.75 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.3 p30 -94.69 148.87 21.83 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.747 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -145.01 134.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.008 179.035 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.594 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.6 m -149.94 124.6 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.744 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.0 m-85 -85.09 128.6 59.42 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 41.0 Cg_endo -68.8 -175.02 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.76 2.307 . . . . 0.0 113.129 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 3.7 mt-10 -77.14 -8.96 58.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.139 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HG3' ' HG2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -86.01 -35.69 20.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.72 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 1.1 t80 -65.64 -72.1 0.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 76' ' ' GLU . 20.8 m170 36.59 53.22 1.03 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -73.78 145.44 45.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.747 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -14.02 3.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -53.62 4.69 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -133.14 15.03 4.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.485 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' LEU . 1.9 ptpp? -18.69 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.67 55.91 6.83 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.553 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.83 91.78 5.24 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.852 -0.205 . . . . 0.0 111.473 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.837 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.47 105.8 9.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.84 -172.17 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.701 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.4 mtmt -129.09 138.79 52.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.369 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.747 ' CD2' HG21 ' A' ' 72' ' ' VAL . 12.7 m-30 -136.9 157.91 45.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.392 . . . . 0.0 111.688 178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.65 103.2 7.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 176.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -101.09 162.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.61 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -135.6 104.38 5.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.904 178.022 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.969 ' HA ' HG22 ' A' ' 23' ' ' ILE . 19.2 tp -66.69 153.21 43.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.716 0.293 . . . . 0.0 111.693 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -145.18 -111.29 0.1 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -72.01 102.96 3.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.716 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.19 116.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.257 177.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.591 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 20.6 mp0 -143.85 173.94 11.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.252 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -92.43 84.08 5.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.631 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.628 ' HD3' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.03 133.19 54.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.531 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -147.93 52.39 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.481 0.658 . . . . 0.0 110.031 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 9' ' ' LYS . 2.0 tt -104.9 120.49 49.87 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.741 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.41 100.58 1.04 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.352 2.035 . . . . 0.0 112.573 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -99.45 -58.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.88 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.94 34.38 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.098 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.883 -179.958 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.1 m 59.4 31.29 20.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -37.16 84.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.53 121.28 16.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.22 -66.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.15 160.38 29.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.646 ' O ' HD21 ' A' ' 102' ' ' LEU . 45.0 m -128.96 153.49 47.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.975 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.629 ' HA ' HD11 ' A' ' 102' ' ' LEU . 43.2 m95 -141.21 173.84 11.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 0.0 110.815 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -144.43 15.54 1.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.548 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 6.8 pt-20 -67.16 140.23 57.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 112.168 -178.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -67.11 -151.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.617 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.87 21.43 4.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.678 0.275 . . . . 0.0 111.282 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.75 -164.31 32.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.929 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.46 -171.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 111.661 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 14.5 p -67.98 148.21 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 177.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -136.15 165.52 25.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.6 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.219 -177.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -118.27 71.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.0 0.429 . . . . 0.0 111.589 -179.236 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 6.0 m-20 -99.82 -176.28 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.669 ' HG2' ' CG1' ' A' ' 43' ' ' VAL . 0.2 OUTLIER -138.75 113.86 9.41 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.519 179.283 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.1 m -93.75 166.83 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.6 m -120.59 112.55 19.06 Favored 'General case' 0 C--O 1.23 0.038 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.27 152.87 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.376 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.1 p-10 -119.62 123.26 43.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.707 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.3 p90 -141.51 170.42 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 m -152.07 117.6 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.214 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -165.77 161.32 34.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.84 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.749 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -97.83 -168.33 1.65 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.742 0.417 . . . . 0.0 110.095 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.814 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 3.5 p -94.02 -109.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.304 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.637 ' H ' HG13 ' A' ' 29' ' ' VAL . 6.1 p-10 -93.12 40.44 1.06 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.984 0.811 . . . . 0.0 109.102 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 5.43 58.84 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.292 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' SER . 0.8 OUTLIER -122.23 -174.31 2.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 110.569 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -57.09 128.54 37.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.471 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 86' ' ' LYS . 78.8 t80 -111.38 157.24 20.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.613 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.83 -75.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.116 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.91 49.84 4.03 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.17 -15.99 12.54 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.539 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 126.51 13.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.552 . . . . 0.0 111.327 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.8 141.02 44.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.177 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 87.0 p -114.09 -60.67 1.85 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -102.61 71.42 1.19 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.744 ' HB3' HG12 ' A' ' 23' ' ' ILE . 7.5 t80 -86.81 112.8 22.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.669 ' CG1' ' HG2' ' A' ' 20' ' ' ARG . 25.2 t -90.41 95.46 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.979 0.419 . . . . 0.0 110.776 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -90.48 134.01 34.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.39 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 20' ' ' ARG . . . -96.26 104.61 16.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 178.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 4.7 mmm -69.78 84.91 0.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.973 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.65 55.44 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.774 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 1.7 tm0? -108.07 -71.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.588 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.11 -54.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.921 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 69.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 110.568 179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.58 114.37 0.69 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 164.1 50.61 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.665 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 29.6 Cg_endo -62.49 -12.82 29.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.143 1.895 . . . . 0.0 111.662 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.99 -62.27 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.606 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.773 ' HA ' HD13 ' A' ' 59' ' ' ILE . 40.9 m-85 -69.03 -46.69 67.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 110.126 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 20.2 tt0 -53.42 -20.01 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.37 -75.55 0.26 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.625 0.25 . . . . 0.0 111.116 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -67.1 -53.49 26.03 Favored Glycine 0 CA--C 1.509 -0.31 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.626 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.057 HD11 HD12 ' A' ' 92' ' ' ILE . 3.4 mp -78.53 38.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.546 0.688 . . . . 0.0 111.151 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -50.53 -53.9 26.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.045 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' HA3' ' HB ' ' A' ' 15' ' ' VAL . . . 110.1 45.51 0.94 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.477 -178.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.89 -9.13 7.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.452 -0.874 . . . . 0.0 112.54 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.4 mmpt? -126.09 83.01 2.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.62 93.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 178.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 95' ' ' LYS . . . 106.59 38.06 2.3 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.58 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 1.4 tt0 -98.21 167.36 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.111 0.481 . . . . 0.0 112.064 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 4.3 pt-20 -135.68 102.12 4.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.407 178.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 29.0 p90 -136.5 167.52 21.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.094 0.474 . . . . 0.0 111.802 -177.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 31.5 m -124.86 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.487 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.89 165.73 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.835 179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -94.76 151.57 19.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -146.15 134.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.829 178.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.772 HG23 ' HB2' ' A' ' 87' ' ' ALA . 55.3 m -152.37 122.02 6.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.601 ' CG ' HD21 ' A' ' 83' ' ' LEU . 8.0 m-85 -84.75 127.72 63.96 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.816 0.341 . . . . 0.0 111.872 -178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 42.2 Cg_endo -68.08 -177.16 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.84 2.36 . . . . 0.0 113.351 -179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.2 pm0 -76.79 -12.49 59.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.578 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -86.68 -34.01 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 111.007 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -66.38 -70.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.393 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.3 m170 34.68 72.37 0.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.067 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -85.7 139.74 31.11 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.142 0.496 . . . . 0.0 110.921 179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -44.67 -26.27 0.36 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.469 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.11 -38.69 10.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -177.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.771 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -134.57 15.36 3.7 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.553 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -31.04 122.32 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.06 51.89 43.33 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 113.825 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.615 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -99.14 91.7 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.071 0.435 . . . . 0.0 111.404 179.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.772 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.04 93.65 6.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.814 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.39 -174.03 3.17 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.651 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 3.8 ttpt -125.14 138.77 54.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.357 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 11.1 m-30 -136.83 156.14 48.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.89 103.72 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 175.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.057 HD12 HD11 ' A' ' 59' ' ' ILE . 3.2 mt -102.19 164.35 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -173.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.62 ' N ' HG22 ' A' ' 92' ' ' ILE . 22.4 m-20 -135.36 104.79 5.99 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.477 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.01 ' HA ' HG22 ' A' ' 23' ' ' ILE . 14.7 tp -65.3 152.55 43.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.974 0.416 . . . . 0.0 111.874 -178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 12.9 mmtp -147.11 -107.78 0.09 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 103.11 4.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -177.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.604 HG23 HG12 ' A' ' 21' ' ' VAL . 2.1 p -111.69 106.57 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 4.9 mt-10 -123.82 -172.82 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.707 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 4.9 tm-20 -109.82 87.9 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.946 0.403 . . . . 0.0 112.071 -178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -75.16 163.0 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.463 179.405 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER 177.8 57.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.088 179.194 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.3 mp -75.15 -55.54 2.22 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.07 -179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 15.9 Cg_exo -68.85 117.0 4.73 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.235 1.957 . . . . 0.0 111.843 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -90.15 -56.6 3.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 mp -95.72 116.03 28.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.95 -179.946 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.87 83.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -114.58 118.49 33.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 mmt -97.09 111.1 23.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -85.1 152.55 23.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.99 144.07 45.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.147 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -106.85 143.5 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -143.13 161.12 39.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.096 0.474 . . . . 0.0 111.637 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 29.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.565 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.1 mt-10 -68.23 141.34 55.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.998 -178.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HG2' ' CG ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -69.4 -159.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.504 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.11 23.43 9.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.729 0.3 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -105.98 -157.17 22.04 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.965 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -167.74 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.238 0.542 . . . . 0.0 112.231 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.611 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.9 p -67.12 154.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.464 177.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.6 mt-10 -135.81 159.79 40.56 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.4 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.944 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 46' ' ' MET . 46.1 mt-10 -118.04 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.964 0.411 . . . . 0.0 110.739 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 1.012 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.26 -168.72 1.62 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.833 ' HD2' HG22 ' A' ' 43' ' ' VAL . 2.2 mmt180 -143.96 112.48 6.5 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG12 HG23 ' A' ' 97' ' ' VAL . 33.5 m -93.59 168.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.768 0.318 . . . . 0.0 111.72 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 95.1 m -118.04 114.21 22.79 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 94' ' ' LEU . 10.0 pt -128.89 152.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.276 0.56 . . . . 0.0 112.403 -178.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' SER . 6.2 p-10 -121.86 125.78 47.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -141.48 170.39 15.82 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.0 m -153.06 115.88 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.12 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -164.61 174.2 40.6 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.549 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.07 171.89 7.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.452 . . . . 0.0 111.304 -179.668 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.763 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 43.5 t -95.36 -89.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.826 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.14 42.6 1.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.53 -7.86 66.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.759 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' C ' ' HB3' ' A' ' 28' ' ' SER . 14.1 pt-20 -126.67 111.6 14.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.2 OUTLIER -64.63 114.5 4.45 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.089 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.64 -135.89 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.825 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.1 mm-40 -69.87 -51.33 34.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.18 17.91 11.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.105 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -58.75 -11.31 10.32 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.046 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -150.38 126.2 10.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.286 0.565 . . . . 0.0 111.131 179.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.97 144.24 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.332 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -115.49 -59.54 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.037 0.446 . . . . 0.0 110.702 -179.874 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.03 71.2 1.12 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.549 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 17.2 t80 -92.8 102.76 15.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.889 0.376 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG22 ' HD2' ' A' ' 20' ' ' ARG . 9.6 p -79.96 98.98 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.237 0.542 . . . . 0.0 111.457 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.695 HD12 HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -89.57 139.2 30.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.947 -179.563 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -102.61 105.52 16.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.72 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mmt -69.92 82.32 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 64.59 0.8 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.473 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 1.2 tt0 -119.8 -68.84 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.86 -53.24 1.12 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.952 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.61 66.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 179.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.446 ' CE ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -46.81 113.01 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.021 HD11 HG13 ' A' ' 72' ' ' VAL . 1.5 pt -68.92 161.67 70.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.858 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 25.7 Cg_endo -61.03 -19.86 65.05 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.273 1.982 . . . . 0.0 111.863 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -68.5 -63.42 3.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.372 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.855 ' CE2' HG11 ' A' ' 72' ' ' VAL . 26.3 m-85 -67.71 -41.91 82.8 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.192 0.52 . . . . 0.0 109.911 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 18.7 tt0 -58.57 -18.68 31.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.1 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 18.3 t70 -79.46 -73.71 0.33 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.984 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.35 -49.05 34.29 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.888 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.098 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mp -80.42 36.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.378 0.609 . . . . 0.0 111.515 -179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -50.96 -51.62 50.73 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 176.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.615 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.66 48.47 0.79 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.104 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.437 ' CD2' ' HG3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -123.9 -17.39 6.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.49 -0.855 . . . . 0.0 112.592 -178.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' HD23 ' A' ' 94' ' ' LEU . 17.3 mmtp -120.38 84.79 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.472 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.72 98.35 0.05 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.568 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 94' ' ' LEU . . . 101.97 38.81 3.04 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.234 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -97.79 166.61 11.39 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.16 101.14 4.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.526 178.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 35.0 p90 -134.26 167.2 21.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 21.3 m -124.94 116.42 22.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.709 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.59 164.28 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.099 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 1.1 m-20 -96.18 152.2 18.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 52' ' ' ILE . 13.5 t -146.64 135.01 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.0 110.231 178.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 87' ' ' ALA . 3.2 m -147.36 125.44 12.11 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.8 m-85 -85.05 128.56 59.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.311 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.47 176.0 3.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.383 2.055 . . . . 0.0 112.651 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.3 tt0 -73.37 -9.69 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.51 -36.77 18.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.3 t80 -64.32 -69.89 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 18.0 m170 35.51 73.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.05 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -81.04 151.17 28.52 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.339 178.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -53.04 -30.9 38.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.49 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -95.19 -35.93 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.834 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -133.09 17.86 4.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.034 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.5 pttm -32.88 127.47 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 55.69 9.71 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.425 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -98.43 86.46 3.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 73' ' ' THR . . . -75.82 91.61 2.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.763 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -128.98 -174.65 3.32 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -132.94 138.79 47.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.424 179.179 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.4 OUTLIER -139.99 166.89 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.456 . . . . 0.0 111.542 177.111 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.25 103.67 8.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 176.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.098 HD12 HD11 ' A' ' 59' ' ' ILE . 3.8 mt -97.36 162.21 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.579 ' N ' HG22 ' A' ' 92' ' ' ILE . 1.6 t30 -135.51 104.52 5.85 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.027 178.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.884 HD12 HG22 ' A' ' 23' ' ' ILE . 15.7 tp -65.85 158.21 28.44 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 4.6 mmmt -151.44 -112.92 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.158 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.09 103.53 3.31 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.43 106.95 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.979 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 24.4 mt-10 -132.59 164.62 26.26 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.84 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 1.012 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -92.81 100.31 12.81 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' HG3' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -77.47 160.22 28.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.035 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -168.6 75.6 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 5.3 mp -74.27 154.24 88.2 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.94 110.77 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.374 2.049 . . . . 0.0 112.232 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.54 139.23 33.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.09 165.12 11.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.786 -179.864 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.6 p -64.54 109.86 2.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -70.74 139.46 51.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 mtt -154.29 151.8 29.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -94.79 146.65 24.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.32 148.64 35.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.989 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 146.23 29.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -143.43 162.94 34.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.83 30.69 0.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.546 178.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.5 pt-20 -62.58 135.22 57.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.082 -178.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -62.96 -156.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.844 -179.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 98' ' ' GLU . 25.0 m-20 -133.29 19.87 4.01 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.714 0.292 . . . . 0.0 111.652 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.0 -161.88 23.8 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.78 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.94 -170.82 0.12 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 8.9 p -67.91 150.08 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -136.67 164.58 27.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.57 -73.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.374 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 46' ' ' MET . 11.1 pt-20 -118.63 71.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.941 0.4 . . . . 0.0 111.822 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.555 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 4.6 m-20 -99.28 -175.65 3.07 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.787 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -141.85 111.8 6.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.609 178.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG21 ' CG2' ' A' ' 59' ' ' ILE . 33.7 m -93.1 168.54 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.896 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 94.9 m -117.42 113.54 22.22 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.994 HG22 ' HA ' ' A' ' 94' ' ' LEU . 14.7 pt -126.37 157.48 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.514 0.673 . . . . 0.0 112.797 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 93' ' ' ASN . 10.4 t0 -121.68 121.7 37.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.769 ' HB3' HG13 ' A' ' 92' ' ' ILE . 1.7 p90 -141.35 167.53 21.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.679 . . . . 0.0 112.668 -178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 38' ' ' LYS . 51.4 m -154.91 120.34 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.61 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -170.09 174.78 44.22 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.722 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.641 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -109.67 -168.89 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.863 ' HA ' ' CB ' ' A' ' 88' ' ' ALA . 2.6 p -94.18 -108.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.16 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.44 39.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.104 0.866 . . . . 0.0 108.919 178.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.88 7.03 58.98 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 28' ' ' SER . 2.3 mt-10 -123.21 -174.9 3.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.331 0.586 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.03 123.91 16.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.319 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 55.1 t80 -106.79 157.35 17.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.056 177.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.19 -73.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.04 49.72 4.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -56.03 -18.95 21.05 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.248 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HG3' HG23 ' A' ' 26' ' ' THR . 0.0 OUTLIER -144.17 116.52 8.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.983 0.42 . . . . 0.0 110.876 179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.25 140.4 47.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.329 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.1 t -111.46 -57.97 2.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -102.66 72.0 1.21 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.713 ' CD2' HD11 ' A' ' 23' ' ' ILE . 1.4 t80 -88.1 107.24 18.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.787 HG12 ' HG2' ' A' ' 20' ' ' ARG . 28.3 t -81.81 96.02 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.84 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -91.04 134.01 34.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.774 -179.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.51 106.56 18.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.864 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.654 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 6.0 mmm -72.43 87.93 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.443 . . . . 0.0 111.796 -179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.95 58.28 1.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.716 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 9.6 tp60 -118.83 -64.37 1.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 110.453 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -99.82 -56.17 0.97 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.085 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' NH1' ' HB2' ' A' ' 77' ' ' GLU . 0.4 OUTLIER 175.84 61.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.335 179.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.725 ' HE3' ' HB3' ' A' ' 55' ' ' PHE . 8.6 mtp -46.05 116.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 110.944 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -70.16 165.96 38.46 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.287 179.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.18 -34.27 98.36 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.481 2.12 . . . . 0.0 111.615 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.796 ' HA3' HG12 ' A' ' 72' ' ' VAL . . . -56.39 -59.75 10.18 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.396 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.812 ' HA ' HD13 ' A' ' 59' ' ' ILE . 42.7 m-85 -70.5 -45.34 65.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.718 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.2 tt0 -55.3 -18.25 6.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.698 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.75 -77.0 0.18 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -70.97 -50.68 22.25 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.016 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.5 mp -80.09 37.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.366 0.603 . . . . 0.0 111.568 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 7.2 mmtt -49.72 -54.87 16.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 175.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.663 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 110.86 45.93 0.86 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.232 -177.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.492 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -125.04 -21.8 4.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.753 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HD2' ' NE2' ' A' ' 62' ' ' HIS . 0.7 OUTLIER -116.21 84.59 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 0.0 110.991 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.07 97.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 104.67 38.36 2.59 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.345 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 2.2 tp10 -98.17 164.84 12.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.035 0.445 . . . . 0.0 112.045 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -134.82 107.07 7.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.314 178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 24.1 p90 -139.63 166.97 23.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.029 -178.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 27.3 m -125.19 120.33 31.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.785 179.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.71 155.56 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.785 179.576 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -99.0 141.03 32.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.796 HG12 ' HA3' ' A' ' 54' ' ' GLY . 34.8 m -138.0 150.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.832 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 ' HB2' ' A' ' 87' ' ' ALA . 8.6 m -150.65 125.76 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.66 ' CD2' HD21 ' A' ' 83' ' ' LEU . 12.3 m-85 -84.26 128.03 63.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.492 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.81 178.89 2.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 7.2 pt-20 -76.94 -6.5 52.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.172 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.532 ' HB2' ' NH1' ' A' ' 50' ' ' ARG . 3.5 mt-10 -87.13 -38.33 16.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 0.0 110.689 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.9 t80 -61.39 -69.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.104 0.478 . . . . 0.0 110.184 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 17.5 m170 34.17 67.49 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.164 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 84' ' ' LYS . . . -86.36 150.03 24.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.912 0.387 . . . . 0.0 110.722 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 1.6 tt0 -57.49 -14.16 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -50.53 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.889 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.77 27.53 3.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.466 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 8.3 ptpp? -34.01 124.43 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.47 54.8 5.47 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 114.244 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.24 94.06 6.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 73' ' ' THR . . . -81.91 91.08 6.51 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.863 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -129.88 178.2 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -124.79 136.49 53.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.552 179.078 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HA ' ' HA3' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -141.31 172.77 12.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.12 0.486 . . . . 0.0 110.942 175.315 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.55 103.01 7.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 70' ' ' ILE . 1.7 mp -90.35 159.5 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -175.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 92' ' ' ILE . 4.2 m-80 -132.93 104.46 6.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.04 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.994 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.8 tp -64.86 153.69 39.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.631 0.253 . . . . 0.0 111.506 -178.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' THR . 21.0 mttt -151.95 -107.98 0.05 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.929 179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -72.27 103.42 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.6 p -111.09 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.429 178.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 26.5 mt-10 -130.97 170.85 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.331 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 12.8 tm-20 -92.08 89.32 6.89 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -68.01 172.88 5.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.353 179.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 178.23 81.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.007 179.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.67 127.19 84.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.93 105.02 1.44 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.395 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.91 -31.96 61.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.788 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 105' ' ' LEU . 1.6 mm? -105.22 135.65 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.3 p -170.2 157.33 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.327 . . . . 0.0 110.702 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -150.6 130.47 13.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -40.39 2.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.21 148.75 29.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.16 145.66 27.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -124.4 159.17 31.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.592 ' HZ3' ' HB2' ' A' ' 20' ' ' ARG . 31.3 m95 -139.31 178.69 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.149 0.5 . . . . 0.0 111.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -145.03 14.42 1.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.644 179.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.9 pt-20 -71.56 137.41 48.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 112.164 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -66.28 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.542 179.759 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.2 21.93 4.84 Favored 'General case' 0 C--O 1.231 0.084 0 O-C-N 122.277 -0.264 . . . . 0.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.4 -163.1 34.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.567 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -172.94 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.463 -179.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 46' ' ' MET . 14.2 p -67.93 150.22 11.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.77 177.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.6 mt-10 -135.94 164.09 28.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.53 -73.98 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.461 -177.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' MET . 16.7 mt-10 -118.48 72.91 0.89 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -178.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.609 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.4 m-20 -100.11 -170.23 1.85 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.856 ' HD2' HG12 ' A' ' 43' ' ' VAL . 2.7 mmt85 -145.47 111.79 5.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.932 178.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.737 HG21 ' CG2' ' A' ' 59' ' ' ILE . 32.9 m -93.39 172.8 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -120.31 111.86 18.31 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.898 HD12 HD13 ' A' ' 92' ' ' ILE . 23.0 pt -126.86 154.21 36.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.7 p-10 -122.56 123.59 41.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.792 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.7 p90 -141.78 167.9 21.04 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -150.7 117.11 5.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.953 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -158.87 171.28 35.47 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.412 179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.782 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 1.1 p -110.0 172.11 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 87' ' ' ALA . 2.0 p -115.25 -71.08 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.662 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.736 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.89 38.59 1.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.358 . . . . 0.0 110.208 178.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.75 -14.24 64.31 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.804 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -134.67 129.94 35.57 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.839 0.352 . . . . 0.0 110.513 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 6.6 pt-20 -60.45 121.46 12.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.38 0.61 . . . . 0.0 111.01 -179.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.24 -135.82 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.895 -178.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -70.07 -57.69 4.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.116 0.484 . . . . 0.0 110.558 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.2 7.89 59.3 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.673 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.62 -8.54 4.07 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.077 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.24 119.3 7.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.088 0.47 . . . . 0.0 110.52 179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.5 145.7 50.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.458 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 8.5 m -115.32 -58.88 2.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -103.15 70.63 1.08 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD2' ' HE2' ' A' ' 25' ' ' PHE . 7.5 t80 -90.92 108.76 20.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.745 -0.382 . . . . 0.0 109.985 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' HD2' ' A' ' 20' ' ' ARG . 23.6 t -86.97 96.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -89.91 143.22 26.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.138 -179.152 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.661 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -104.52 105.66 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.697 ' HG3' HG21 ' A' ' 15' ' ' VAL . 2.4 mmm -67.1 77.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.15 72.66 0.9 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.027 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -70.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.111 0.482 . . . . 0.0 110.158 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' ARG . . . -95.31 -53.18 1.62 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.735 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER 177.0 69.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.674 179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.75 109.93 0.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -67.63 162.65 55.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.773 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 18.1 Cg_endo -58.86 -18.21 40.79 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.313 2.009 . . . . 0.0 111.72 179.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.46 -60.53 3.72 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.679 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.867 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.2 m-85 -70.05 -45.22 67.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.841 0.353 . . . . 0.0 110.676 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -54.83 -20.48 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.55 -78.03 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.183 179.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -65.85 -52.32 38.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.466 -178.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.0 HD11 HD12 ' A' ' 92' ' ' ILE . 2.5 mp -80.2 37.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.402 0.62 . . . . 0.0 111.69 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' HG21 ' A' ' 15' ' ' VAL . 6.1 mttt -51.81 -50.1 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.71 38.89 1.67 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.255 -178.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.483 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.6 OUTLIER -125.95 10.56 7.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.577 -0.811 . . . . 0.0 111.86 -179.014 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -141.55 78.48 1.64 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.717 0.294 . . . . 0.0 111.227 -179.813 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.52 95.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.61 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.18 32.58 4.89 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.35 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.706 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -100.06 154.2 18.6 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.839 -0.213 . . . . 0.0 111.108 178.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -117.96 108.77 15.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' CE1' ' HB ' ' A' ' 92' ' ' ILE . 32.1 p90 -136.3 166.27 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 111.504 -178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 26.3 m -126.43 126.37 43.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.602 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -133.97 165.65 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.885 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.551 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.9 t70 -94.42 147.42 23.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.8 m -146.2 133.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.03 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 2.9 m -147.47 123.41 10.69 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.009 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CG ' HD21 ' A' ' 83' ' ' LEU . 6.2 m-85 -85.38 126.99 65.43 Favored Pre-proline 0 C--N 1.321 -0.661 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.401 -179.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.08 177.1 3.27 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.486 2.124 . . . . 0.0 112.906 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -73.18 -12.67 60.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.308 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.56 -31.19 21.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.068 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.1 t80 -68.68 -69.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.103 0.478 . . . . 0.0 110.258 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 19.9 m170 35.86 75.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -84.55 145.01 28.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.012 0.434 . . . . 0.0 110.413 178.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -50.12 -27.54 5.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -95.08 -37.03 11.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.863 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -135.16 18.03 3.43 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.323 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.99 123.27 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.603 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.22 52.52 39.88 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.646 179.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.18 90.4 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -78.14 96.94 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.691 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -135.8 -171.97 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.714 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 2.9 ttpt -126.17 140.3 52.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.704 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 15.4 m-30 -136.95 156.21 48.74 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 178.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.6 103.55 8.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 175.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD12 HD11 ' A' ' 59' ' ' ILE . 3.5 mt -102.19 159.97 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -174.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' GLU . 35.8 t-20 -135.5 104.07 5.7 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 113.951 -1.477 . . . . 0.0 108.572 177.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 23' ' ' ILE . 17.9 tp -66.41 157.85 30.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.893 -178.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -151.14 -104.98 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.254 179.509 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -73.92 103.05 4.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.736 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -111.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.406 178.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 8.3 mt-10 -123.66 -176.99 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.269 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 tm-20 -108.45 88.19 2.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 111.813 -179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -71.99 132.87 44.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.367 179.344 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.24 74.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 6.1 mp -74.07 -53.2 4.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 102' ' ' LEU . 56.3 Cg_endo -70.89 107.05 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.361 2.041 . . . . 0.0 112.287 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.28 131.04 36.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.0 177.62 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.661 -0.176 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -91.51 164.67 13.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -147.63 178.88 8.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 ptp -101.76 37.83 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.91 -60.73 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.58 152.5 30.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.05 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -114.91 135.3 54.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.877 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -139.9 154.18 47.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.442 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 33.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.762 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 2.2 pt-20 -70.03 134.06 47.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.08 -178.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -63.99 -158.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.002 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 22.18 7.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.716 0.293 . . . . 0.0 111.326 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.32 -157.48 21.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.737 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.67 -169.32 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.699 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.648 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.2 p -66.65 153.68 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.414 177.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 17' ' ' ALA . 3.8 mt-10 -135.07 160.37 38.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.96 -74.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.896 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 46' ' ' MET . 8.8 mt-10 -117.79 68.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.061 0.457 . . . . 0.0 110.942 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.961 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.54 -167.08 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.862 -178.949 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.863 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.0 115.84 6.82 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.534 179.427 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 97' ' ' VAL . 18.0 m -94.01 176.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.311 . . . . 0.0 111.422 178.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 88.9 m -121.75 114.51 21.19 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 94' ' ' LEU . 18.2 pt -130.2 151.55 36.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.629 ' HB3' ' O ' ' A' ' 40' ' ' SER . 5.6 p-10 -122.16 124.92 45.0 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.752 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.0 p90 -142.34 170.45 15.68 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -150.61 116.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.58 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -158.83 169.22 35.12 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.418 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -110.05 166.61 10.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.949 0.404 . . . . 0.0 111.571 -179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -96.04 -86.61 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.814 179.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.764 ' H ' HG13 ' A' ' 29' ' ' VAL . 2.0 p30 -94.86 43.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 109.984 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.38 -6.81 65.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.342 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -133.82 115.88 15.02 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.938 0.399 . . . . 0.0 110.513 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 2.4 pt-20 -60.31 115.75 3.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.231 0.539 . . . . 0.0 110.958 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -82.82 -134.19 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.635 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -69.85 -56.68 6.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.004 0.43 . . . . 0.0 110.762 179.324 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.93 16.05 13.38 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.881 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 27' ' ' GLY . . . -60.81 -10.56 19.57 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.93 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.14 123.88 8.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 110.816 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 145.38 50.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.175 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -115.8 -59.37 2.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.759 -179.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -103.17 70.6 1.07 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.738 ' HB3' HG13 ' A' ' 23' ' ' ILE . 10.7 t80 -92.98 104.88 17.06 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.981 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.4 p -79.78 98.3 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -89.62 135.5 33.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.994 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.72 104.54 16.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.337 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.725 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -69.9 81.62 0.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.61 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.74 67.51 0.74 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.75 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -123.9 -69.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.504 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.96 -56.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.997 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -177.8 67.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.907 0.384 . . . . 0.0 110.389 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.33 110.26 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.99 161.62 71.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.434 179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 19.7 Cg_endo -58.28 -21.06 50.53 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.209 1.939 . . . . 0.0 111.44 179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -66.95 -63.76 3.66 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.231 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.85 ' HA ' HD13 ' A' ' 59' ' ' ILE . 36.9 m-85 -69.62 -46.19 66.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.131 0.491 . . . . 0.0 110.368 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 2.4 tt0 -53.26 -22.54 7.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.085 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 38.2 t70 -80.38 -75.51 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -64.89 -55.78 20.25 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.37 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.012 HD11 HD12 ' A' ' 92' ' ' ILE . 2.6 mp -77.26 39.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.797 0.808 . . . . 0.0 110.727 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 3.9 mmtt -51.36 -53.3 37.64 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 175.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.775 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 41.66 1.31 Allowed Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.715 -178.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CD2' ' HG3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -128.9 15.39 6.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.279 -0.96 . . . . 0.0 112.114 -179.085 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 94' ' ' LEU . 32.3 mtmt -146.75 78.73 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.05 98.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.4 35.15 4.8 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 5.7 tp10 -99.21 163.02 12.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.607 0.242 . . . . 0.0 111.439 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB3' ' OD1' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -127.33 106.06 8.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.846 178.398 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 30.9 p90 -136.58 166.56 23.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.104 0.478 . . . . 0.0 111.383 -178.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 18.2 m -127.14 126.92 43.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.17 165.06 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.749 179.632 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.564 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 3.0 m-20 -94.81 149.58 21.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.136 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG21 ' CE2' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -146.62 134.42 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.058 178.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 87' ' ' ALA . 22.3 m -150.35 123.06 8.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.623 ' CD2' HD21 ' A' ' 83' ' ' LEU . 7.6 m-85 -84.55 130.12 54.71 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.707 0.289 . . . . 0.0 111.395 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.72 179.65 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.576 2.184 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.501 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 4.4 mm-40 -77.12 -3.23 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -92.15 -36.17 13.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.888 0.375 . . . . 0.0 110.847 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.503 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 2.8 t80 -64.38 -71.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 24.6 m170 39.52 70.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.925 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -82.33 146.53 29.35 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.057 0.456 . . . . 0.0 110.835 178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.92 -30.43 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.553 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -95.0 -34.14 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.925 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -135.21 14.9 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.088 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.4 OUTLIER -30.5 122.06 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.99 57.21 15.35 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.359 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.729 ' HE2' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -98.42 85.87 3.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.784 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.08 99.65 5.42 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -139.33 -172.49 3.36 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.709 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -128.0 139.13 52.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 113.712 -1.585 . . . . 0.0 107.702 178.702 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.818 ' CE2' HG21 ' A' ' 72' ' ' VAL . 10.4 m-30 -137.05 157.11 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.197 0.453 . . . . 0.0 112.029 178.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.92 104.03 8.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.012 HD12 HD11 ' A' ' 59' ' ' ILE . 3.4 mt -102.69 162.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -173.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.611 ' N ' HG22 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -135.44 104.69 5.93 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.902 177.742 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.992 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.3 tp -67.83 155.72 38.71 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.54 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 6.0 mmtt -148.16 -108.91 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -71.82 103.48 3.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.775 HG21 ' O ' ' A' ' 61' ' ' GLY . 1.5 p -110.51 108.05 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.885 178.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.0 mt-10 -134.85 169.64 17.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.039 -179.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -91.93 89.47 7.02 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.702 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.762 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -66.88 170.85 6.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.255 178.696 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.04 75.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.056 179.031 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.562 HD13 ' HD2' ' A' ' 100' ' ' ARG . 5.1 mp -75.62 129.32 81.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.069 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.71 127.81 13.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.469 2.113 . . . . 0.0 112.219 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -84.88 -57.8 2.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 mt -106.85 174.23 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.752 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.939 -179.935 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.92 145.09 34.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -81.23 153.72 27.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.94 89.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.691 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -96.32 157.93 15.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.42 145.7 45.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.095 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.2 m -126.55 143.09 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.439 ' CH2' HG21 ' A' ' 43' ' ' VAL . 53.8 m95 -140.96 161.58 37.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.201 0.524 . . . . 0.0 111.505 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -146.8 19.88 1.29 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 4.1 pt-20 -65.16 142.58 58.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.283 -178.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 27.9 pttt -68.68 -154.11 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.76 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 21.95 4.82 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.714 0.292 . . . . 0.0 111.653 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.498 ' H ' ' HG3' ' A' ' 11' ' ' LYS . . . -102.15 -160.7 26.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.586 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.89 -171.5 0.42 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 111.858 -179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -67.9 149.95 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.853 177.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 3.7 mt-10 -135.84 163.31 30.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.163 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.33 -72.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.515 -177.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 46' ' ' MET . 7.1 pt-20 -118.15 72.54 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 111.634 -179.17 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 99' ' ' GLU . 13.3 m-20 -100.58 -173.07 2.31 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.5 109.77 4.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 178.712 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.845 HG12 HG23 ' A' ' 97' ' ' VAL . 14.6 m -93.38 172.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.752 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 77.2 m -116.79 114.7 24.33 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.036 HG22 ' HA ' ' A' ' 94' ' ' LEU . 1.3 pt -130.7 151.08 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 40' ' ' SER . 3.5 p-10 -119.05 125.85 50.29 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.736 ' CB ' HG12 ' A' ' 92' ' ' ILE . 7.5 p90 -142.26 168.43 19.74 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -150.25 115.65 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -157.04 170.37 34.31 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.429 -179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -109.05 174.74 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.754 -179.604 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -119.69 -69.43 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.753 178.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 29' ' ' VAL . 4.3 t0 -95.68 37.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.7 62.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.782 -178.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.3 130.55 37.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.026 0.441 . . . . 0.0 110.736 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -57.5 119.98 7.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.114 -179.721 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 86' ' ' LYS . 6.1 p90 -83.45 -134.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.561 -179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.09 -54.7 11.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.083 0.468 . . . . 0.0 110.651 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.87 12.88 46.5 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.537 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.693 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -57.36 -10.09 5.23 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.01 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -148.59 134.11 18.66 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.092 0.473 . . . . 0.0 110.487 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.32 144.61 31.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.085 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -114.89 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 110.992 -179.641 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.82 70.48 1.11 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HD2' HD11 ' A' ' 23' ' ' ILE . 9.6 t80 -92.25 106.02 18.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.012 0.434 . . . . 0.0 110.021 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 ' HG2' ' A' ' 20' ' ' ARG . 14.0 p -79.55 100.1 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.763 HD12 HG21 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -91.93 135.5 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.277 -179.076 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . . . -99.47 105.37 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.333 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.592 ' HG3' HG21 ' A' ' 15' ' ' VAL . 5.9 mmm -69.45 78.97 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 70.48 0.95 Allowed Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.424 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -126.23 -64.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.73 0.3 . . . . 0.0 110.267 179.067 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.49 -55.85 1.0 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.984 179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.47 63.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.271 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -45.36 113.72 0.63 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.695 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' THR . 1.9 pt -68.24 155.7 91.72 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.0 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 10.7 Cg_endo -53.49 -19.77 14.32 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.946 2.431 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.593 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -73.6 -57.98 4.75 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.32 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' HA ' HD13 ' A' ' 59' ' ' ILE . 45.7 m-85 -69.82 -48.65 58.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.819 0.343 . . . . 0.0 110.928 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -53.36 -18.46 2.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -75.57 0.26 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.925 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -65.73 -55.4 20.18 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.291 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.075 HD11 HD12 ' A' ' 92' ' ' ILE . 3.0 mp -77.8 39.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-O 122.019 0.914 . . . . 0.0 110.789 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -51.95 -53.34 42.34 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 175.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.19 42.88 1.23 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.42 -178.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -126.97 12.59 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.337 -0.931 . . . . 0.0 112.314 -178.63 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 1.6 mttt -145.31 81.08 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.518 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.89 98.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.565 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.52 36.79 4.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.688 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 1.8 tp10 -98.41 169.15 9.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.057 0.456 . . . . 0.0 112.124 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 14.6 mt-10 -135.65 103.36 5.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.817 178.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 26.8 p90 -136.51 167.25 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 111.213 -178.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 56.8 m -126.73 129.07 47.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.685 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.07 167.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.061 0.458 . . . . 0.0 110.928 179.821 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.5 m-20 -92.59 149.07 21.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 90' ' ' PHE . 2.5 m -145.73 131.76 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.433 179.405 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' ALA . 20.6 m -148.36 122.24 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CD2' HD21 ' A' ' 83' ' ' LEU . 6.6 m-85 -85.44 128.43 59.33 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.8 0.334 . . . . 0.0 111.693 -179.043 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.38 -178.81 2.36 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.85 2.366 . . . . 0.0 113.103 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -76.62 -8.16 56.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.049 179.64 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -87.76 -36.99 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.043 0.449 . . . . 0.0 110.625 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.21 -69.82 0.29 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.374 179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 20.5 m170 35.69 66.5 0.34 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.634 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.841 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -76.19 140.04 41.5 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 121.074 0.464 . . . . 0.0 110.56 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.58 -24.79 1.45 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.16 -39.21 10.22 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.24 17.73 4.06 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.574 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -32.46 127.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.481 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.76 52.44 20.68 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.15 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.38 92.01 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.591 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.713 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -77.93 97.76 5.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 28' ' ' SER . . . -135.16 -171.0 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -177.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.742 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 4.5 mtmm -126.82 139.67 52.93 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.594 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.742 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.3 m-30 -136.75 153.82 50.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.14 103.39 8.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.075 HD12 HD11 ' A' ' 59' ' ' ILE . 3.3 mt -101.83 162.6 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' N ' HG22 ' A' ' 92' ' ' ILE . 23.9 m-20 -135.69 104.9 5.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.341 177.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.036 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -66.31 153.57 42.28 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -145.92 -108.69 0.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.996 179.478 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -73.78 103.31 4.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG23 HG12 ' A' ' 21' ' ' VAL . 1.7 p -109.42 109.02 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.589 178.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 11.5 mt-10 -131.15 172.61 11.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -93.75 86.39 5.11 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.983 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -64.9 157.53 27.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.174 178.789 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -167.71 71.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.347 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.657 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 6.4 mp -77.97 -52.17 1.61 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.252 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 24.1 Cg_exo -63.97 115.98 3.43 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.46 122.69 29.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.18 98.91 8.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.862 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.87 136.27 28.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.784 0.326 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -69.76 176.52 3.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttm -115.52 -55.26 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.92 141.88 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 153.17 28.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.021 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -110.81 142.04 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' CH2' ' HD3' ' A' ' 20' ' ' ARG . 54.6 m95 -142.42 160.92 39.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.178 0.513 . . . . 0.0 111.291 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 26.38 1.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.175 179.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.766 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -64.64 140.17 58.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.15 0.5 . . . . 0.0 112.119 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.979 ' HG2' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -66.34 -156.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.001 -179.41 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -129.48 19.95 5.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.49 -156.87 20.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.672 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.17 -172.43 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 111.904 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.652 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 7.5 p -67.58 153.35 8.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.818 177.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -135.33 160.27 38.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 178.246 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -21.29 -71.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.814 -178.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 46' ' ' MET . 12.7 pt-20 -118.49 67.71 0.77 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 111.634 -179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -100.96 -167.35 1.42 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.826 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -145.67 115.99 7.52 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 97' ' ' VAL . 32.8 m -94.14 172.31 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.737 179.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.8 m -121.01 113.5 20.17 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.005 HG22 ' HA ' ' A' ' 94' ' ' LEU . 8.7 pt -128.88 150.99 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.632 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -116.89 123.9 48.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.349 178.182 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CB ' HG12 ' A' ' 92' ' ' ILE . 6.4 p90 -141.99 165.56 27.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.8 m -151.01 115.61 5.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.813 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 90' ' ' PHE . . . -161.46 172.23 37.62 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.534 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.24 173.43 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 111.615 -179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 30' ' ' ASP . 2.0 p -111.96 -71.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.526 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.731 ' H ' HG13 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -95.71 34.79 1.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.361 . . . . 0.0 110.072 178.737 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.47 66.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.078 -179.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' C ' ' HB3' ' A' ' 28' ' ' SER . 13.3 mt-10 -132.85 118.88 19.5 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.958 0.408 . . . . 0.0 110.404 179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.736 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -56.92 118.16 4.68 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.925 -179.026 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -82.74 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.316 -178.544 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mt-10 -69.62 -55.49 9.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.005 0.431 . . . . 0.0 110.762 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.93 13.74 35.82 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.683 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -58.17 -11.5 9.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.428 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 122.61 9.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.119 0.485 . . . . 0.0 111.067 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.87 142.91 47.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -113.19 -58.95 2.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.82 -179.904 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -103.09 71.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.785 ' HB3' HG13 ' A' ' 23' ' ' ILE . 9.7 t80 -90.69 109.2 20.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.127 0.489 . . . . 0.0 110.062 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.826 HG12 ' HG2' ' A' ' 20' ' ' ARG . 43.7 t -84.45 97.48 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.761 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.53 133.04 34.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.275 -179.136 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' NE ' ' A' ' 20' ' ' ARG . . . -96.55 104.75 16.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.388 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.72 ' HB2' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -70.12 82.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.91 68.84 0.74 Allowed Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.666 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -70.07 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 110.197 179.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.16 -54.32 1.04 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.789 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 177.31 70.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 179.852 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -48.75 113.43 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.456 . . . . 0.0 110.997 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.995 HD11 HG13 ' A' ' 72' ' ' VAL . 1.2 pt -68.96 162.82 61.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.968 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 26.4 Cg_endo -61.74 -14.02 33.78 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.5 2.133 . . . . 0.0 112.198 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -76.84 -63.01 2.38 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.09 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.884 ' HA ' HD13 ' A' ' 59' ' ' ILE . 19.7 m-85 -67.24 -43.77 81.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.277 0.561 . . . . 0.0 110.006 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HA ' ' HE2' ' A' ' 46' ' ' MET . 2.8 tt0 -61.27 -14.24 24.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.973 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 23.5 t70 -78.91 -73.42 0.33 Allowed 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.793 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 68' ' ' PHE . . . -75.31 -47.79 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.439 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 92' ' ' ILE . 2.8 mp -77.48 39.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.906 0.86 . . . . 0.0 110.725 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.6 mmtt -52.0 -53.11 45.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.98 43.26 1.12 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 113.471 -1.695 . . . . 0.0 109.682 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.461 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -124.47 -14.95 6.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.199 -1.001 . . . . 0.0 112.257 -178.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mttp -116.88 80.51 1.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 0.0 110.726 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -60.18 96.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.417 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.478 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 102.56 37.31 3.29 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.345 179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.691 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.6 tp10 -98.27 168.33 10.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 0.0 112.416 -178.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 2.9 mp0 -135.79 105.71 6.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.371 178.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HZ ' HG13 ' A' ' 59' ' ' ILE . 34.6 p90 -136.85 167.06 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.089 0.471 . . . . 0.0 111.717 -178.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -124.1 114.74 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.888 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -129.78 164.17 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.843 179.587 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 9.9 t70 -95.57 151.67 19.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.995 HG13 HD11 ' A' ' 52' ' ' ILE . 12.1 t -146.88 133.11 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.721 0.295 . . . . 0.0 110.321 178.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 87' ' ' ALA . 6.0 m -147.24 124.97 11.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CD2' HD21 ' A' ' 83' ' ' LEU . 5.4 m-85 -84.86 130.64 51.89 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.737 0.303 . . . . 0.0 111.453 -179.087 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 77' ' ' GLU . 50.4 Cg_endo -69.65 174.73 8.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.673 2.249 . . . . 0.0 112.769 -179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.89 -12.55 61.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.397 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 3.2 pm0 -86.73 -30.47 21.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.276 . . . . 0.0 111.077 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CD1' ' HD2' ' A' ' 74' ' ' PHE . 5.4 t80 -70.41 -69.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.209 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 13.4 m170 33.62 79.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 179.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.65 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -87.95 147.47 25.03 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.015 0.436 . . . . 0.0 110.402 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.44 -26.43 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.588 ' ND2' HD12 ' A' ' 83' ' ' LEU . 1.1 p-10 -95.39 -39.39 10.04 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -133.98 17.93 3.81 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.037 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 10.0 pttm -32.67 127.88 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.25 54.56 15.13 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.694 -0.684 . . . . 0.0 113.533 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.81 85.76 3.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -75.8 95.78 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.2 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 29' ' ' VAL . . . -133.49 -170.31 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.424 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 9.7 mtmt -134.77 138.75 44.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.441 179.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -139.73 166.55 24.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 111.918 176.569 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -125.48 104.06 8.22 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 175.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 59' ' ' ILE . 4.5 mt -99.32 162.7 2.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -173.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.605 ' N ' HG22 ' A' ' 92' ' ' ILE . 3.3 m120 -134.72 104.76 6.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.36 177.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.005 ' HA ' HG22 ' A' ' 23' ' ' ILE . 15.5 tp -67.21 153.39 43.78 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.286 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HA ' ' N ' ' A' ' 65' ' ' GLY . 8.0 mtpp -149.29 -106.7 0.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.166 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -74.71 103.33 4.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.729 HG23 HG12 ' A' ' 21' ' ' VAL . 1.6 p -110.6 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CB ' ' HB2' ' A' ' 10' ' ' GLU . 2.5 mp0 -125.03 169.89 11.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 -179.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 34.8 mt-10 -94.29 86.56 4.95 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -69.59 160.59 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.415 178.605 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -165.32 67.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.04 0.447 . . . . 0.0 110.722 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.07 138.09 75.84 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.59 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.66 117.85 5.37 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.484 2.123 . . . . 0.0 112.256 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.52 109.61 19.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -160.1 -46.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.38 141.98 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.674 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 -44.84 1.81 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.437 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -81.95 104.56 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.979 0.418 . . . . 0.0 110.953 -179.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.11 147.79 49.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.072 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.11 146.96 44.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.846 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -143.74 164.75 29.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.147 0.498 . . . . 0.0 111.319 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -146.59 21.19 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.968 179.305 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 10.7 pt-20 -71.7 138.42 48.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.054 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' GLU . 4.1 pttt -66.67 -153.53 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.769 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.27 24.33 4.85 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.64 0.257 . . . . 0.0 111.64 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.25 -160.39 28.25 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.772 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.67 -172.88 0.68 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.984 0.421 . . . . 0.0 111.941 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.565 ' HB ' ' HA3' ' A' ' 61' ' ' GLY . 11.7 p -67.97 149.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.221 177.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 19' ' ' ASP . 4.9 mt-10 -136.06 164.06 28.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 16' ' ' GLU . . . -20.3 -73.95 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.448 -177.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' MET . 5.7 pt-20 -118.46 71.79 0.85 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.669 -0.412 . . . . 0.0 112.041 -178.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.677 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 5.2 m-20 -100.23 -172.09 2.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.687 ' HG2' HG12 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -142.47 115.08 8.56 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.28 179.224 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.884 HG21 ' CG2' ' A' ' 59' ' ' ILE . 27.9 m -93.76 168.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 122.633 0.373 . . . . 0.0 111.942 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 53.2 m -121.7 112.2 18.11 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.927 HG22 HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -130.38 154.62 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.026 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 40' ' ' SER . 4.0 p-10 -120.26 124.14 44.93 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.748 ' CB ' HG12 ' A' ' 92' ' ' ILE . 11.7 p90 -142.14 168.78 18.94 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 m -149.95 116.64 5.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.953 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 37' ' ' GLY . . . -161.39 161.91 33.43 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.108 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -107.55 175.0 5.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 87' ' ' ALA . 1.7 p -109.9 -76.11 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.921 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.0 t0 -95.69 35.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 110.206 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.76 -7.57 67.95 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.535 -179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' C ' ' HB3' ' A' ' 28' ' ' SER . 5.7 mt-10 -132.03 112.39 12.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.75 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 7.5 pt-20 -57.85 119.43 6.68 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.896 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -82.56 -137.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.72 -178.075 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 34' ' ' PHE . 2.0 mm-40 -70.25 -54.92 10.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.084 0.469 . . . . 0.0 110.165 178.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 12.56 34.69 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.346 179.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' GLU . . . -59.85 -10.41 13.5 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.802 179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 123.13 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.114 0.483 . . . . 0.0 110.48 179.254 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.23 146.05 51.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -113.57 -59.36 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.999 -179.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.09 70.75 1.09 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 23' ' ' ILE . 6.6 t80 -87.62 114.1 23.92 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.893 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG12 ' HG2' ' A' ' 20' ' ' ARG . 41.1 t -89.65 95.47 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -89.77 132.05 35.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.099 -179.456 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' A' ' 48' ' ' GLN . . . -96.14 104.53 16.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.129 179.15 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.829 ' HE1' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -68.8 86.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.935 0.398 . . . . 0.0 111.802 -179.189 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.52 54.78 0.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.635 179.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -132.22 -67.91 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 0.0 110.014 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -100.01 65.9 0.59 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.677 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 39.57 67.19 0.48 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.06 113.76 0.86 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.57 162.43 62.71 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.653 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.36 -19.27 50.13 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.22 1.947 . . . . 0.0 111.691 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 71' ' ' ASP . . . -69.14 -61.6 4.46 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.56 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 59' ' ' ILE . 57.5 m-85 -71.58 -44.89 63.68 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.43 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.829 ' HG3' ' HE1' ' A' ' 46' ' ' MET . 4.3 tt0 -52.83 -23.44 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.23 -75.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -63.62 -56.79 17.31 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.337 -178.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.976 HD11 HD12 ' A' ' 92' ' ' ILE . 3.2 mp -78.18 39.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.0 111.266 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -50.46 -52.55 37.02 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 97' ' ' VAL . . . 109.74 40.0 1.51 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 113.671 -1.604 . . . . 0.0 109.775 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.415 ' H ' ' HD2' ' A' ' 62' ' ' HIS . 0.4 OUTLIER -125.2 17.34 8.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.379 -0.911 . . . . 0.0 112.195 -179.126 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 69.6 mmtt -146.81 80.96 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.852 0.358 . . . . 0.0 111.283 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LYS . . . -59.92 93.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.38 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 95' ' ' LYS . . . 103.8 38.17 2.81 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.087 179.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -98.36 168.65 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 1.2 pm0 -135.78 100.45 4.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.58 178.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' HE2' ' HB2' ' A' ' 94' ' ' LEU . 34.2 p90 -133.97 167.05 21.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.136 0.493 . . . . 0.0 111.783 -178.146 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 15.9 m -125.34 126.44 45.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.736 179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -134.16 167.37 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.388 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -94.13 147.63 22.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -144.48 131.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 179.11 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 87' ' ' ALA . 17.2 m -150.77 122.02 7.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CG ' HD21 ' A' ' 83' ' ' LEU . 5.9 m-85 -84.91 133.25 43.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -178.12 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.723 2.282 . . . . 0.0 112.921 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 1.5 mt-10 -77.13 -14.17 59.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.218 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -86.58 -32.75 20.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.385 -179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.468 ' CG ' ' HD2' ' A' ' 74' ' ' PHE . 4.6 t80 -65.78 -71.1 0.2 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 84' ' ' LYS . 25.5 m170 37.12 76.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -83.83 146.7 27.97 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.4 -31.04 8.78 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -95.29 -35.46 11.79 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.681 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.895 ' CD1' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.89 17.99 3.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.69 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -33.93 125.91 0.44 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.59 53.47 20.83 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.337 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.659 ' CE ' ' HB3' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -99.09 95.62 7.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.908 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -83.36 94.22 7.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.678 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . . . -130.62 -174.55 3.39 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.724 ' O ' ' HD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -123.91 138.52 54.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.888 178.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.724 ' HD1' ' O ' ' A' ' 89' ' ' LYS . 14.7 m-30 -136.83 154.1 50.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' THR . . . -124.62 103.91 8.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 175.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.976 HD12 HD11 ' A' ' 59' ' ' ILE . 2.4 mt -103.4 163.42 3.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 -174.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.607 ' N ' HG22 ' A' ' 92' ' ' ILE . 24.4 m-80 -135.4 104.72 5.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 177.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.927 HD12 HG22 ' A' ' 23' ' ' ILE . 13.6 tp -65.05 154.37 38.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 7.3 mtpm? -148.58 -105.22 0.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.026 179.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.06 103.03 5.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 61' ' ' GLY . 2.0 p -111.81 106.52 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.44 178.036 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.677 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 3.2 mt-10 -121.76 -171.31 2.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.418 -178.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 2.4 tm-20 -114.39 87.68 2.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.887 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -70.54 153.32 43.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 179.222 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.43 63.78 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.711 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 5.6 mp -74.44 -55.55 2.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.46 -179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 102' ' ' LEU . 56.6 Cg_endo -70.56 121.08 7.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.249 1.966 . . . . 0.0 112.476 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -98.04 -60.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.737 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.47 88.94 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.029 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.927 179.843 . . . . . . . . 1 1 . 1 stop_ save_